Processing 00000000.tx.1: Acidic and neutral sialidase in the erythrocyte membrane of type 2diabetic patients Bruno Venerando, Amelia Fiorilli, Gianluigi Croci, Cristina Tringali, Giancarlo Goi, Laura Mazzanti, Giovanna Curatola, Giovanni Segalini, Luca Massaccesi, Adriana Lombardo, and Guido Tettamanti From the Department of Medical Chemistry and Biochemistry School of Medicine, University of Milan; 

Phrase: "Acidic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001128:Acidic [Chemical]
   928 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "neutral sialidase in the erythrocyte membrane of type 2diabetic patients Bruno Venerando,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   751   C1417682:SIALIDASE, MEMBRANE [Gene or Genome]
   736   C0027803:Sialidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Amelia Fiorilli,"

Phrase: "Gianluigi Croci,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0376238:Crocus [Plant]

Phrase: "Cristina Tringali,"

Phrase: "Giancarlo Goi,"

Phrase: "Laura Mazzanti,"

Phrase: "Giovanna Curatola,"

Phrase: "Giovanni Segalini,"

Phrase: "Luca Massaccesi,"

Phrase: "Adriana Lombardo,"

Phrase: "and"

Phrase: "Guido Tettamanti From the Department of Medical Chemistry"

Phrase: "and"

Phrase: "Biochemistry School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0036375:School [Manufactured Object,Organization]

Phrase: "University of Milan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: ";"
Processing 00000000.tx.2: Diabetic Unit of Bassini HospitalCinisello Balsamo; 

Phrase: "Diabetic Unit of Bassini HospitalCinisello Balsamo"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439148:Unit [Quantitative Concept]
   753   C1519795:Unit [Quantitative Concept]
   753   C1704753:Unit [Manufactured Object]
   753   C1880519:Unit [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.3: both of Milan, Italy; 

Phrase: "both of Milan,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0238767:Both [Spatial Concept]
   790   C1706086:Both [Qualitative Concept]

Phrase: "Italy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]

Phrase: ";"
Processing 00000000.tx.4: and Institute of Biochemistry, School of Medicine, University of Ancona, Italy.  

Phrase: "and"

Phrase: "Institute of Biochemistry,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021622:institute [Organization]
   790   C1272753:Institute [Idea or Concept]

Phrase: "School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0036375:School [Manufactured Object,Organization]

Phrase: "University of Ancona,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0041740:University [Manufactured Object,Organization]

Phrase: "Italy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]
Processing 00000000.tx.5: Abstract Top Abstract Introduction Patients, materials, and... 

Phrase: "Abstract Top Abstract Introduction Patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030705:Patients [Patient or Disabled Group]

Phrase: "materials,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and..."
Processing 00000000.tx.6: Results Discussion References The behavior of the 2sialidase forms present in the erythrocyte membrane was investigated in 117subjects with type 2diabetes mellitus versus 95healthy controls. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The behavior of the 2sialidase forms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0004927:Behavior [Individual Behavior]
   753   C2707008:Behavior [Clinical Attribute]

Phrase: "present in the erythrocyte membrane"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0014780:Erythrocyte Membrane [Cell Component]
   760   C0014792:Erythrocyte [Cell]
   760   C0025255:Membrane [Tissue]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "was"

Phrase: "investigated in 117subjects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1292732:investigated [Functional Concept]

Phrase: "with type 2diabetes mellitus"

Phrase: "versus"

Phrase: "95healthy controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.7: A significant increase of the acidic form of sialidase, which is anchored to the membrane by a glycosylphosphatidylinositol bridge, was observed in erythrocyte resealed membranes. 

Phrase: "A significant increase of the acidic form of sialidase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "which"

Phrase: "is"

Phrase: "anchored to the membrane"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   881   C1622010:anchored to membrane [Cell Component]
   770   C0025255:Membrane [Tissue]
   770   C0596901:Membrane [Cell Component]
   770   C1293132:anchored [Therapeutic or Preventive Procedure]
   770   C1706182:Membrane [Manufactured Object]

Phrase: "by a glycosylphosphatidylinositol bridge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0456378:Bridge [Medical Device]

Phrase: "was"

Phrase: "observed in erythrocyte"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0014792:Erythrocyte [Cell]
   790   C1441672:Observed [Functional Concept]

Phrase: "resealed"

Phrase: "membranes."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.8: On the contrary, the neutral form of the enzyme, the only one capable of removing lipid- and protein-bound sialic acid from endogenous and exogenous sialoderivatives, was significantly reduced with a consequent increase of erythrocyte membrane total sialic acid content. 

Phrase: "On the contrary,"

Phrase: "the neutral form of the enzyme,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "the only one capable of removing lipid-"

Phrase: "and"

Phrase: "protein-bound sialic acid from endogenous"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0067762:Sialic Acid [Biologically Active Substance,Carbohydrate]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "exogenous sialoderivatives,"

Phrase: "was"

Phrase: "significantly"

Phrase: "reduced with a consequent increase of erythrocyte membrane total sialic acid content."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   753   C0014780:Erythrocyte Membrane [Cell Component]
   753   C0067762:Sialic Acid [Biologically Active Substance,Carbohydrate]
   736   C0001128:Acid [Chemical]
   736   C0014792:Erythrocyte [Cell]
   736   C0025255:Membrane [Tissue]
   736   C0202406:Acid [Laboratory Procedure]
   736   C0392756:Reduced [Qualitative Concept]
   736   C0423896:Content [Mental Process]
   736   C0439175:% total [Quantitative Concept]
   736   C0439810:Total [Qualitative Concept]
   736   C0442805:Increase [Functional Concept]
   736   C0456205:Content [Conceptual Entity]
   736   C0596901:Membrane [Cell Component]
   736   C1706182:Membrane [Manufactured Object]
   715   C0686907:Consequence of [Functional Concept]
Processing 00000000.tx.9: Disease duration, therapy, glycemia, parameters of metabolic control, and presence of complications, except nephropathies, had no influence on the tested enzyme activities. 

Phrase: "Disease duration,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0872146:disease duration [Temporal Concept]
   861   C0449238:Duration [Temporal Concept]
   861   C2926735:Duration [Pharmacologic Substance]

Phrase: "therapy,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039798:therapy [Functional Concept]
  1000   C0087111:Therapy [Therapeutic or Preventive Procedure]
  1000   C1363945:Therapy [Finding]

Phrase: "glycemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005802:glycemia [Carbohydrate]

Phrase: "parameters of metabolic control,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0449381:Parameters [Finding]
   737 E C0549193:Parameter [Spatial Concept]
   737 E C1704769:Parameter [Conceptual Entity]
   737 E C2350001:Parameter [Quantitative Concept]

Phrase: "and"

Phrase: "presence of complications,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]

Phrase: "except nephropathies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022658:nephropathies [Disease or Syndrome]

Phrase: "had"

Phrase: "no influence on the tested enzyme activities."
Processing 00000000.tx.10: Diabetic subjects showed a different erythrocyte age distribution, with an almost double proportion of young red cells and only one quarter of senescent ones compared with controls. 

Phrase: "Diabetic subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a different erythrocyte age distribution,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0001782:Age Distribution [Quantitative Concept]
   812   C0001779:Age [Organism Attribute]
   812   C0520511:distribution [Idea or Concept]
   812   C1704711:Distribution [Functional Concept]

Phrase: "with an almost"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "proportion of young red cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709707:Proportion [Quantitative Concept]

Phrase: "and"

Phrase: "only one quarter of senescent ones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C2825406:Quarter [Quantitative Concept]
   753   C2986716:QUARTER [Body Part, Organ, or Organ Component]

Phrase: "compared with controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.11: In young erythrocytes, diabetic and control subjects had the same distribution of the 2enzymes, while in senescent cells the acidic enzyme was increased 3.5-fold and the neutral form was reduced by half in the diabetic subjects. 

Phrase: "In young erythrocytes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014772:Erythrocytes [Laboratory Procedure]
   861   C0014792:Erythrocytes [Cell]

Phrase: "diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "had"

Phrase: "the same distribution of the 2enzymes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "while in senescent cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0750519:while [Idea or Concept]
   770   C3282337:Cells [Cell]
   767   C0007581:Cell Senescence [Cell Function]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "the acidic enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "3.5-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C0442758:3 5 [Quantitative Concept]

Phrase: "and"

Phrase: "the neutral form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "was"

Phrase: "reduced by half"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0392756:Reduced [Qualitative Concept]
   790   C2825407:Half [Quantitative Concept]

Phrase: "in the diabetic subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.12: The increase of both acidic sialidase and total membrane-bound sialic acid, together with an overpresence of young red cells in diabetics, suggests that in this pathological condition there might be an altered aging process with a diminished expression of the neutral form of the enzyme and an increase of bound sialic acid. 

Phrase: "The increase of both acidic sialidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "total membrane-bound sialic acid,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0067762:Sialic Acid [Biologically Active Substance,Carbohydrate]
   804   C0001128:Acid [Chemical]
   804   C0202406:Acid [Laboratory Procedure]
   748   C0036087:Salivas [Body Substance]
   748   C1546769:Saliva [Intellectual Product]
   748   C1608524:Saliva [Body Substance]

Phrase: "together with an overpresence"

Phrase: "of young red cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0014792:Red cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0332575:Red [Finding]
   827   C1260956:Red [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "in diabetics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:diabetics [Finding]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that in this pathological condition there"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0012634:condition [Disease or Syndrome]
   753   C0030664:Pathological [Biomedical Occupation or Discipline]
   753   C0348080:Condition [Qualitative Concept]
   753   C1521733:Pathological [Functional Concept]
   753   C1705253:Condition [Conceptual Entity]

Phrase: "might"

Phrase: "be"

Phrase: "an altered aging process with a diminished expression of the neutral form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1510835:Aging Process [Organism Function]
   736   C1184743:Process [Body Part, Organ, or Organ Component]
   736   C1522240:Process [Phenomenon or Process]

Phrase: "of the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "an increase of bound sialic acid."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]
Processing 00000000.tx.13: It has been suggested that the expression of the neutral enzyme requires some activation mechanism that is impaired in diabetes. 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the expression of the neutral enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "requires"

Phrase: "some activation mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "is"

Phrase: "impaired in diabetes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C0221099:Impaired [Functional Concept]
   790   C0684336:Impaired [Pathologic Function]
Processing 00000000.tx.14: (Blood. 

Phrase: "(Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.15: 2002;99:1064-1070)  2002 by The American Society of Hematology.  

Phrase: "2002"

Phrase: ";99"

Phrase: ":"

Phrase: "1064-1070"

Phrase: ")"

Phrase: "2002 by The American Society of Hematology."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C1515949:American Society of Hematology [Professional Society]
   748   C0018943:Haematology NOS [Biomedical Occupation or Discipline]
   748   C0037455:society [Organization]
   748   C0200627:HEMATOLOGY [Laboratory Procedure]
   748   C0596070:American [Population Group]
Processing 00000000.tx.16: Introduction Top Abstract Introduction Patients, materials, and... 

Phrase: "Introduction Top Abstract Introduction Patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030705:Patients [Patient or Disabled Group]

Phrase: "materials,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and..."
Processing 00000000.tx.17: Results Discussion References Alterations in the sialic acid content of different tissues in patients with both type 1and 2of diabetes mellitus have been reported.1-3 However, while an increase in the sialic acid content of plasma has been consistently observed,4-6 conflicting results have been obtained with regard to different tissues from diabetic patients: most investigators have observed a decrease,1,7,8 while others have observed an increase9 or no difference at all.10 As to the erythrocyte membrane, where sialic acid plays an important role in the maintenance of red cell structure, permeability, integrity, viability, and survival in circulating blood11-13 and where it is physiologically decreased during aging, the effect of the diabetic condition is yet unclear.14 To date, little information is available on the possible involvement of sialidase in diabetic disease.1,15-17 This enzyme is present in the erythrocytes, as opposed to other cell types, only at the plasma membrane level together with different sialoderivatives. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alterations in the sialic acid content of different tissues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1515926:Alteration [Idea or Concept]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with both type 1and 2of diabetes mellitus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C1320657:type diabetes [Finding]
   840   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   804   C0011847:Diabetes [Disease or Syndrome]

Phrase: "have"

Phrase: "been"

Phrase: "reported.1-3 However,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0684224:Reported [Intellectual Product]
   812   C0700287:Reported [Health Care Activity]
   812   C3496591:Reported [Clinical Attribute]
   779 E C3273238:Report [Intellectual Product]

Phrase: "while"

Phrase: "an increase in the sialic acid content of plasma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "consistently"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "4-6 conflicting results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1274040:Result [Functional Concept]
   779   C1546471:Result [Idea or Concept]
   779   C2825142:Result [Finding]

Phrase: "have"

Phrase: "been"

Phrase: "obtained with regard to different tissues"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0040300:Tissues [Tissue]
   753   C1301820:Obtained [Functional Concept]
   753   C1705242:Different [Qualitative Concept]
   719 E C1547928:Tissue [Intellectual Product]
   719 E C1706701:Obtain [Activity]

Phrase: "from diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: ":"

Phrase: "most investigators"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035173:Investigators [Professional or Occupational Group]

Phrase: "have"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a decrease,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "7,"

Phrase: "8"

Phrase: "while"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "have"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "an increase9"

Phrase: "or"

Phrase: "no difference at all.10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "As to the erythrocyte membrane,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0014780:Erythrocyte Membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "where sialic acid"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0067762:Sialic Acid [Biologically Active Substance,Carbohydrate]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
   771   C0036087:Salivas [Body Substance]
   771   C1546769:Saliva [Intellectual Product]
   771   C1608524:Saliva [Body Substance]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an important role in the maintenance of red cell structure,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]

Phrase: "permeability,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031164:Permeability [Natural Phenomenon or Process]
   928 E C0205326:Permeable [Functional Concept]

Phrase: "integrity,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205266:integrity [Qualitative Concept]
  1000   C0872403:integrity [Individual Behavior]
  1000   C1947912:Integrity [Qualitative Concept]

Phrase: "viability,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443348:viability [Qualitative Concept]

Phrase: "and"

Phrase: "survival in circulating blood11-13"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]

Phrase: "and"

Phrase: "where"

Phrase: "it"

Phrase: "is"

Phrase: "physiologically"

Phrase: "decreased during aging,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0001811:Ageing [Organism Function]
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: "the effect of the diabetic condition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "yet unclear.14 To date,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0011008:Date [Temporal Concept]
   760   C2348077:Date [Food]

Phrase: "little information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1533716:Information [Idea or Concept]
   789 E C3242430:informational [Idea or Concept]

Phrase: "is"

Phrase: "available on the possible involvement of sialidase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0470187:Available [Functional Concept]
           Availability of

Phrase: "in diabetic disease.1,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   873   C1425075:MALS-1 [Gene or Genome]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0241863:DIABETIC [Finding]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "15-17"

Phrase: "This enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "is"

Phrase: "present in the erythrocytes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "as"

Phrase: "opposed to other cell types,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0449475:Cell types [Intellectual Product]
   773 E C0007634:Cell Type [Cell]
           Cell
   760   C0332307:Types [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C1547052:*Type [Quantitative Concept]

Phrase: "only at the plasma membrane level"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0007603:Plasma membrane [Cell Component]
   753   C0025255:Membrane [Tissue]
   753   C0032105:Plasma [Body Substance]
   753   C0205171:Only [Quantitative Concept]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C0596901:Membrane [Cell Component]
   753   C1547707:Level [Geographic Area]
   753   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   753   C1706182:Membrane [Manufactured Object]
   753   C1720467:Only [Intellectual Product]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "together with different sialoderivatives."
Processing 00000000.tx.18: Recent studies have shown that the erythrocyte plasma membrane is characterized by the presence of 2different forms of sialidase having optimal pH in the acidic and neutral range, respectively, and also differing both in terms of membrane anchoring modalities and interaction with endogenous substrates.18,19 Because of recent reports on the involvement of several erythrocyte membrane glycohydrolases in the diabetic pathological process,20 and in an attempt to contribute to the understanding of this very important and controversial issue, we performed several experiments in subjects with type 2diabetes with the following objectives: (a) to detect a possible relationship between erythrocyte membrane sialic acid content and the variation in activity of the 2sialidase forms; 

Phrase: "Recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the erythrocyte plasma membrane"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   913   C0014780:Erythrocyte Membrane [Cell Component]
   901   C0007603:Plasma membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0032105:Plasma [Body Substance]
   827   C0596901:Membrane [Cell Component]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "is"

Phrase: "characterized by the presence of 2different"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1880022:Characterized [Activity]

Phrase: "forms of sialidase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0027803:Sialidase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0348078:Form [Qualitative Concept]
   790   C0376315:Form [Manufactured Object]
   790   C1522492:Form [Functional Concept]

Phrase: "having"

Phrase: "optimal pH in the acidic"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0020283:[pH] [Quantitative Concept]
   760   C0450407:ph+ [Finding]
   760   C0450408:ph++ [Finding]
   760   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "neutral range,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]

Phrase: "respectively,"

Phrase: "and"

Phrase: "also"

Phrase: "differing"

Phrase: "both in terms of membrane anchoring modalities"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   748   C0025255:Membrane [Tissue]
   748   C0238767:Both [Spatial Concept]
   748   C0596901:Membrane [Cell Component]
   748   C0695347:modalities [Idea or Concept]
   748   C1293132:Anchoring [Therapeutic or Preventive Procedure]
   748   C1624581:anchoring [Molecular Function]
   748   C1706086:Both [Qualitative Concept]
   748   C1706182:Membrane [Manufactured Object]
   714   C1515273:Term [Temporal Concept]
   714 E C1547664:Modality [Diagnostic Procedure]
   714   C1705313:Term [Idea or Concept]
   714   C2826302:TERM [Intellectual Product]

Phrase: "and"

Phrase: "interaction with endogenous substrates.18,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1515033:Substrate Interaction [Molecular Function]
   760   C1704675:Interaction [Functional Concept]

Phrase: "19 Because of recent reports"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0332185:Recent [Temporal Concept]
   760   C0684224:Reports [Intellectual Product]
   760   C0700287:reports [Health Care Activity]
   726 E C3273238:Report [Intellectual Product]

Phrase: "on the involvement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involvement [Functional Concept]

Phrase: "of several erythrocyte membrane glycohydrolases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017976:Glycohydrolases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "in the diabetic pathological process,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0030660:Pathological process [Pathologic Function]
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "20"

Phrase: "and in an attempt to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1515981:And [Idea or Concept]
   760   C1516084:Attempt [Event]

Phrase: "contribute to the understanding of this very important"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0162340:Understanding [Mental Process]
   744   C0442824:Very [Qualitative Concept]
   744   C1880177:Contribute [Activity]

Phrase: "and"

Phrase: "controversial issue,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033213:Issue [Finding]
   861   C1706387:Issue [Intellectual Product]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "several experiments in subjects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0681814:Experiments [Research Activity]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "with type 2diabetes"

Phrase: "with the following objectives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0018017:objectives [Intellectual Product]
   827 E C1571702:Objective [Qualitative Concept]

Phrase: ":"

Phrase: "(a) to"

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "a possible relationship between erythrocyte membrane sialic acid content"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0439849:Relationship [Qualitative Concept]
   742   C1705630:Relationship [Idea or Concept]
   742   C1706279:Relationship [Idea or Concept]
   742   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "the variation in activity of the 2sialidase forms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205419:Variation [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.19: (b) to verify the possible impact of metabolic control, disease duration, therapy, and complications on the sialic acid-sialidase system; 

Phrase: "(b) to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "the possible impact of metabolic control,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1825598:IMPACT [Gene or Genome]

Phrase: "disease duration,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0872146:disease duration [Temporal Concept]
   861   C0449238:Duration [Temporal Concept]
   861   C2926735:Duration [Pharmacologic Substance]

Phrase: "therapy,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039798:therapy [Functional Concept]
  1000   C0087111:Therapy [Therapeutic or Preventive Procedure]
  1000   C1363945:Therapy [Finding]

Phrase: "and"

Phrase: "complications on the sialic acid-sialidase system"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0009566:Complications [Pathologic Function]
   748   C1171258:complications [Pathologic Function]
   714 E C2362589:Complication [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.20: (c) given the important role of sialic acid in erythrocyte aging, to investigate if mean erythrocyte age is modified by the diabetic condition and, secondarily, to verify in both healthy and diabetic subjects the content of the 2sialidases in erythrocytes of different ages; 

Phrase: "(c)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the important role of sialic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in erythrocyte aging,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014768:Erythrocyte Aging [Cell Function]
   861   C0001811:Ageing [Organism Function]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "if"

Phrase: "mean erythrocyte age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0001779:Age [Organism Attribute]

Phrase: "is"

Phrase: "modified by the diabetic condition"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0205349:Modified By [Qualitative Concept]
   760   C0012634:condition [Disease or Syndrome]
   760   C0241863:DIABETIC [Finding]
   760   C0348080:Condition [Qualitative Concept]
   760   C0392747:Modified [Functional Concept]
   760   C1705253:Condition [Conceptual Entity]

Phrase: "and"

Phrase: ","

Phrase: "secondarily,"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "verify in both healthy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1711411:Verify [Functional Concept]

Phrase: "and"

Phrase: "diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "the content of the 2sialidases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0423896:Content [Mental Process]
   760   C0456205:Content [Conceptual Entity]

Phrase: "in erythrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014772:Erythrocytes [Laboratory Procedure]
  1000   C0014792:Erythrocytes [Cell]

Phrase: "of different ages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: ";"
Processing 00000000.tx.21: and (d) considering the important biophysical and biochemical modifications occurring in the erythrocyte membrane in diabetes,21-23 to evaluate possible changes affecting the 2sialidase forms of the erythrocyte membrane.  

Phrase: "and ("

Phrase: "d)"

Phrase: "considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considering [Idea or Concept]

Phrase: "the important biophysical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005553:Biophysical [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "biochemical modifications"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392747:Modification [Functional Concept]
   827   C1554963:modification [Qualitative Concept]

Phrase: "occurring in the erythrocyte membrane"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0014780:Erythrocyte Membrane [Cell Component]
   760   C0014792:Erythrocyte [Cell]
   760   C0025255:Membrane [Tissue]
   760   C0596901:Membrane [Cell Component]
   760   C1706182:Membrane [Manufactured Object]
   726   C1709305:Occur [Activity]
   726   C2745955:OCCUR [Temporal Concept]

Phrase: "in diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "21-23 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450348:23 [Quantitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "possible changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the 2sialidase"

Phrase: "forms of the erythrocyte membrane."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0014780:Erythrocyte Membrane [Cell Component]
   760   C0014792:Erythrocyte [Cell]
   760   C0025255:Membrane [Tissue]
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C0596901:Membrane [Cell Component]
   760   C1522492:Form [Functional Concept]
   760   C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.22: Patients, materials, and methods Top Abstract Introduction Patients, materials, and... 

Phrase: "Patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "materials,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Top Abstract Introduction Patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030705:Patients [Patient or Disabled Group]

Phrase: "materials,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and..."
Processing 00000000.tx.23: Results Discussion References Materials Commercial chemicals were of the highest grade available. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Materials Commercial chemicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0220806:Chemicals [Chemical]
   793 E C3272558:Chemical [Intellectual Product]

Phrase: "were of the highest"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1522410:Highest [Qualitative Concept]
   737 E C0205250:High [Qualitative Concept]
   737 E C1299351:High [Qualitative Concept]
   737 E C2700149:HIGH [Intellectual Product]

Phrase: "grade"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441800:Grade [Classification]
  1000   C0919553:Grade [Classification]
  1000   C3244287:grade [Finding]

Phrase: "available."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470187:Available [Functional Concept]
Processing 00000000.tx.24: Recombinant phosphatidylinositol-specific phospholipase C (PIPLC) from Bacillus thuringiensis (2000U/mg) was purchased from Oxford Glyco System (Abingdon, United Kingdom); 

Phrase: "Recombinant phosphatidylinositol-specific phospholipase C (PIPLC) from Bacillus thuringiensis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0089795:Phosphatidylinositol-Specific Phospholipase C [Amino Acid, Peptide, or Protein,Enzyme]
           Phosphatidylinositol phospholipase C
   833   C1335226:PHOSPHOLIPASE C, PHOSPHATIDYLINOSITOL-SPECIFIC [Gene or Genome]
   793   C0136864:Phosphatidylinositol Phospholipase C [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0031669:Phospholipase C [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   744   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205369:Specific [Qualitative Concept]
   744   C1552740:specific [Intellectual Product]
   744   C2348046:Phosphatidylinositol [Lipid]

Phrase: "(2000U/mg)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "was"

Phrase: "purchased from Oxford Glyco System"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0449913:System [Functional Concept]
   760   C0869011:purchased [Activity]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]

Phrase: "(Abingdon,"

Phrase: "United Kingdom"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041700:United Kingdom [Geographic Area]
   861   C1708611:Kingdom [Classification]
   827   C0166872:unite [Biomedical or Dental Material]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.25: 4-methylumbelliferone (MU), 4-methylumbelliferyl -N-acetyl-D-neuraminic acid (MU-NeuAc), N-acetyl-D-neuraminic acid (NeuAc), creatine hydrate, crystalline bovine serum albumin (BSA), N-2-hydroxyethylpiperazine-N-2-ethane sulfonic acid (HEPES), and Percoll were from Sigma Chemical (St Louis, MO). 

Phrase: "4-methylumbelliferone (MU),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020411:4-Methylumbelliferone [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
           Methylumbelliferone

Phrase: "4-methylumbelliferyl -N-acetyl-D-neuraminic acid (MU-NeuAc),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   818   C0027801:Neuraminic acid [Biologically Active Substance,Carbohydrate]
   795   C0001128:Acid [Chemical]
   795   C0202406:Acid [Laboratory Procedure]

Phrase: "N-acetyl-"

Phrase: "D-"

Phrase: "neuraminic acid (NeuAc),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027801:Neuraminic acid [Biologically Active Substance,Carbohydrate]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "creatine hydrate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0720930:hydrate [Organic Chemical,Pharmacologic Substance]

Phrase: "crystalline bovine serum albumin (BSA),"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   861   C0728877:serum albumin [Laboratory or Test Result]
   812   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0007452:Bovine [Mammal]
   812   C0229671:Serum [Body Substance]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "N-2-hydroxyethylpiperazine-N-2-ethane sulfonic acid (HEPES),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   878   C2825385:HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   812   C0038762:sulfonic acid [Inorganic Chemical]
   793   C0001128:Acid [Chemical]
   793   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "Percoll"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070386:Percoll [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "were from Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1719918:Sigma [Intellectual Product]

Phrase: "Chemical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220806:Chemical [Chemical]
  1000   C3272558:Chemical [Intellectual Product]

Phrase: "(St Louis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.26: Dowex 2X8 resin (200to 400mesh) was obtained from Bio-Rad Laboratories (Richmond, VA). 

Phrase: "Dowex 2X8 resin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035191:Resin [Biomedical or Dental Material]

Phrase: "(200to 400mesh"

Phrase: ")"

Phrase: "was"

Phrase: "obtained from Bio-Rad Laboratories"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0022877:Laboratories [Manufactured Object,Organization]
   760   C1301820:Obtained [Functional Concept]
   760   C1619828:Laboratories [Intellectual Product]
   726 E C1706701:Obtain [Activity]
   726 E C3244292:laboratory [Functional Concept]

Phrase: "(Richmond,"

Phrase: "VA)."
Processing 00000000.tx.27: Water doubly distilled in a glass apparatus was used to prepare the different solutions. 

Phrase: "Water doubly"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0599638:WATER [Substance]
   861   C1550678:Water [Inorganic Chemical]
   789 E C0443350:Watery [Qualitative Concept]

Phrase: "distilled in a glass apparatus"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0017596:Glass [Manufactured Object]
   760   C0243111:apparatus [Manufactured Object]
   760   C0681549:distilled [Occupational Activity]
   760   C1947936:Glass [Medical Device]
   760   C1947951:Apparatus [Anatomical Structure]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prepare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521827:Prepare [Functional Concept]

Phrase: "the different solutions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0037633:Solutions [Substance]
   827 E C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.28: Subjects A total of 117type 2diabetic patients were selected from the diabetes outpatient clinic of the Bassini Hospital of Cinisello Balsamo (Milan, Italy) and from the Department of Diabetology, Italian National Research Center on Aging (Ancona, Italy). 

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "A total of 117type 2diabetic patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]

Phrase: "were"

Phrase: "selected from the diabetes outpatient clinic of the Bassini Hospital of Cinisello Balsamo"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   763   C0029916:hospital outpatient clinic [Health Care Related Organization,Manufactured Object]
   750   C0002424:Outpatient Clinic [Health Care Related Organization,Manufactured Object]
           Clinic
   749   C0587906:Hospital clinic [Health Care Related Organization,Manufactured Object]
   735   C0011847:Diabetes [Disease or Syndrome]
   735   C0011849:Diabetes [Disease or Syndrome]
   735   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   735   C0029921:Out-patient [Patient or Disabled Group]
   735   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   735   C1510665:Hospital [Qualitative Concept]
   735   C1548439:Outpatient [Idea or Concept]
   735   C1549405:Outpatient [Classification]
   702   C1707391:Select [Activity]

Phrase: "(Milan,"

Phrase: "Italy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]

Phrase: ")"

Phrase: "and from the Department of Diabetology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1441552:Diabetology [Diagnostic Procedure]
   753   C1515981:And [Idea or Concept]
   753   C1704729:Department [Organization]

Phrase: "Italian National Research Center on Aging"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0683939:research center [Manufactured Object,Organization]
   753   C0205099:Center [Spatial Concept]

Phrase: "(Ancona,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445432:Ancona [Intellectual Product]

Phrase: "Italy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]

Phrase: ")."
Processing 00000000.tx.29: The disease was diagnosed according to World Health Organization criteria.24 Some patients with good metabolic control (glycated hemoglobin [HbA1c] 7.0%) had received no pharmacologic treatment according to the American Diabetes Association guidelines for diabetes treatment 25; 

Phrase: "The disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "was"

Phrase: "diagnosed according to World Health Organization criteria.24"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   800   C0043237:World Health Organization [Health Care Related Organization]
   770   C0043236:World Health [Idea or Concept]
   770   C0920545:health organization [Health Care Related Organization]
   744   C0011900:Diagnosed [Finding]
   744   C0018684:Health [Idea or Concept]
   744   C0029237:Organisation [Physiologic Function]
   744   C0029246:Organization [Organization]
   744   C0220885:organization [Qualitative Concept]
   744   C0243161:criteria [Intellectual Product]
   744   C0680240:according [Social Behavior]
   744   C1300196:Organization [Functional Concept]
   744   C1522486:Organization [Professional or Occupational Group]
   744   C2700280:World [Population Group]

Phrase: "Some patients with good metabolic control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030705:Patients [Patient or Disabled Group]

Phrase: "(glycated hemoglobin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017853:Glycated haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0019046:Haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[HbA1c"

Phrase: "] 7.0%"

Phrase: ")"

Phrase: "had"

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "no pharmacologic treatment according to the American Diabetes Association guidelines"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   757   C0746919:NO TREATMENT [Finding]
   757   C0935576:treatment guidelines [Therapeutic or Preventive Procedure]
   757   C3275118:NO TREATMENT [Finding]
   739   C0039798:treatment [Functional Concept]
   739   C0087111:Treatment [Therapeutic or Preventive Procedure]
   739   C1522326:Treatment [Functional Concept]
   739   C1533734:Treatment [Therapeutic or Preventive Procedure]
   739   C1705169:Treatment [Conceptual Entity]
   739   C3538994:TREATMENT [Research Activity]
   710   C0013216:Pharmacological Treatment [Therapeutic or Preventive Procedure]

Phrase: "for diabetes treatment 25"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: ";"
Processing 00000000.tx.30: others had been treated with oral hypoglycemic drugs and/or insulin. 

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "had"

Phrase: "been"

Phrase: "treated with oral hypoglycemic drugs"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0020616:Hypoglycemic Drugs [Pharmacologic Substance]
           Hypoglycaemic
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   806   C0359086:Oral hypoglycaemic [Pharmacologic Substance]
   760   C0013227:Drugs [Pharmacologic Substance]
   760   C0442027:Oral [Spatial Concept]
   760   C1522326:Treated [Functional Concept]
   726 E C1254351:Drug [Pharmacologic Substance]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "and/or"

Phrase: "insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.31: All patients were on an appropriate diet. 

Phrase: "All patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "were on an appropriate diet."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0012155:Diet [Food]
   760   C1442959:Diet [Organism Function]
   760   C1519433:DIET [Therapeutic or Preventive Procedure]
   760   C1548787:Appropriate [Qualitative Concept]
   760   C2983588:DIET [Food]
Processing 00000000.tx.32: Thyroid, renal, and liver function tests were normal. 

Phrase: "Thyroid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040132:Thyroid, NOS [Body Part, Organ, or Organ Component]

Phrase: "renal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022646:Renal [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "liver function tests"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
  1000   C0023901:Liver Function Tests [Laboratory Procedure]
           liver tests
   901   C0232741:Liver function [Organ or Tissue Function]
   827   C0022885:Tests [Laboratory Procedure]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0031843:function [Physiologic Function]
   827   C0392366:Tests [Intellectual Product]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C1705273:Function [Intellectual Product]
   827   C2346688:LIVER [Food]
   793 E C0039593:Test [Functional Concept]
   771 E C0205054:Hepatic [Body Location or Region]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "were"

Phrase: "normal."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.33: Diabetic complications were evaluated through medical history, clinical examination, fundoscopy, electrocardiogram, large-vessel Doppler ultrasonography, proteinuria and microalbuminuria, electromyography, and tests for the detection of autonomic neuropathy. 

Phrase: "Diabetic complications"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0342257:Diabetic Complications [Pathologic Function]
   861   C0009566:Complications [Pathologic Function]
   861   C1171258:complications [Pathologic Function]
   827 E C2362589:Complication [Idea or Concept]
   777 E C0231242:Complicated [Functional Concept]

Phrase: "were"

Phrase: "evaluated through medical history,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0262926:Medical History [Finding]
           History
   833   C1704706:Medical History [Idea or Concept]
   770   C0019664:History [Occupation or Discipline]
   770   C0019665:history [Intellectual Product]
   770   C0205476:Medical [Functional Concept]
   770   C0220825:Evaluated [Functional Concept]
   770   C0262512:History, NOS [Organism Attribute]
   770   C1705255:History [Conceptual Entity]
   770   C2004062:History [Finding]

Phrase: "clinical examination,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031809:Clinical examination [Health Care Activity]
   861   C0205210:Clinical [Qualitative Concept]

Phrase: "fundoscopy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029090:Fundoscopy [Diagnostic Procedure]

Phrase: "electrocardiogram,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013798:Electrocardiogram [Finding]
  1000   C1547122:Electro-Cardiogram [Spatial Concept]
  1000   C1623258:Electrocardiogram [Diagnostic Procedure]
  1000   C1705651:Electrocardiogram [Idea or Concept]

Phrase: "large-vessel Doppler ultrasonography,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0242837:Ultrasonography, Doppler [Diagnostic Procedure]
   812   C0041618:Ultrasonography [Diagnostic Procedure]
   812   C0175676:ultrasonography [Diagnostic Procedure]
   812   C0554756:Doppler [Diagnostic Procedure]

Phrase: "proteinuria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033687:Proteinuria [Finding]
  1000   C1962972:Proteinuria [Finding]

Phrase: "and"

Phrase: "microalbuminuria,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "electromyography,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013839:Electromyography [Diagnostic Procedure]
   900 E C0180677:Electromyographs [Medical Device]

Phrase: "and"

Phrase: "tests for the detection of autonomic neuropathy."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0259749:Autonomic neuropathy [Disease or Syndrome]
   748   C0004388:Autonomic [Body System]
   748   C0022885:Test [Laboratory Procedure]
   748   C0039593:Test [Functional Concept]
   748   C0392366:Tests [Intellectual Product]
   748   C0442874:Neuropathy [Disease or Syndrome]
   748   C1511790:Detection [Therapeutic or Preventive Procedure]
Processing 00000000.tx.34: Supine blood pressure was recorded and hypertension defined as systolic blood pressure above 160mm Hg and/or diastolic blood pressure above 90mm Hg and/or if patients were on antihypertensive treatment. 

Phrase: "Supine blood pressure"
Meta Candidates (Total=16; Excluded=7; Pruned=0; Remaining=9)
   901   C0005823:Blood Pressure [Organism Function]
   901   C1271104:Blood Pressure [Finding]
   901   C1272641:Blood pressure [Finding]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0033095:Pressure [Phenomenon or Process]
   827   C0229664:Blood [Body Substance]
   827   C0460139:Pressure [Finding]
   827   C1306345:Pressure [Functional Concept]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "recorded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]

Phrase: "and"

Phrase: "hypertension"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020538:Hypertension [Disease or Syndrome]
  1000   C1963138:Hypertension [Finding]

Phrase: "defined as systolic blood pressure"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   862   C0488055:Systolic blood pressure [Clinical Attribute]
   862   C0871470:Systolic blood pressure [Clinical Attribute]
           Systolic Pressure
   862   C1306620:systolic blood pressure [Diagnostic Procedure]
   806   C0005823:Blood Pressure [Organism Function]
   806   C1271104:Blood Pressure [Finding]
   806   C1272641:Blood pressure [Finding]
   760   C0005767:Blood [Tissue]
   760   C0005768:blood [Body Substance]
   760   C0033095:Pressure [Phenomenon or Process]
   760   C0039155:Systolic [Temporal Concept]
   760   C0229664:Blood [Body Substance]
   760   C0460139:Pressure [Finding]
   760   C1306345:Pressure [Functional Concept]
   760   C1704788:Defined [Conceptual Entity]
   760   C3539106:Defined [Intellectual Product]

Phrase: "above 160mm Hg"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0025424:Hg [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   861   C2347108:Hg+ [Element, Ion, or Isotope]
   861   C2347109:Hg++ [Element, Ion, or Isotope]
   861   C2348272:Hg [Element, Ion, or Isotope]

Phrase: "and/or"

Phrase: "diastolic blood pressure above 90mm Hg"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0428883:Diastolic blood pressure [Clinical Attribute]
           Diastolic Pressure
   833   C1305849:diastolic blood pressure [Diagnostic Procedure]
   790   C0005823:Blood Pressure [Organism Function]
   790   C1271104:Blood Pressure [Finding]
   790   C1272641:Blood pressure [Finding]
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0012000:Diastolic [Clinical Attribute]
   753   C0033095:Pressure [Phenomenon or Process]
   753   C0229664:Blood [Body Substance]
   753   C0460139:Pressure [Finding]
   753   C1306345:Pressure [Functional Concept]

Phrase: "and/or"

Phrase: "if"

Phrase: "patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "were on antihypertensive treatment."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0003364:Antihypertensive [Pharmacologic Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.35: Height and weight were measured and body mass index calculated. 

Phrase: "Height"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0489786:Height [Organism Attribute]
   928 E C0205250:High [Qualitative Concept]
   928 E C1299351:High [Qualitative Concept]
   928 E C1522410:Highest [Qualitative Concept]
   928 E C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "weight"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005910:weight [Organism Attribute]
  1000   C0043100:Weight [Quantitative Concept]
  1000   C1305866:weight [Diagnostic Procedure]
  1000   C1705104:Weight [Idea or Concept]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "body mass index"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0005893:Body Mass Index [Diagnostic Procedure]
  1000   C1305855:Body mass index [Clinical Attribute]
   901   C0518010:body mass [Finding]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C0577559:Mass [Finding]
   827   C0918012:Index [Intellectual Product]
   827   C1268086:Body [Anatomical Structure]
   827   C1306372:*Mass [Quantitative Concept]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]
   743 E C1995017:Bodies [Cell Component]

Phrase: "calculated."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]
Processing 00000000.tx.36: Ninety-five controls were selected from apparently healthy adult subjects who had entered the Laboratory of Clinical Chemistry and Microbiology of the Bassini Hospital for scheduled hematochemical follow-up evaluations. 

Phrase: "Ninety-five controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "selected from apparently healthy adult subjects"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   790   C0686750:Healthy adult [Finding]
   783   C1708335:HEALTHY SUBJECTS [Population Group]
   753   C0001675:Adult [Age Group]
   753   C0750541:apparently [Idea or Concept]
   753   C1706450:Adult [Human]
   748 E C1552227:Adult Health [Intellectual Product]
   748 E C1552259:Adult Health [Professional or Occupational Group]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C1707391:Select [Activity]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "who"

Phrase: "had"

Phrase: "entered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521975:Entered [Qualitative Concept]
   966 E C1522196:ENTER [Functional Concept]

Phrase: "the Laboratory of Clinical Chemistry"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0151339:Laboratory: chemistry [Laboratory Procedure]
   760   C0022877:Laboratory [Manufactured Object,Organization]
   760   C3244292:laboratory [Functional Concept]

Phrase: "and"

Phrase: "Microbiology of the Bassini Hospital"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025952:Microbiology [Biomedical Occupation or Discipline]
   760   C0025953:microbiology [Intellectual Product]
   760   C0085672:Microbiology [Laboratory Procedure]

Phrase: "for scheduled hematochemical follow-up evaluations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0220825:Evaluations [Functional Concept]
   771 E C1261322:Evaluation [Health Care Activity]
Processing 00000000.tx.37: None of these subjects had signs of metabolic, endocrinologic, or hemolytic diseases; 

Phrase: "None of these subjects"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "had"

Phrase: "signs of metabolic, endocrinologic,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0220912:signs [Functional Concept]
   770   C0220913:signs [Manufactured Object]
   770   C0311392:SIGNS [Finding]
   737 E C1547188:Sign [Idea or Concept]

Phrase: "or"

Phrase: "hemolytic diseases"
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   983   C1263988:Haemolytic disease NOS [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   861   C0312853:Haemolytic [Qualitative Concept]
   861   C2945560:Hemolytic [Laboratory or Test Result]
   789 E C0019054:HAEMOLYSIS [Pathologic Function]
   789 E C1630417:% haemolysis [Quantitative Concept]
   789 E C1836721:MALS [Finding]
   789 E C2937287:Haemolysis [Cell Function]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.38: hemoglobinopathies; 

Phrase: "hemoglobinopathies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019045:Hemoglobinopathies [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.39: major organ diseases; 

Phrase: "major organ diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0012634:Diseases [Disease or Syndrome]
   755 E C1836721:MALS [Finding]
   755 E C3538764:MALS [Gene or Genome]
   755 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.40: or a positive family history for diabetes. 

Phrase: "or"

Phrase: "a positive family history for diabetes."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0241889:Family history [Finding]
   790   C1705495:Family History [Idea or Concept]
   753   C0015576:Family [Family Group]
   753   C0019664:History [Occupation or Discipline]
   753   C0019665:history [Intellectual Product]
   753   C0262512:History, NOS [Organism Attribute]
   753   C0262926:History [Finding]
   753   C1704727:Family [Conceptual Entity]
   753   C1705255:History [Conceptual Entity]
   753   C2004062:History [Finding]
Processing 00000000.tx.41: Although appropriate for comparison with diabetic subjects, the control group was significantly different in terms of mean age. 

Phrase: "Although"

Phrase: "appropriate for comparison"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1548787:Appropriate [Qualitative Concept]
   718 E C0814634:appropriateness [Qualitative Concept]

Phrase: "with diabetic subjects,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "the control group"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0009932:Control Group [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "significantly different in terms of mean age."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705242:Different [Qualitative Concept]
   738   C0699810:age difference [Age Group]
Processing 00000000.tx.42: All the subjects gave their informed consent for blood drawing. 

Phrase: "All"

Phrase: "the subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "their informed consent for blood drawing."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0021430:Informed Consent [Regulation or Law]
   753   C1511481:Consent [Functional Concept]
   753   C1522154:Informed [Qualitative Concept]
   753   C1554192:consent [Idea or Concept]
   719 E C0537670:Inform [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   719 E C0700287:inform [Health Care Activity]
   719 E C1552002:inform [Idea or Concept]
Processing 00000000.tx.43: The main characteristics of the study population are shown in Table 1.  

Phrase: "The main characteristics of the study population"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0032661:Population Characteristics [Group Attribute]
   774   C1568011:Study Characteristics [Intellectual Product]
   748   C1521970:Characteristics [Qualitative Concept]

Phrase: "are"

Phrase: "shown in Table 1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.44: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.45: Main characteristics of the subjects considered in the study Blood collection and red cell separation Blood samples were obtained by vein puncture from both healthy adult donors and diabetic patients and processed immediately. 

Phrase: "Main characteristics of the subjects"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C0681884:subject characteristics [Research Activity]
   781   C1519021:Subject Characteristics [Organism Attribute]
   781   C1706465:Subject Characteristics [Idea or Concept]
   760   C1521970:Characteristics [Qualitative Concept]

Phrase: "considered in the study Blood collection"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0229664:Blood [Body Substance]
   753   C0557651:Study [Manufactured Object]
   753   C0750591:considered [Idea or Concept]
   753   C1516698:Collection [Functional Concept]
   753   C1704814:Collection [Idea or Concept]
   753   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "red cell separation Blood samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0178913:blood samples [Body Substance]
   771   C0370003:Sample [Substance]
   771   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "obtained by vein puncture"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0600406:vein puncture [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C0033119:Puncture [Finding]
   770   C0034117:Puncture [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C0042449:Vein [Body Part, Organ, or Organ Component]
   770   C1278960:Vein [Body Part, Organ, or Organ Component]
   770   C1301820:Obtained [Functional Concept]
   770   C1881711:PUNCTURE [Phenomenon or Process]
   737 E C1706701:Obtain [Activity]

Phrase: "from both healthy adult donors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0013018:Donors [Population Group]
   827   C1527169:Donors [Finding]
   793 E C0040288:Donor [Population Group]
   734   C0686750:Healthy adult [Finding]

Phrase: "and"

Phrase: "diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "immediately."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]
Processing 00000000.tx.46: Heparin was used as anticoagulant. 

Phrase: "Heparin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "was"

Phrase: "used as anticoagulant."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   841   C0238662:ANTICOAGULANT USE [Finding]
   790   C0003280:Anticoagulant [Pharmacologic Substance]
   790   C0848112:anti coagulant [Therapeutic or Preventive Procedure]
   790   C1273517:used [Finding]
   790   C3536711:Anti-coagulant [Pharmacologic Substance]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.47: Erythrocytes from controls and diabetic patients were separated from leukocytes and platelets by filtration through a column of -cellulose and microcrystalline cellulose (2:1 by weight) according to the method of Beutler26 in HEPES-buffered isotonic saline: 133mM NaCl, 4.5mM KCl, 10mM HEPES, pH 7.4.

Phrase: "Erythrocytes from controls"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0014772:Erythrocytes [Laboratory Procedure]
   790   C0014792:Erythrocytes [Cell]

Phrase: "and"

Phrase: "diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "separated from leukocytes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0023516:Leukocytes [Cell]
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]

Phrase: "and"

Phrase: "platelets by filtration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0005821:Platelets [Cell]
   790   C1963076:Platelets [Finding]

Phrase: "through a column of -cellulose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]

Phrase: "and"

Phrase: "microcrystalline cellulose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0669247:microcrystalline cellulose [Biomedical or Dental Material,Carbohydrate,Pharmacologic Substance]
  1000   C3255827:micro-crystalline cellulose [Pharmacologic Substance]
   861   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
   861   C3255829:microcrystalline [Pharmacologic Substance]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "1 by weight"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0005910:weight [Organism Attribute]
   790   C0043100:Weight [Quantitative Concept]
   790   C1305866:weight [Diagnostic Procedure]
   790   C1705104:Weight [Idea or Concept]
   790   C2827734:1+ [Quantitative Concept]
   790   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "according to the method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "of Beutler26"

Phrase: "in HEPES-buffered isotonic saline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   807   C0445115:Isotonic saline [Inorganic Chemical,Pharmacologic Substance]
   791   C0036082:Saline [Substance]

Phrase: ":"

Phrase: "133mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "4.5mM KCl,"

Phrase: "10mM HEPES,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   895   C2825385:HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   818   C0038762:sulfonic acid [Inorganic Chemical]
   795   C0001128:Acid [Chemical]
   795   C0202406:Acid [Laboratory Procedure]

Phrase: "pH 7.4."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.48: The hematocrit of the filtered blood was adjusted to approximately 30% and the suspensions stored at 4C until used. 

Phrase: "The hematocrit of the filtered blood"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0018935:Haematocrit [Laboratory Procedure]
   753   C0518014:Haematocrit [Laboratory or Test Result]

Phrase: "was"

Phrase: "adjusted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456081:Adjusted [Functional Concept]

Phrase: "to approximately 30%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332232:Approximately [Qualitative Concept]
   827   C1883351:To [Qualitative Concept]

Phrase: "and"

Phrase: "the suspensions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0038960:Suspensions [Biomedical or Dental Material]
   966 E C1382107:Suspension [Substance]
   966 E C1705537:Suspension [Functional Concept]

Phrase: "stored at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450376:4c [Intellectual Product]
   756   C1698986:Store [Functional Concept]

Phrase: "until"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.49: Cell counts were performed in a Burker chamber (PBI International, Milan, Italy). 

Phrase: "Cell counts"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007584:Counts, Cell [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0439157:counts [Quantitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C0750480:Count [Activity]
   827 E C1705566:Count [Quantitative Concept]

Phrase: "were"

Phrase: "performed in a Burker chamber"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0884358:Performed [Functional Concept]
   760   C0935616:Chamber [Body Part, Organ, or Organ Component]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(PBI International, Milan,"

Phrase: "Italy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]

Phrase: ")."
Processing 00000000.tx.50: Preparation of discontinuous Percoll gradients Human erythrocytes of different biological age, from both controls and diabetic patients, were separated as described by Salvo et al27 and following the modifications suggested by Mosca et al.28 Briefly, the following solutions were prepared at 26C: HEPES-buffered stock solution (HBS stock): 2.66M NaCl, 0.09M KCl, 0.2M HEPES, pH 7.4; 

Phrase: "Preparation of discontinuous Percoll gradients Human erythrocytes of different biological age,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0455052:Preparation [Health Care Activity]
   738   C1521827:Preparation [Functional Concept]

Phrase: "from both controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "diabetic patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "separated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086972:Separated [Finding]
  1000   C0443299:separated [Spatial Concept]
  1000   C0687118:Separated [Functional Concept]

Phrase: "as"

Phrase: "described by Salvo et al27"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the modifications"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0392747:Modification [Functional Concept]
   966   C1554963:modification [Qualitative Concept]

Phrase: "suggested by Mosca et al.28 Briefly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1705535:Suggest [Idea or Concept]

Phrase: "the following solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0037633:Solutions [Substance]
   827 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "were"

Phrase: "prepared at 26C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1521827:Prepare [Functional Concept]

Phrase: ":"

Phrase: "HEPES-buffered stock solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0037633:Solution [Substance]
   791   C0525069:Solution [Biomedical or Dental Material]

Phrase: "(HBS stock"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710198:Stock [Idea or Concept]

Phrase: ")"

Phrase: ":"

Phrase: "2.66M NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.09M KCl,"

Phrase: "0.2M HEPES,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   878   C2825385:HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   812   C0038762:sulfonic acid [Inorganic Chemical]
   793   C0001128:Acid [Chemical]
   793   C0202406:Acid [Laboratory Procedure]

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ";"
Processing 00000000.tx.51: solution A (BSA-HEPES-buffered solution, pH 7.4): 19volumes of 5.25% (w/v) BSA in water solution added to 1volume of HBS-stock solution; 

Phrase: "solution A (BSA-HEPES-buffered solution,"

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ":"

Phrase: "19volumes of 5.25%"

Phrase: "(w/v"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0560267:%W/V [Quantitative Concept]

Phrase: ")"

Phrase: "BSA in water solution"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   833   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   790   C0728877:serum albumin [Laboratory or Test Result]
   783   C0359180:Albumin solution [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   783 E C0523465:Albumin - serum [Laboratory Procedure]
   753   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0007452:Bovine [Mammal]
   753   C0229671:Serum [Body Substance]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]

Phrase: "added to 1volume of HBS-stock solution"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0019043:HbS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0037633:Solution [Substance]
   748   C0525069:Solution [Biomedical or Dental Material]
   748   C1524062:Added [Functional Concept]
   748   C1710198:Stock [Idea or Concept]
   714 E C1883712:Add [Functional Concept]

Phrase: ";"
Processing 00000000.tx.52: solution B (BSA-Percoll-HEPES-buffered solution, pH 7.4): 19volumes of 5.25% (w/v) BSA in Percoll added to 1volume of HBS-stock solution. 

Phrase: "solution B (BSA-Percoll-HEPES-buffered solution,"

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ":"

Phrase: "19volumes of 5.25%"

Phrase: "(w/v"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0560267:%W/V [Quantitative Concept]

Phrase: ")"

Phrase: "BSA in Percoll"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   862   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   806   C0728877:serum albumin [Laboratory or Test Result]
   797 E C0523465:Albumin - serum [Laboratory Procedure]
   760   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0007452:Bovine [Mammal]
   760   C0229671:Serum [Body Substance]
   760   C1140701:bovine [Mammal]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]

Phrase: "added to 1volume of HBS-stock solution."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0019043:HbS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0037633:Solution [Substance]
   748   C0525069:Solution [Biomedical or Dental Material]
   748   C1524062:Added [Functional Concept]
   748   C1710198:Stock [Idea or Concept]
   714 E C1883712:Add [Functional Concept]
Processing 00000000.tx.53: Solutions A and B were filtered through 0.45m cellulose acetate filters and mixed to form 5solutions at final "Percoll" concentrations of 60%, 66%, 70%, 74%, and 80% (vol/vol; density 1.087-1.098g/mL, pH 7.4). 

Phrase: "Solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0037633:Solutions [Substance]
   966 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "were"

Phrase: "filtered through 0.45m cellulose acetate filters"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0050505:cellulose acetate [Biomedical or Dental Material,Carbohydrate,Indicator, Reagent, or Diagnostic Aid]
   748   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   748   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
   748   C1442463:45M [Temporal Concept]
   714   C0180860:Filter [Manufactured Object]
   714   C0581406:Filter [Medical Device]
   714   C1522664:Filter [Intellectual Product]
   714   C1704449:Filter [Conceptual Entity]
   714   C1704684:Filter [Medical Device]
   714   C1875155:FILTER [Medical Device]

Phrase: "and"

Phrase: "mixed"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205430:Mixed [Functional Concept]
  1000   C3160715:Mixed [Finding]
   966 E C1421951:MIX [Gene or Genome]
   966 E C1720722:Mix [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "5solutions at final ""Percoll"" concentrations of 60%,"

Phrase: "66%,"

Phrase: "70%,"

Phrase: "74%,"

Phrase: "and"

Phrase: "80%"

Phrase: "(vol/vol"

Phrase: "; density 1.087-1.098g/mL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0439526:/mL [Quantitative Concept]

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.54: Discontinuous 5-step gradients were prepared by overlayering 1.0mL of 80%, 8.0mL of 74%, 8.0mL of 70%, 8.0mL of 66%, and 4.0mL of 60% of Percoll concentration using a peristalting pump in 36mL tubes. 

Phrase: "Discontinuous 5-step gradients"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0812409:gradients [Quantitative Concept]
   779 E C0439182:% gradient [Quantitative Concept]

Phrase: "were"

Phrase: "prepared by overlayering 1.0mL of 80%,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1521827:Prepare [Functional Concept]

Phrase: "8.0mL of 74%,"

Phrase: "8.0mL of 70%,"

Phrase: "8.0mL of 66%,"

Phrase: "and"

Phrase: "4.0mL of 60% of Percoll concentration"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a peristalting pump in 36mL tubes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0182537:Pump [Medical Device]
   753   C1706421:Pump [Manufactured Object]
Processing 00000000.tx.55: The same discontinuous Percoll gradient was successfully applied for diabetic patient erythrocyte separation. 

Phrase: "The same discontinuous Percoll gradient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439182:% gradient [Quantitative Concept]
   812   C0812409:Gradient [Quantitative Concept]

Phrase: "was"

Phrase: "successfully"

Phrase: "applied for diabetic patient erythrocyte separation."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0014792:Erythrocyte [Cell]
   753   C0030705:*^patient [Patient or Disabled Group]
   753   C0036679:Separation [Pathologic Function]
   753   C0185125:Applied [Health Care Activity]
   753   C0237868:Separation [Social Behavior]
   753   C0241863:DIABETIC [Finding]
   753   C1881713:SEPARATION [Phenomenon or Process]
   719 E C1632850:Apply [Functional Concept]
   719 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.56: Fractionation of erythrocytes according to biological age This study was performed on 10healthy subjects (mean age 469 years) and 10diabetic patients (mean age 4713 years; fasting blood glucose 10.111.1 mM/L; HbA1c 7.9%2.6%) who were part of the study population. 

Phrase: "Fractionation of erythrocytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0016640:fractionation [Laboratory Procedure]
   790   C0524811:fractionation [Therapeutic or Preventive Procedure]
   790   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "according to biological age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "performed on 10healthy subjects"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0884358:Performed [Functional Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(mean age 469 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   875   C1510829:Age-Years [Temporal Concept]
   812   C0439234:years [Temporal Concept]
   779 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "10diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "(mean age 4713 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   875   C1510829:Age-Years [Temporal Concept]
   812   C0439234:years [Temporal Concept]
   779 E C0439508:/year [Temporal Concept]

Phrase: "; fasting blood glucose 10.111.1 mM/L"

Phrase: "; HbA1c 7.9%2.6%"

Phrase: ")"

Phrase: "who"

Phrase: "were"

Phrase: "part of the study population."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1292711:Part of [Spatial Concept]
   760   C0449719:Part [Spatial Concept]
   760   C1709471:Part [Quantitative Concept]
Processing 00000000.tx.57: Four tubes containing 4.0mL each of filtered blood (hematocrit 30%, corresponding to 20 109-24109 cells per tube) in 10mM HEPES buffer, pH 7.4,containing 133mM NaCl, 4.5mM KCl, were layered on the discontinuous gradient. 

Phrase: "Four tubes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0175730:tubes [Medical Device]
   861   C1547937:Tubes [Intellectual Product]
   861   C1704474:Tubes [Quantitative Concept]
   827 E C1561954:tube [Conceptual Entity]
   827 E C1704730:TUBE [Medical Device]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "4.0mL"

Phrase: "each of filtered blood"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   816   C0180863:filter blood [Medical Device]
   770   C0005767:Blood [Tissue]
   770   C0005768:blood [Body Substance]
   770   C0229664:Blood [Body Substance]
   770   C1457900:Each [Quantitative Concept]
   752 E C0336600:Vascular filter [Medical Device]
   737   C0180860:Filter [Manufactured Object]
   737   C0581406:Filter [Medical Device]
   737   C1522664:Filter [Intellectual Product]
   737   C1704449:Filter [Conceptual Entity]
   737   C1704684:Filter [Medical Device]
   737   C1875155:FILTER [Medical Device]

Phrase: "(hematocrit 30%,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0018935:Haematocrit [Laboratory Procedure]
   861   C0518014:Haematocrit [Laboratory or Test Result]

Phrase: "corresponding to 20 109-24109 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "per tube"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0175730:Tube [Medical Device]
  1000   C1547937:Tube NOS [Intellectual Product]
  1000   C1561954:tube [Conceptual Entity]
  1000   C1704730:TUBE [Medical Device]

Phrase: ")"

Phrase: "in 10mM HEPES buffer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   711   C2825385:HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "133mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "4.5mM KCl,"

Phrase: "were"

Phrase: "layered on the discontinuous gradient."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0439182:% gradient [Quantitative Concept]
   760   C0439599:Discontinuous [Temporal Concept]
   760   C0812409:Gradient [Quantitative Concept]
   760   C0934502:Layered [Body Part, Organ, or Organ Component]
   760   C1444662:Discontinuous [Finding]
   726 E C1522408:Layer [Qualitative Concept]
   726 E C1561599:Layer [Intellectual Product]
Processing 00000000.tx.58: In parallel, the fractionation was performed using a buffer with high content of KCl (133mM) and low content of NaCl (4.5mM), according to the indications of Sorette.29 Centrifugation was carried out in a swing-out rotor at 2000g for 15minutes at 20C. 

Phrase: "In parallel,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C2348042:Parallel [Qualitative Concept]
   861   C2826345:PARALLEL [Research Activity]

Phrase: "the fractionation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016640:fractionation [Laboratory Procedure]
  1000   C0524811:fractionation [Therapeutic or Preventive Procedure]
  1000   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a buffer with high content of KCl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(133mM"

Phrase: ")"

Phrase: "and"

Phrase: "low content of NaCl (4.5mM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "according to the indications"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0392360:Indications [Idea or Concept]
   966 E C3146298:Indication [Functional Concept]

Phrase: "of Sorette.29 Centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in a swing-out rotor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439787:Out [Spatial Concept]
   753   C0849355:Out [Qualitative Concept]

Phrase: "at 2000g"

Phrase: "for 15minutes"

Phrase: "at 20C."
Processing 00000000.tx.59: The centrifuge was slowly decelerated over 3minutes to prevent gradient disturbance. 

Phrase: "The centrifuge"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0179834:centrifuge [Medical Device]

Phrase: "was"

Phrase: "slowly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439834:Slowly [Qualitative Concept]

Phrase: "decelerated over 3minutes to"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "gradient disturbance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2699787:Disturbance [Qualitative Concept]
Processing 00000000.tx.60: The plasma (about 1.5mL) remaining above the gradient was removed, and all cell fractions were collected manually over the liquid interface by aspiration from the top of the gradient using a Pasteur pipette attached to a peristalting pump (about 26fractions, usually 1.2mL for tube). 

Phrase: "The plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "(about 1.5mL"

Phrase: ")"

Phrase: "remaining above the gradient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1527428:Remaining [Qualitative Concept]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "all cell fractions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0805525:Cell fractions [Cell Component]
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "manually over the liquid interface"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0302908:Liquid [Substance]
   760   C1304698:Liquid [Finding]
   760   C1546699:Liquid NOS [Intellectual Product]
   760   C1561501:Liquid NOS [Substance]
   760   C1708533:Interface [Manufactured Object]
   760   C2698172:Interface [Intellectual Product]

Phrase: "by aspiration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0220787:Aspiration [Health Care Activity]
  1000   C0349707:Aspiration [Therapeutic or Preventive Procedure]
  1000   C0700198:Aspiration [Pathologic Function]
  1000   C2827071:Aspiration [Finding]

Phrase: "from the top"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "of the gradient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439182:% gradient [Quantitative Concept]
  1000   C0812409:Gradient [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Pasteur pipette"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0491340:PIPETTE, PASTEUR [Medical Device]
   861   C0182301:Pipette [Medical Device]
   861   C1706407:Pipette [Medical Device]

Phrase: "attached to a peristalting pump"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0182537:Pump [Medical Device]
   760   C0231441:Attached [Finding]
   760   C1706421:Pump [Manufactured Object]
   726 E C1314972:ATTACH [Intellectual Product]

Phrase: "("

Phrase: "about 26fractions,"

Phrase: "usually 1.2mL for tube"

Phrase: ")."
Processing 00000000.tx.61: The following age-dependent red cell parameters were characterized in each fraction: mean cellular volume (MCV), mean cellular hemoglobin (MCH), and mean cellular hemoglobin concentration (MCHC), determined with a Cell Counter (Coulter STKR, Coulter Scientifics, Milan, Italy); 

Phrase: "The following age-dependent red cell parameters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   799   C0449381:Parameters [Finding]
   766 E C0549193:Parameter [Spatial Concept]
   766 E C1704769:Parameter [Conceptual Entity]
   766 E C2350001:Parameter [Quantitative Concept]

Phrase: "were"

Phrase: "characterized in each fraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1264633:Fraction [Quantitative Concept]
   770   C1554103:Fraction [Idea or Concept]
   770   C1880022:Characterized [Activity]

Phrase: ":"

Phrase: "mean cellular volume (MCV),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0449468:*Volume [Quantitative Concept]
   827   C1690016:% volume [Qualitative Concept]
   827   C1705102:Volume [Intellectual Product]
   827   C2700258:Volume [Laboratory Procedure]

Phrase: "mean cellular hemoglobin (MCH),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019046:Haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "mean cellular hemoglobin concentration (MCHC),"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0019029:haemoglobin concentration [Laboratory or Test Result]
   861   C1314664:Haemoglobin concentration [Laboratory Procedure]
   861   C1318517:Haemoglobin concentration [Laboratory or Test Result]
   812   C0019046:Haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "determined with a Cell Counter"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0007634:Cell [Cell]
   760   C0677601:Counter [Manufactured Object]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1705206:Counter [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "(Coulter STKR,"

Phrase: "Coulter Scientifics,"

Phrase: "Milan,"

Phrase: "Italy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.62: HbA1c, determined by immunoenzymatic assay (Roche, Basel, Switzerland); 

Phrase: "HbA1c,"

Phrase: "determined by immunoenzymatic assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0086231:Immunoenzymatic assay, NOS [Laboratory Procedure]
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C1510438:Assay [Laboratory Procedure]

Phrase: "(Roche,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331965:Roche [Health Care Related Organization]

Phrase: "Basel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331779:Basel [Health Care Related Organization]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.63: and red cell creatine, measured by the method described by Griffiths et al30 using recrystallized creatine as standard. 

Phrase: "and"

Phrase: "red cell creatine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0010286:Creatine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0014792:Red Cell [Cell]

Phrase: "measured by the method"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0025663:Method [Intellectual Product]
   770   C0444706:Measured [Qualitative Concept]
   770   C0449851:Method [Functional Concept]
   770   C0871511:METHOD [Intellectual Product]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "described by Griffiths et al30"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "recrystallized creatine as standard."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0010286:Creatine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.64: Manual reticulocyte counts were made according to Brecher.31 The fractions containing the young cells concentrated in the upper layer (over 60%), the average age cells layered over 66% and 70%, and the fractions containing the senescent cells layered over 74% were pooled and washed 3times with HEPES-buffered isotonic saline at 4C to remove Percoll. 

Phrase: "Manual reticulocyte counts"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   988   C0523157:Reticulocyte count, manual [Laboratory Procedure]
   901   C0206161:Reticulocyte Counts [Laboratory Procedure]
   896   C1441639:Manual count [Laboratory Procedure]
   884 E C1318442:reticulocyte count [Laboratory or Test Result]
   827   C0439157:counts [Quantitative Concept]
   793 E C0750480:Count [Activity]
   793 E C1705566:Count [Quantitative Concept]

Phrase: "were"

Phrase: "made according to Brecher.31"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0450355:31 [Intellectual Product]
   760   C0680240:according [Social Behavior]
   726   C1881534:Make [Functional Concept]

Phrase: "The fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the young cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "concentrated in the upper layer"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0934502:Layer [Body Part, Organ, or Organ Component]
   760   C1282910:Upper [Spatial Concept]
   760   C1522408:Layer [Qualitative Concept]
   760   C1561599:Layer [Intellectual Product]
   760   C1880165:Concentrated [Biomedical or Dental Material]
   726 E C1880310:Concentrate [Manufactured Object]
   726 E C2003864:Concentrate [Substance]

Phrase: "(over 60%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205136:Over [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "the average age cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0178537:age cells [Temporal Concept]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "layered over 66%"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0934502:Layered [Body Part, Organ, or Organ Component]
   756 E C1522408:Layer [Qualitative Concept]
   756 E C1561599:Layer [Intellectual Product]

Phrase: "and"

Phrase: "70%,"

Phrase: "and"

Phrase: "the fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the senescent cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "layered over 74%"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0934502:Layered [Body Part, Organ, or Organ Component]
   756 E C1522408:Layer [Qualitative Concept]
   756 E C1561599:Layer [Intellectual Product]

Phrase: "were"

Phrase: "pooled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]

Phrase: "and"

Phrase: "washed 3times"

Phrase: "with HEPES-buffered isotonic saline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   807   C0445115:Isotonic saline [Inorganic Chemical,Pharmacologic Substance]
   791   C0036082:Saline [Substance]

Phrase: "at 4C to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "Percoll."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070386:Percoll [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.65: Preparation of unsealed and resealed membranes from different erythrocyte populations Unsealed ghost membranes obtained from young, average aged, and old control and diabetic erythrocytes were prepared at 4C according to Steck et al,32 and resealed ghosts were obtained according to Venerando et al.19 Assessment of the resealed ghosts and verification of efficacy of the treatment was performed by determining the activity of acetylcholinesterase (Ach-esterase)33 and NADH-cytocrome c oxidoreductase (NADH-cyt C ox/red).32 Release of sialidase from resealed membranes, obtained from control and diabetic erythrocytes, by treatment with PIPLC Resealed membranes obtained from controls and diabetic erythrocytes were treated with PIPLC according to Venerando et al19 using 2.5mg protein. 

Phrase: "Preparation of unsealed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0455052:Preparation [Health Care Activity]
   790   C1521827:Preparation [Functional Concept]

Phrase: "and"

Phrase: "resealed"

Phrase: "membranes from different erythrocyte populations Unsealed ghost membranes"

Phrase: "obtained from young, average aged,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0001779:Aged [Organism Attribute]
   760   C0001792:Aged [Population Group]
   760   C0332239:Young [Temporal Concept]
   760   C1301820:Obtained [Functional Concept]
   760   C1510992:Average [Quantitative Concept]
   760   C1999167:aged [Population Group]
   760   C2825518:AVERAGE [Quantitative Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "old control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "diabetic erythrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014772:Erythrocytes [Laboratory Procedure]
   861   C0014792:Erythrocytes [Cell]

Phrase: "were"

Phrase: "prepared at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450376:4c [Intellectual Product]
   756   C1521827:Prepare [Functional Concept]

Phrase: "according to Steck et al,32"

Phrase: "and"

Phrase: "resealed"

Phrase: "ghosts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014776:ghosts [Cell Component]

Phrase: "were"

Phrase: "obtained according to Venerando et al.19 Assessment of the resealed ghosts"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   736   C0014776:ghosts [Cell Component]
   736   C0680240:according [Social Behavior]
   736   C1261322:Assessment [Health Care Activity]
   736   C1301820:Obtained [Functional Concept]
   736   C1516048:Assessment [Activity]
   703 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "verification of efficacy of the treatment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237944:Verification [Research Activity]
   753   C1711411:Verification [Functional Concept]

Phrase: "was"

Phrase: "performed by determining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C1550369:Performed By [Qualitative Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "the activity of acetylcholinesterase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C1149827:acetylcholinesterase activity [Molecular Function]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "(Ach-esterase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014894:Esterase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "33"

Phrase: "and"

Phrase: "NADH-cytocrome c oxidoreductase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0682753:NADH oxidoreductase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0030016:Oxidoreductase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1537381:oxidoreductase [Gene or Genome]

Phrase: "(NADH-cyt C ox/red).32 Release of sialidase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0030685:Release [Health Care Activity]
   742   C0391871:Release [Functional Concept]
   742   C0439180:% release [Quantitative Concept]
   742   C0680255:release [Health Care Activity]
   742   C1283071:Release [Functional Concept]
   742   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "from resealed membranes,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "obtained from control"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1301820:Obtained [Functional Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "diabetic erythrocytes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014772:Erythrocytes [Laboratory Procedure]
   861   C0014792:Erythrocytes [Cell]

Phrase: "by treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with PIPLC Resealed membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0025255:Membranes [Tissue]
   779 E C0596901:Membrane [Cell Component]
   779 E C1706182:Membrane [Manufactured Object]
   729 E C0205287:Membranous [Qualitative Concept]

Phrase: "obtained from controls"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C1301820:Obtained [Functional Concept]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756 E C1706701:Obtain [Activity]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "diabetic erythrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014772:Erythrocytes [Laboratory Procedure]
   861   C0014792:Erythrocytes [Cell]

Phrase: "were"

Phrase: "treated with PIPLC"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0031669:Phospholipase C [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "according to Venerando et al19"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "2.5mg protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.66: Preliminary experiments on resealed membranes obtained from diabetic erythrocytes have confirmed that the methodology described above can be also employed for this purpose. 

Phrase: "Preliminary experiments on resealed membranes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0681814:Experiments [Research Activity]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "obtained from diabetic erythrocytes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   773   C0427458:erythrocytes increased [Finding]
   770   C0014772:Erythrocytes [Laboratory Procedure]
   770   C0014792:Erythrocytes [Cell]
   770   C0241863:DIABETIC [Finding]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "have"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the methodology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0969625:methodology [Intellectual Product]
  1000   C3266812:Methodology [Idea or Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "can"

Phrase: "be"

Phrase: "also"

Phrase: "employed for this purpose."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0557351:Employed [Finding]
   770   C1285529:Purpose [Functional Concept]
   737 E C0457083:Employ [Functional Concept]
Processing 00000000.tx.67: Total sialic acid content in resealed membranes obtained from control and diabetic erythrocytes The total sialic acid content of resealed membranes obtained from control and diabetic erythrocytes was determined by the chromatographic micro procedure of Caimi et al34 on samples digested for 90minutes in 0.1N sulfuric acid at 80C, from which insoluble material was removed by centrifugation. 

Phrase: "Total sialic acid content in resealed membranes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]

Phrase: "obtained from control"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1301820:Obtained [Functional Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "diabetic erythrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014772:Erythrocytes [Laboratory Procedure]
   861   C0014792:Erythrocytes [Cell]

Phrase: "The total sialic acid content of resealed membranes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0423896:Content [Mental Process]
   744   C0456205:Content [Conceptual Entity]

Phrase: "obtained from control"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1301820:Obtained [Functional Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "diabetic erythrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014772:Erythrocytes [Laboratory Procedure]
   861   C0014792:Erythrocytes [Cell]

Phrase: "was"

Phrase: "determined by the chromatographic micro procedure of Caimi et al34"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   739   C0085672:MICRO [Laboratory Procedure]
   739   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   739   C1553035:Micro [Quantitative Concept]
   739   C1948041:Procedure [Therapeutic or Preventive Procedure]
   739   C2700391:Procedure [Activity]
   739   C3274430:PROCEDURE [Health Care Activity]
   739   C3538935:Procedure [Idea or Concept]
   739   C3539779:Procedure [Intellectual Product]

Phrase: "on samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "digested for 90minutes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "in 0.1N sulfuric acid"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0038784:Sulfuric acid [Inorganic Chemical,Pharmacologic Substance]
   861   C1161333:sulphuric acid [Pharmacologic Substance]
   825 E C0038775:sulfur acid [Chemical Viewed Structurally]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   811 E C0038787:Sulfurous acid [Inorganic Chemical]
   741   C0038774:Sulfur [Element, Ion, or Isotope,Pharmacologic Substance]
   741   C2348286:SULFUR [Element, Ion, or Isotope]

Phrase: "at 80C,"

Phrase: "from which insoluble material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Material [Substance]

Phrase: "was"

Phrase: "removed by centrifugation."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C0849355:Removed [Qualitative Concept]
   756 E C1883720:Remove [Activity]
   756 E C3244314:remove [Functional Concept]
Processing 00000000.tx.68: The total ganglioside-bound and protein-bound NeuAc present in young and senescent resealed membranes was determined according to Tettamanti et al.35 Ganglioside-bound NeuAc was determined according to Svennerholm36 after exhaustive dialysis of the sample against distilled water (3changes a day for at least 3days). 

Phrase: "The total ganglioside-bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0332297:bound [Spatial Concept]
   827   C1145667:Bound [Activity]
   827   C1167622:Bound [Molecular Function]
   827   C1689898:% bound [Quantitative Concept]
   827   C2349209:Bound [Conceptual Entity]

Phrase: "and"

Phrase: "protein-bound NeuAc present in young"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "senescent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C0231337:Senescence [Finding]
   928   C1999167:Senescence [Population Group]

Phrase: "resealed"

Phrase: "membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "determined according to Tettamanti et al.35 Ganglioside-bound NeuAc"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   756   C0027801:Neuraminic acid [Biologically Active Substance,Carbohydrate]
   738   C0001128:Acid [Chemical]
   738   C0017082:Ganglioside [Lipid,Pharmacologic Substance]
   738   C0202406:Acid [Laboratory Procedure]
   738   C0332297:bound [Spatial Concept]
   738   C0680240:according [Social Behavior]
   738   C1145667:Bound [Activity]
   738   C1167622:Bound [Molecular Function]
   738   C1689898:% bound [Quantitative Concept]
   738   C2349209:Bound [Conceptual Entity]

Phrase: "was"

Phrase: "determined according to Svennerholm36"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680240:according [Social Behavior]

Phrase: "after exhaustive dialysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0011945:Dialysis [Natural Phenomenon or Process]
   861   C0011946:dialysis [Therapeutic or Preventive Procedure]
   861   C0917873:dialysis [Therapeutic or Preventive Procedure]
   861   C1059964:Dialysis [Eukaryote]

Phrase: "of the sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "against distilled water"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0599638:WATER [Substance]
   861   C0681549:distilled [Occupational Activity]
   861   C1550678:Water [Inorganic Chemical]
   789 E C0443350:Watery [Qualitative Concept]

Phrase: "(3changes"

Phrase: "a day for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332173:/day [Temporal Concept]
   790   C0439228:day [Temporal Concept]
   790   C0439505:/day [Temporal Concept]

Phrase: "at least 3days"

Phrase: ")."
Processing 00000000.tx.69: Glycoprotein-bound NeuAc was determined by measuring free NeuAc, liberated after hydrolysis at 80C in 0.1N sulfuric acid for 90minutes, by the chromatographic micro procedure of Caimi et al.34 Action of neutral sialidase on endogenous substrates Resealed membranes obtained from controls and diabetic erythrocytes were incubated at 37C for 18hours in mixtures containing, in a final volume of 1mL, of 50mM/L citric acid-sodium phosphate buffer, pH 7.2,containing 0.15M NaCl and 1mg protein. 

Phrase: "Glycoprotein-bound NeuAc"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027801:Neuraminic acid [Biologically Active Substance,Carbohydrate]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "was"

Phrase: "determined by measuring free NeuAc,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0027801:Neuraminic acid [Biologically Active Substance,Carbohydrate]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0332296:free [Functional Concept]
   753   C0444706:measuring [Qualitative Concept]
   753   C0449770:measuring [Quantitative Concept]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "liberated after hydrolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "at 80C"

Phrase: "in 0.1N sulfuric acid"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0038784:Sulfuric acid [Inorganic Chemical,Pharmacologic Substance]
   861   C1161333:sulphuric acid [Pharmacologic Substance]
   825 E C0038775:sulfur acid [Chemical Viewed Structurally]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   811 E C0038787:Sulfurous acid [Inorganic Chemical]
   741   C0038774:Sulfur [Element, Ion, or Isotope,Pharmacologic Substance]
   741   C2348286:SULFUR [Element, Ion, or Isotope]

Phrase: "for 90minutes,"

Phrase: "by the chromatographic micro procedure"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0085672:MICRO [Laboratory Procedure]
   827   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C1553035:Micro [Quantitative Concept]
   827   C1948041:Procedure [Therapeutic or Preventive Procedure]
   827   C2700391:Procedure [Activity]
   827   C3274430:PROCEDURE [Health Care Activity]
   827   C3538935:Procedure [Idea or Concept]
   827   C3539779:Procedure [Intellectual Product]

Phrase: "of Caimi et al.34 Action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0441472:Action [Functional Concept]
   804   C3266814:Action [Activity]

Phrase: "of neutral sialidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027803:Sialidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "on endogenous substrates Resealed membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0025255:Membranes [Tissue]
   779 E C0596901:Membrane [Cell Component]
   779 E C1706182:Membrane [Manufactured Object]
   729 E C0205287:Membranous [Qualitative Concept]

Phrase: "obtained from controls"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C1301820:Obtained [Functional Concept]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756 E C1706701:Obtain [Activity]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "diabetic erythrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014772:Erythrocytes [Laboratory Procedure]
   861   C0014792:Erythrocytes [Cell]

Phrase: "were"

Phrase: "incubated at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 18hours"

Phrase: "in mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439962:mixtures [Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: ","

Phrase: "in a final volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "of 1mL,"

Phrase: "of 50mM/L citric acid-sodium phosphate buffer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   845   C3256935:sodium phosphate buffer [Pharmacologic Substance]
   818   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   795   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "pH 7.2,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.15M NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "1mg protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.70: At the end of the incubation, the mixtures were centrifuged at 28000g for 20minutes, and the supernatant was collected. 

Phrase: "At the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the incubation,"

Phrase: "the mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439962:mixtures [Substance]

Phrase: "were"

Phrase: "centrifuged at 28000g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "for 20minutes,"

Phrase: "and"

Phrase: "the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "collected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]
Processing 00000000.tx.71: The pellet was washed 3times with 0.2mL of 0.15M NaCl. 

Phrase: "The pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "3times with 0.2mL of 0.15M NaCl."
Processing 00000000.tx.72: At the end, the supernatants were recentrifuged at 4C at 150000g for 10minutes. 

Phrase: "At the end,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "the supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "recentrifuged at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0450376:4c [Intellectual Product]

Phrase: "at 150000g"

Phrase: "for 10minutes."
Processing 00000000.tx.73: The final supernatants and the final pellets were analyzed as described above. 

Phrase: "The final supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "and"

Phrase: "the final pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0993610:pellets [Biomedical or Dental Material]
   827 E C0441436:Pellet [Manufactured Object]
   827 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "analyzed as described above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0936012:Analyzed [Research Activity]
   770   C1552738:described [Idea or Concept]
Processing 00000000.tx.74: Blank mixtures containing protein inactivated at 100C for 10minutes were run concomitantly. 

Phrase: "Blank mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:mixtures [Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inactivated at 100C"

Phrase: "for 10minutes"

Phrase: "were"

Phrase: "run"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035953:run [Daily or Recreational Activity]
  1000   C0600140:run [Finding]
  1000   C1704688:Run [Functional Concept]
  1000   C2346414:Run [Finding]

Phrase: "concomitantly."
Processing 00000000.tx.75: Enzyme assays The assays of resealed membrane sialidases obtained from control and diabetic erythrocytes were routinely determined by fluorimetric methods.37 The assay mixtures, containing in a final volume of 0.1mL, 50mM citric acid-sodium phosphate buffer (at established optimal pHs), 0.15M NaCl, 0.6mM MU-NeuAc (optimum concentration), 10to 60g protein of enzyme preparation, and 0.6mg albumin, were incubated for up to 30minutes at 37C. 

Phrase: "Enzyme assays"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C2717977:Enzyme Assays [Laboratory Procedure]
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "The assays of resealed membrane sialidases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0005507:Assay [Laboratory Procedure]
   719   C0243073:assay [Qualitative Concept]
   719   C1510438:Assay [Laboratory Procedure]

Phrase: "obtained from control"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1301820:Obtained [Functional Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "diabetic erythrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014772:Erythrocytes [Laboratory Procedure]
   861   C0014792:Erythrocytes [Cell]

Phrase: "were"

Phrase: "routinely"

Phrase: "determined by fluorimetric methods.37"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0025663:Methods [Intellectual Product]
   760   C0025664:methods [Intellectual Product]
   760   C0449851:Methods [Functional Concept]
   726 E C0871511:METHOD [Intellectual Product]

Phrase: "The assay mixtures,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:mixtures [Substance]

Phrase: "containing in a final volume of 0.1mL,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0205088:Final [Temporal Concept]
   744   C0332256:Containing [Functional Concept]
   744   C0449468:*Volume [Quantitative Concept]
   744   C1546485:Final [Idea or Concept]
   744   C1690016:% volume [Qualitative Concept]
   744   C1705102:Volume [Intellectual Product]
   744   C2700258:Volume [Laboratory Procedure]
   744   C2700400:Containing [Activity]

Phrase: "50mM citric acid-sodium phosphate buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C3256935:sodium phosphate buffer [Pharmacologic Substance]
   827   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   799   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "("

Phrase: "at established optimal pHs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0265220:PHS [Disease or Syndrome]
   827   C1705397:PHS [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "0.15M NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.6mM MU-NeuAc"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0027801:Neuraminic acid [Biologically Active Substance,Carbohydrate]
   793   C0001128:Acid [Chemical]
   793   C0202406:Acid [Laboratory Procedure]

Phrase: "(optimum concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: ")"

Phrase: ","

Phrase: "10to 60g protein of enzyme preparation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "0.6mg albumin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "incubated for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1439852:Incubated [Laboratory Procedure]

Phrase: "up to 30minutes"

Phrase: "at 37C."
Processing 00000000.tx.76: The blank mixtures consisted of the incubation mixtures lacking the enzyme preparation. 

Phrase: "The blank mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:mixtures [Substance]

Phrase: "consisted of the incubation mixtures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439962:mixtures [Substance]
   726   C0332529:CONSIST [Qualitative Concept]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the enzyme preparation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0360722:Enzyme preparation [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0455052:Preparation [Health Care Activity]
   861   C1521827:Preparation [Functional Concept]
Processing 00000000.tx.77: Enzyme activities were expressed as units (U), ie, the amount of enzyme that liberates 1M of product per minute at 37C under optimal conditions. 

Phrase: "Enzyme activities"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0243102:enzyme activity [Molecular Function]
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "were"

Phrase: "expressed as units (U),"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0439148:Units [Quantitative Concept]
   790   C1519795:Units [Quantitative Concept]
   756 E C1704753:Unit [Manufactured Object]
   756 E C1880519:Unit [Quantitative Concept]

Phrase: "ie"

Phrase: ","

Phrase: "the amount of enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "that"

Phrase: "liberates"

Phrase: "1M of product"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470296:1M [Quantitative Concept]

Phrase: "per minute"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0439232:minute [Temporal Concept]
  1000   C0700321:minute [Quantitative Concept]
  1000   C0702093:/minute [Temporal Concept]
  1000   C1282918:Minute [Quantitative Concept]
  1000   C2347166:Minute [Quantitative Concept]

Phrase: "at 37C"

Phrase: "under optimal conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.78: Other methods Protein content was determined by the method of Lowry et al38 using crystalline BSA as the standard; 

Phrase: "Other methods Protein content"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]

Phrase: "was"

Phrase: "determined by the method of Lowry et al38"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0025663:Method [Intellectual Product]
   744   C0449851:Method [Functional Concept]
   744   C0871511:METHOD [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "crystalline BSA as the standard"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   814   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   778   C0728877:serum albumin [Laboratory or Test Result]
   774 E C0523465:Albumin - serum [Laboratory Procedure]
   748   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0007452:Bovine [Mammal]
   748   C0229671:Serum [Body Substance]
   748   C1140701:bovine [Mammal]
   748   C1546774:Serum [Intellectual Product]
   748   C1550100:Serum [Body Substance]

Phrase: ";"
Processing 00000000.tx.79: when HEPES buffer was present, the Coomassie brilliant blue Bradford method39 was used. 

Phrase: "when"

Phrase: "HEPES buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   729   C2825385:HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "the Coomassie brilliant blue Bradford method39"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   717   C0056270:coomassie Brilliant Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.80: Ach-esterase activity was determined by the method of Ellman et al,33 and NADH-cyt C ox/red was determined by the method reported by Steck and Kant.32 Total phospholipids were extracted according to Ladisch and Gillard40 and determined as phosphorus by the method of Barlett.41 Fasting venous plasma glucose and fructosamine (as 1deoxy-1-morpholino-D-fructose) were measured by colorimetric assay (Roche). 

Phrase: "Ach-esterase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1149811:esterase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "determined by the method of Ellman et al,33"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0025663:Method [Intellectual Product]
   742   C0449851:Method [Functional Concept]
   742   C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "NADH-cyt C ox/red"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332575:Red [Finding]
   804   C1260956:Red [Qualitative Concept]

Phrase: "was"

Phrase: "determined by the method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025663:Method [Intellectual Product]
   770   C0449851:Method [Functional Concept]
   770   C0871511:METHOD [Intellectual Product]

Phrase: "reported by Steck"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C1709908:Reported By [Group]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "Kant.32 Total phospholipids"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0031676:Phospholipids [Biologically Active Substance,Lipid]
   812   C0439175:% total [Quantitative Concept]
   812   C0439810:Total [Qualitative Concept]
   779 E C0202177:Phospholipid [Laboratory Procedure]

Phrase: "were"

Phrase: "extracted according to Ladisch"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C0680240:according [Social Behavior]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "Gillard40"

Phrase: "and"

Phrase: "determined as phosphorus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031705:Phosphorus [Element, Ion, or Isotope]
   790   C0080014:PHOSPHORUS [Element, Ion, or Isotope]

Phrase: "by the method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "of Barlett.41"

Phrase: "Fasting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "venous plasma glucose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0202042:Plasma glucose [Laboratory Procedure]
   901   C0455280:plasma glucose [Laboratory or Test Result]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "and"

Phrase: "fructosamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0060765:Fructosamine [Carbohydrate]

Phrase: "("

Phrase: "as 1deoxy-1-morpholino-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881903:Morpholino [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "D-"

Phrase: "fructose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016745:Fructose [Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: "were"

Phrase: "measured by colorimetric assay"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C1510438:Assay [Laboratory Procedure]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "(Roche"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331965:Roche [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.81: Statistical analysis Tests of skewness and kurtosis showed significant differences from normal distribution, and nonparametric analysis techniques were used. 

Phrase: "Statistical analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "Tests of skewness"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0022885:Test [Laboratory Procedure]
   790   C0039593:Test [Functional Concept]
   790   C0392366:Tests [Intellectual Product]

Phrase: "and"

Phrase: "kurtosis"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "significant differences from normal distribution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "nonparametric analysis techniques"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0025664:techniques [Intellectual Product]
   827   C0449851:Techniques [Functional Concept]

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.82: The data were transformed into ranges, the means being compared by the Mann-Whitney and Wilcoxon tests. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "transformed into ranges,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1510411:Transformed [Pathologic Function]
   790   C1514721:*Ranges [Quantitative Concept]
   756 E C2348147:Range [Quantitative Concept]
   756 E C3542016:Range [Intellectual Product]

Phrase: "the means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "being"

Phrase: "compared by the Mann-Whitney"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "Wilcoxon tests."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0871608:Wilcoxon Test [Intellectual Product]
   861   C0022885:Tests [Laboratory Procedure]
   861   C0392366:Tests [Intellectual Product]
   827 E C0039593:Test [Functional Concept]
Processing 00000000.tx.83: Multiple comparisons of the means were done by the Kruskal-Wallis test and, when necessary, adjusted with the Bonferroni correction; 

Phrase: "Multiple comparisons of the means"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1707455:Comparison [Activity]

Phrase: "were"

Phrase: "done by the Kruskal-Wallis test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1708614:Kruskal-Wallis Test [Intellectual Product]
   753   C0022885:Test [Laboratory Procedure]
   753   C0039593:Test [Functional Concept]
   753   C0392366:test [Intellectual Product]
   753   C1272695:Done [Qualitative Concept]
   753   C2746065:Done [Temporal Concept]

Phrase: "and"

Phrase: ","

Phrase: "when"

Phrase: "necessary,"

Phrase: "adjusted with the Bonferroni correction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   844   C2347434:Adjusted Bonferroni Correction [Quantitative Concept]
           Adjusted Bonferroni
   760   C0456081:Adjusted [Functional Concept]
   760   C1705565:CORRECTION [Intellectual Product]
   760   C1947976:Correction [Functional Concept]

Phrase: ";"
Processing 00000000.tx.84: the correlations were done by the Spearman method. 

Phrase: "the correlations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707520:Correlation [Qualitative Concept]

Phrase: "were"

Phrase: "done by the Spearman method."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0025663:Method [Intellectual Product]
   760   C0449851:Method [Functional Concept]
   760   C0871511:METHOD [Intellectual Product]
   760   C1272695:Done [Qualitative Concept]
   760   C2746065:Done [Temporal Concept]
Processing 00000000.tx.85: For all the analyses, the SPSS/PC package (SPSS, Chicago, IL) was used.42  Results Top Abstract Introduction Patients, materials, and... 

Phrase: "For all"

Phrase: "the analyses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "the SPSS/PC package"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0013194:Package [Medical Device]
   827   C2700580:Package [Manufactured Object]

Phrase: "(SPSS,"

Phrase: "Chicago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008044:Chicago [Geographic Area]

Phrase: "IL)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: "was"

Phrase: "used.42  Results Top Abstract Introduction Patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0030705:Patients [Patient or Disabled Group]

Phrase: "materials,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and..."
Processing 00000000.tx.86: Results Discussion References In a preliminary phase of this investigation using the methodology optimized by Venerando et al,19 we verified by the specific enzymatic markersAch-esterase and NADH-cyt C ox/redthat the resealed membranes from diabetics had the same conformational characteristics as those from healthy subjects (data not shown). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "References In a preliminary phase of this investigation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0205390:Phase [Temporal Concept]
   744   C0439611:Preliminary [Temporal Concept]
   744   C1261322:Investigation [Health Care Activity]
   744   C1514811:Reference [Idea or Concept]
   744   C1552578:investigation [Idea or Concept]
   744   C1706462:Reference [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the methodology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0969625:methodology [Intellectual Product]
  1000   C3266812:Methodology [Idea or Concept]

Phrase: "optimized by Venerando et al,19"

Phrase: "we"

Phrase: "verified by the specific enzymatic markersAch-esterase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0014894:Esterase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205369:Specific [Qualitative Concept]
   748   C1552740:specific [Intellectual Product]
   748   C1711411:Verified [Functional Concept]

Phrase: "and"

Phrase: "NADH-cyt C ox/redthat"

Phrase: "the resealed membranes from diabetics"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0025255:Membranes [Tissue]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "had"

Phrase: "the same conformational characteristics as those from healthy subjects"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   745   C0681884:subject characteristics [Research Activity]
   745   C1519021:Subject Characteristics [Organism Attribute]
   745   C1706465:Subject Characteristics [Idea or Concept]
   742   C1521970:Characteristics [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.87: The optimal conditions for the assay of both acidic and neutral sialidase forms as well as their main characteristics and kinetic properties were defined using these membranes. 

Phrase: "The optimal conditions for the assay of both acidic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   708   C0012634:condition [Disease or Syndrome]
   708   C0348080:Condition [Qualitative Concept]
   708   C1705253:Condition [Conceptual Entity]

Phrase: "and"

Phrase: "neutral sialidase forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0348078:forms [Qualitative Concept]
   827   C0376315:Forms [Manufactured Object]
   793 E C1522492:Form [Functional Concept]

Phrase: "as well as"

Phrase: "their main characteristics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521970:Characteristics [Qualitative Concept]

Phrase: "and"

Phrase: "kinetic properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]

Phrase: "were"

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "these membranes."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.88: For the 2enzyme forms, optimum pH (Figure 1) and Km values were the same as those observed in previously investigated healthy subjects (25.5106 and 3.05106 for acidic and neutral sialidase, respectively).19 On the contrary, the apparent Vmax values were markedly different in the 2erythrocyte populations, the acidic form having higher values and the neutral form lower values in diabetic patient erythrocytes compared with healthy subjects. 

Phrase: "For the 2enzyme forms,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "optimum pH (Figure 1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0020283:[pH] [Quantitative Concept]
   812   C0450407:ph+ [Finding]
   812   C0450408:ph++ [Finding]
   812   C0450409:ph+++ [Finding]
   812   C2698651:Optimum [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "Km values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "the same as those"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1278655:SAME AS [Classification]
   770   C0445247:Same [Qualitative Concept]

Phrase: "observed in previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "healthy subjects"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1708335:HEALTHY SUBJECTS [Population Group]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "(25.5106"

Phrase: "and"

Phrase: "3.05106 for acidic"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0001128:Acidic [Chemical]
   770   C0439086:<3 [Quantitative Concept]
   770   C2827736:3+ [Quantitative Concept]
   770   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "neutral sialidase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027803:Sialidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "respectively"

Phrase: ").19 On the contrary,"

Phrase: "the apparent Vmax values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0042295:Values [Qualitative Concept]
   827   C1710637:Vmax [Phenomenon or Process]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "markedly different in the 2erythrocyte populations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "the acidic form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "having"

Phrase: "higher values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "the neutral form lower values in diabetic patient erythrocytes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0042295:Values [Qualitative Concept]
   708 E C1522609:Value [Quantitative Concept]

Phrase: "compared with healthy subjects."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1708335:HEALTHY SUBJECTS [Population Group]
   770   C1707455:Compared [Activity]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
Processing 00000000.tx.89: View larger version (16K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.90: Effect of pH on the sialidase activity contained in human erythrocyte resealed vesicles from healthy and diabetic subjects. 

Phrase: "Effect of pH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on the sialidase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150037:sialidase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "contained in human erythrocyte"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0014792:Erythrocyte [Cell]
   770   C0086418:Human [Human]
   770   C0332256:contained [Functional Concept]
   770   C2700400:Contained [Activity]

Phrase: "resealed"

Phrase: "vesicles from healthy"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0333262:VESICLES [Acquired Abnormality]
   756 E C1622418:vesicle [Cell Component]
   706 E C0205378:Vesicular [Qualitative Concept]

Phrase: "and"

Phrase: "diabetic subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.91: For details, see "Patients, materials, and methods." 

Phrase: "For details,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522508:Details [Qualitative Concept]
   966 E C1561567:detail [Functional Concept]

Phrase: "see ""Patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "materials,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods."""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.92: Acid and neutral sialidase content in human erythrocytes from controls and diabetic patients The subsequent study of 117diabetic patients (Table 2) showed that the acidic form of the enzyme is significantly increased when compared with controls (1.8-fold), as opposed to the neutral form, which is significantly decreased (1.3-fold). 

Phrase: "Acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001128:Acid [Chemical]
  1000   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "neutral sialidase content in human erythrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]

Phrase: "from controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "The subsequent study of 117diabetic patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the acidic form of the enzyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "is"

Phrase: "significantly"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "when"

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "(1.8-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "opposed to the neutral form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]
   760   C1882074:Neutral [Qualitative Concept]
   760   C2825492:Neutral [Phenomenon or Process]

Phrase: "which"

Phrase: "is"

Phrase: "significantly"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "(1.3-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")."
Processing 00000000.tx.93: As a consequence, the total bound sialic acid is substantially increased in diabetic patients and, obviously, a significantly different acidic-neutral form ratio was also found (Table 2). 

Phrase: "As a consequence,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0686907:Consequence [Functional Concept]

Phrase: "the total bound sialic acid"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0067762:Sialic Acid [Biologically Active Substance,Carbohydrate]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   756   C0036087:Salivas [Body Substance]
   756   C1546769:Saliva [Intellectual Product]
   756   C1608524:Saliva [Body Substance]

Phrase: "is"

Phrase: "substantially"

Phrase: "increased in diabetic patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0205217:Increased [Quantitative Concept]
   770   C0241863:DIABETIC [Finding]
   770   C0442805:Increased [Functional Concept]

Phrase: "and"

Phrase: ","

Phrase: "obviously,"

Phrase: "a significantly different acidic-neutral form ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0456603:Ratio [Quantitative Concept]
   799   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.94: No significant difference of acidic or neutral sialidase activity has been shown relative to the duration of the disease and the type of therapy administered. 

Phrase: "No significant difference of acidic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "or"

Phrase: "neutral sialidase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1150037:sialidase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "relative to the duration of the disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0080103:Relative [Family Group]
   748   C0205345:Relative [Qualitative Concept]
   748   C1547039:*Relative [Quantitative Concept]

Phrase: "and"

Phrase: "the type of therapy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332307:Type [Qualitative Concept]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "administered."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521801:Administered [Functional Concept]
   966 E C1621583:Administer [Functional Concept]
Processing 00000000.tx.95: No correlation with glycemia and parameters of metabolic control either in the whole patient population or within selected subgroups (Table 1) was observed. 

Phrase: "No correlation with glycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "parameters of metabolic control either"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0449381:Parameters [Finding]
   726 E C0549193:Parameter [Spatial Concept]
   726 E C1704769:Parameter [Conceptual Entity]
   726 E C2350001:Parameter [Quantitative Concept]

Phrase: "in the whole patient population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]

Phrase: "or within selected subgroups"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1079230:subgroups [Virus]
   737 E C1515021:Subgroup [Classification]
   737   C1707391:Select [Activity]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "was"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.96: The presence or absence of complications did not seem to influence the enzymatic activities, with the only exception being nephropathies, for which a significant correlation between the acidic-neutral sialidase ratio and the severity of the disease (R=0.365, P<.006) was observed.  

Phrase: "The presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of complications"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "seem"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "influence"

Phrase: "the enzymatic activities,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C2267219:Enzymatic Activity [Molecular Function]
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "with the only exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1554961:exception [Idea or Concept]
   861   C1705847:Exception [Conceptual Entity]

Phrase: "being"

Phrase: "nephropathies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022658:nephropathies [Disease or Syndrome]

Phrase: "for which"

Phrase: "a significant correlation between the acidic-neutral sialidase ratio"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "the severity of the disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0521117:disease severity [Qualitative Concept]
   760   C0439793:Severity [Qualitative Concept]
   760   C2983285:Severity [Intellectual Product]

Phrase: "(R=0.365,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "P<.006"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "was"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.97: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.98: Sialidase activity and total sialic acid content in erythrocyte resealed vesicles from controls and type 2diabetic patients Acidic sialidase release from erythrocyte resealed membranes of controls and diabetic patients after exhaustive treatment with PIPLC Because the acidic sialidase is bound to the erythrocyte membrane through the glycosylphosphatidylinositol (GPI) anchor, which is sensitive to the hydrolytic action of the specific bacterial PIPLC,18 we studied the effect of the B thuringiensis PIPLC on the pools of resealed membranes obtained from healthy and diabetic subjects. 

Phrase: "Sialidase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150037:sialidase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "total sialic acid content in erythrocyte"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]

Phrase: "resealed"

Phrase: "vesicles from controls"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0333262:VESICLES [Acquired Abnormality]
   756 E C1622418:vesicle [Cell Component]
   706 E C0205378:Vesicular [Qualitative Concept]

Phrase: "and"

Phrase: "type 2diabetic patients Acidic sialidase release from erythrocyte"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0030685:Release [Health Care Activity]
   744   C0391871:Release [Functional Concept]
   744   C0439180:% release [Quantitative Concept]
   744   C0680255:release [Health Care Activity]
   744   C1283071:Release [Functional Concept]
   744   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "resealed"

Phrase: "membranes of controls"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0025255:Membranes [Tissue]
   756 E C0596901:Membrane [Cell Component]
   756 E C1706182:Membrane [Manufactured Object]
   706 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "diabetic patients after exhaustive treatment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:Patients [Patient or Disabled Group]

Phrase: "with PIPLC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031669:Phospholipase C [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Because"

Phrase: "the acidic sialidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027803:Sialidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "bound to the erythrocyte membrane"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0014780:Erythrocyte Membrane [Cell Component]
   760   C0014792:Erythrocyte [Cell]
   760   C0025255:Membrane [Tissue]
   760   C0332297:bound [Spatial Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1689898:% bound [Quantitative Concept]
   760   C1706182:Membrane [Manufactured Object]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "through the glycosylphosphatidylinositol (GPI) anchor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1293132:anchor [Therapeutic or Preventive Procedure]

Phrase: "which"

Phrase: "is"

Phrase: "sensitive to the hydrolytic action of the specific bacterial PIPLC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0332324:Sensitive to [Functional Concept]
           Sensitive
   738   C1550474:sensitive [Idea or Concept]

Phrase: "18"

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the effect of the B thuringiensis PIPLC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on the pools"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0337051:pools [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]
   966 E C2349200:Pool [Functional Concept]

Phrase: "of resealed membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "obtained from healthy"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718   C0018684:Health [Idea or Concept]
   718   C0031206:healthiness [Finding]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "diabetic subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.99: The results are reported in Table 3. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "reported in Table 3."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0039224:Table [Manufactured Object]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.100: Following the optimized assay conditions (see "Patients, materials, and methods"), we found a different behavior of the acidic sialidase in the 2populations: in the controls the enzyme is completely released in the supernatant (88%) while in the diabetic patients the release occurs only partially (26%). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the optimized assay conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(see ""Patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "materials,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "a different behavior of the acidic sialidase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0004927:Behavior [Individual Behavior]
   748   C2707008:Behavior [Clinical Attribute]

Phrase: "in the 2populations"

Phrase: ":"

Phrase: "in the"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "is"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "released in the supernatant"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0391871:Released [Functional Concept]
   770   C1283071:Released [Functional Concept]
   770   C1550101:Supernatant [Body Substance]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(88%"

Phrase: ")"

Phrase: "while in the diabetic patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030705:Patients [Patient or Disabled Group]
   760   C0241863:DIABETIC [Finding]
   760   C0750519:while [Idea or Concept]

Phrase: "the release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "only partially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "(26%"

Phrase: ")."
Processing 00000000.tx.101: From Table 3 it can also be seen that neither in the controls nor in diabetic subjects is the neutral form of the enzyme releasable.  

Phrase: "From Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "it"

Phrase: "can"

Phrase: "also"

Phrase: "be"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "that"

Phrase: "neither in the controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C3274651:Neither [Qualitative Concept]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]

Phrase: "nor in diabetic subjects"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0028423:NOR [Geographic Area]
   770   C0028609:NOR [Cell Component]
   770   C0241863:DIABETIC [Finding]
   770   C1513854:NOR [Mammal]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "is"

Phrase: "the neutral form of the enzyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "releasable."
Processing 00000000.tx.102: View this table: [in this window] [in a new window]  Table 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.103: Sialidase release from erythrocyte resealed membranes of controls and type 2diabetic patients after exhaustive treatment with specific bacterial phospholipase C Sialic acid release from erythrocyte resealed membranes of controls and diabetic patients after neutral sialidase action on endogenous substrates The neutral sialidase action on the sialoderivatives present at the level of the erythrocyte membrane itself has been also verified in both populations, and in Table 4 the variations of the sialic acid content are reported. 

Phrase: "Sialidase release from erythrocyte"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "resealed"

Phrase: "membranes of controls"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0025255:Membranes [Tissue]
   756 E C0596901:Membrane [Cell Component]
   756 E C1706182:Membrane [Manufactured Object]
   706 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "type 2diabetic patients after exhaustive treatment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1550335:Patient type [Classification]
   753   C0030705:Patients [Patient or Disabled Group]

Phrase: "with specific bacterial phospholipase C Sialic acid release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   795   C0030685:Release [Health Care Activity]
   795   C0391871:Release [Functional Concept]
   795   C0439180:% release [Quantitative Concept]
   795   C0680255:release [Health Care Activity]
   795   C1283071:Release [Functional Concept]
   795   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "from erythrocyte"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014792:Erythrocyte [Cell]

Phrase: "resealed"

Phrase: "membranes of controls"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0025255:Membranes [Tissue]
   756 E C0596901:Membrane [Cell Component]
   756 E C1706182:Membrane [Manufactured Object]
   706 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "diabetic patients after neutral sialidase action"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030705:Patients [Patient or Disabled Group]

Phrase: "on endogenous substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "The neutral sialidase action on the sialoderivatives"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441472:Action [Functional Concept]
   748   C3266814:Action [Activity]

Phrase: "present at the level of the erythrocyte membrane"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0014780:Erythrocyte Membrane [Cell Component]
   744   C0014792:Erythrocyte [Cell]
   744   C0025255:Membrane [Tissue]
   744   C0150312:Present [Quantitative Concept]
   744   C0441889:Level [Qualitative Concept]
   744   C0449450:Present [Idea or Concept]
   744   C0456079:Level [Classification]
   744   C0596901:Membrane [Cell Component]
   744   C1547707:Level [Geographic Area]
   744   C1706182:Membrane [Manufactured Object]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "itself"

Phrase: "has"

Phrase: "been"

Phrase: "also"

Phrase: "verified in both populations,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0032659:Population [Quantitative Concept]
   770   C1257890:Population [Population Group]
   770   C1711411:Verified [Functional Concept]

Phrase: "and in Table 4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]

Phrase: "the variations of the sialic acid content"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205419:variations [Qualitative Concept]

Phrase: "are"

Phrase: "reported."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.104: The enzyme action is significantly diminished in the diabetic population in which the sialic acid release decreases as compared with controls (6.3% and 21.2% in diabetic and control subjects, respectively). 

Phrase: "The enzyme action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441472:Action [Functional Concept]
   861   C3266814:Action [Activity]

Phrase: "is"

Phrase: "significantly"

Phrase: "diminished in the diabetic population"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0032659:Population [Quantitative Concept]
   760   C0205216:Diminished [Quantitative Concept]
   760   C0241863:DIABETIC [Finding]
   760   C1257890:Population [Population Group]

Phrase: "in which"

Phrase: "the sialic acid release decreases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0547047:decreases [Quantitative Concept]
   779 E C0392756:Decrease [Qualitative Concept]

Phrase: "as"

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "(6.3%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1630409:6/3 [Finding]

Phrase: "and"

Phrase: "21.2% in diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "control subjects,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.105: The observed variation is independent from the chemical nature of the endogenous substrates.  

Phrase: "The observed variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variation [Qualitative Concept]

Phrase: "is"

Phrase: "independent from the chemical nature of the endogenous substrates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0332291:Independent of [Functional Concept]
   742   C0085862:Independent [Idea or Concept]
   742   C1299583:Independent [Finding]
Processing 00000000.tx.106: View this table: [in this window] [in a new window]  Table 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 4."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.107: Release of sialic acid from erythrocyte resealed membranes after neutral sialidase action on endogenous substrates Characterization and identification of erythrocytes from controls and diabetic patients fractionated according to biological age Four cell layers were identified after the fractionation of erythrocytes obtained from the studied subjects (see "Patients, materials, and methods"). 

Phrase: "Release of sialic acid"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "from erythrocyte"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014792:Erythrocyte [Cell]

Phrase: "resealed"

Phrase: "membranes after neutral sialidase action"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   781   C1417682:SIALIDASE, MEMBRANE [Gene or Genome]
   760   C0025255:Membranes [Tissue]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "on endogenous substrates Characterization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "identification of erythrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020792:Identification [Mental Process]
   790   C0205396:Identification [Qualitative Concept]

Phrase: "from controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "fractionated according to biological age Four cell layers"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   767   C0178537:cell age [Temporal Concept]
   744   C0001779:Age [Organism Attribute]
   744   C0005532:Biological [Biomedical Occupation or Discipline]
   744   C0007634:Cell [Cell]
   744   C0205450:Four [Quantitative Concept]
   744   C0205460:biological [Qualitative Concept]
   744   C0680240:according [Social Behavior]
   744   C0934502:layers [Body Part, Organ, or Organ Component]
   744   C1269647:Cell [Cell]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C1979893:Fractionated [Qualitative Concept]
   711 E C1522408:Layer [Qualitative Concept]
   711 E C1561599:Layer [Intellectual Product]

Phrase: "were"

Phrase: "identified after the fractionation of erythrocytes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0014772:Erythrocytes [Laboratory Procedure]
   753   C0014792:Erythrocytes [Cell]
   753   C0016640:fractionation [Laboratory Procedure]
   753   C0205396:Identified [Qualitative Concept]
   753   C0524811:fractionation [Therapeutic or Preventive Procedure]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "obtained from the studied subjects"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C1301820:Obtained [Functional Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726 E C1706701:Obtain [Activity]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "(see ""Patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "materials,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.108: Different parameters were used for characterization: creatine, HbA1c, MCH, MCHC, and MCV27,28,43 (Table 5). 

Phrase: "Different parameters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0449381:Parameters [Finding]
   827 E C0549193:Parameter [Spatial Concept]
   827 E C1704769:Parameter [Conceptual Entity]
   827 E C2350001:Parameter [Quantitative Concept]

Phrase: "were"

Phrase: "used for characterization"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1273517:used [Finding]
   790   C1880022:Characterization [Activity]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: ":"

Phrase: "creatine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010286:Creatine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "HbA1c,"

Phrase: "MCH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019046:Haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "MCHC,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0019029:haemoglobin concentration [Laboratory or Test Result]
   861   C1314664:Haemoglobin concentration [Laboratory Procedure]
   861   C1318517:Haemoglobin concentration [Laboratory or Test Result]
   812   C0019046:Haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "MCV27,"

Phrase: "28,"

Phrase: "43"

Phrase: "(Table 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.109: Creatine and MCV decreased and MCHC and HbA1c increased going from the first to the last layer, while MCH content remained virtually unchanged throughout the gradient.  

Phrase: "Creatine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010286:Creatine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "MCV"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0449468:*Volume [Quantitative Concept]
   827   C1690016:% volume [Qualitative Concept]
   827   C1705102:Volume [Intellectual Product]
   827   C2700258:Volume [Laboratory Procedure]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "MCHC"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0019029:haemoglobin concentration [Laboratory or Test Result]
   861   C1314664:Haemoglobin concentration [Laboratory Procedure]
   861   C1318517:Haemoglobin concentration [Laboratory or Test Result]
   812   C0019046:Haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "HbA1c"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "going from the first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205435:First [Quantitative Concept]
   770   C1279901:First [Qualitative Concept]

Phrase: "to the last layer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0934502:Layer [Body Part, Organ, or Organ Component]
   861   C1522408:Layer [Qualitative Concept]
   861   C1561599:Layer [Intellectual Product]

Phrase: "while"

Phrase: "MCH content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0423896:Content [Mental Process]
   812   C0456205:Content [Conceptual Entity]

Phrase: "remained"

Phrase: "virtually unchanged throughout the gradient."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0442739:Unchanged [Finding]
   760   C2346711:Unchanged [Qualitative Concept]
Processing 00000000.tx.110: View this table: [in this window] [in a new window]  Table 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 5."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.111: Characterization according to biological age of the different erythrocyte density fractions obtained from controls and diabetic patients On the basis of the above markers (Table 5) and according to reported criteria,27,28,43 the different fractions were identified as follows: (a) fraction 1,at 66% Percoll, largely composed of "young erythrocytes" (creatine content 3.930.74 mg for 100cells); 

Phrase: "Characterization according to biological age of the different erythrocyte density fractions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1880022:Characterization [Activity]

Phrase: "obtained from controls"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C1301820:Obtained [Functional Concept]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756 E C1706701:Obtain [Activity]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "diabetic patients On the basis of the above markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0030705:Patients [Patient or Disabled Group]

Phrase: "(Table 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "and according to reported criteria,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0243161:criteria [Intellectual Product]
   760   C0680240:according [Social Behavior]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C1515981:And [Idea or Concept]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]

Phrase: "27,"

Phrase: "28,"

Phrase: "43"

Phrase: "the different fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "(a) fraction 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]

Phrase: "at 66% Percoll,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0070386:Percoll [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "largely"

Phrase: "composed"

Phrase: "of ""young erythrocytes"""
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014772:Erythrocytes [Laboratory Procedure]
   827   C0014792:Erythrocytes [Cell]

Phrase: "(creatine content 3.930.74 mg for 100cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0439269:mg% [Quantitative Concept]
   744   C1960952:mg % [Quantitative Concept]
   744   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.112: (b) fractions 2and 3at 70% and 74% Percoll, composed of "average age erythrocytes" (creatine content 1.62 0.34 and 1.550.29 mg for 100cells, respectively); 

Phrase: "(b) fractions 2and 3at 70%"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C1264633:Fractions [Quantitative Concept]
   804   C2347469:/B [Quantitative Concept]
   771 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "74% Percoll,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0070386:Percoll [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "composed"

Phrase: "of ""average age erythrocytes"""
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0014772:Erythrocytes [Laboratory Procedure]
   812   C0014792:Erythrocytes [Cell]

Phrase: "(creatine content 1.62 0.34"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0010286:Creatine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0423896:Content [Mental Process]
   799   C0456205:Content [Conceptual Entity]

Phrase: "and"

Phrase: "1.550.29 mg for 100cells,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439269:mg% [Quantitative Concept]
   753   C1960952:mg % [Quantitative Concept]
   753   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "respectively"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.113: and (c) fraction 4at 80% Percoll, prevalently made of "senescent erythrocytes" (creatine content 0.540.11 mg for 100cells). 

Phrase: "and ("

Phrase: "c) fraction 4at 80% Percoll,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0070386:Percoll [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "prevalently"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "of ""senescent erythrocytes"""
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014772:Erythrocytes [Laboratory Procedure]
   827   C0014792:Erythrocytes [Cell]

Phrase: "(creatine content 0.540.11 mg for 100cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0439269:mg% [Quantitative Concept]
   744   C1960952:mg % [Quantitative Concept]
   744   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.114: Reticulocytes were mostly confined, 75% of total, to a very thin film at 60% Percoll ("fraction R" [fraction enriched in reticulocytes]; 

Phrase: "Reticulocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035286:Reticulocytes [Cell]

Phrase: "were"

Phrase: "mostly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750554:mostly [Idea or Concept]

Phrase: "confined"

Phrase: ","

Phrase: "75% of total,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439175:% total [Quantitative Concept]
   790   C0439810:Total [Qualitative Concept]

Phrase: "to a very thin film"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1441759:Thin film [Laboratory Procedure]
   827   C0086296:Film [Manufactured Object]
   827   C1561571:film [Biomedical or Dental Material]
   827   C1561572:film [Substance]

Phrase: "at 60% Percoll"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0070386:Percoll [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(""fraction R"" [fraction"

Phrase: "enriched in reticulocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035286:Reticulocytes [Cell]
   790   C0359583:enriched [Food]

Phrase: "]"

Phrase: ";"
Processing 00000000.tx.115: creatine content 4.310.86 mg for 100cells); 

Phrase: "creatine content 4.310.86 mg for 100cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0439269:mg% [Quantitative Concept]
   744   C1960952:mg % [Quantitative Concept]
   744   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.116: the remaining 25% were present in the fraction 1("young erythrocytes"), while the other fractions had no reticulocytes. 

Phrase: "the remaining 25%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1527428:Remaining [Qualitative Concept]

Phrase: "were"

Phrase: "present in the fraction 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "(""young erythrocytes"""
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014772:Erythrocytes [Laboratory Procedure]
   861   C0014792:Erythrocytes [Cell]

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "the other fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "had"

Phrase: "no reticulocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035286:Reticulocytes [Cell]
Processing 00000000.tx.117: Also in diabetics the erythrocyte fractionation by age showed 4cell layers corresponding to those obtained in the controls, with the same specific markers distribution (Table 5). 

Phrase: "Also in diabetics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0241863:diabetics [Finding]

Phrase: "the erythrocyte fractionation by age"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0016640:fractionation [Laboratory Procedure]
   760   C0524811:fractionation [Therapeutic or Preventive Procedure]
   760   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "4cell layers"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0934502:layers [Body Part, Organ, or Organ Component]
   827 E C1522408:Layer [Qualitative Concept]
   827 E C1561599:Layer [Intellectual Product]

Phrase: "corresponding to those"

Phrase: "obtained in the controls,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C1301820:Obtained [Functional Concept]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737 E C1706701:Obtain [Activity]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]

Phrase: "with the same specific markers distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0520511:distribution [Idea or Concept]
   812   C1704711:Distribution [Functional Concept]

Phrase: "(Table 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.118: However, compared with controls, fraction 1appeared larger and contaminated by 20% of all reticulocytes; 

Phrase: "However,"

Phrase: "compared with controls,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "fraction 1appeared"

Phrase: "larger"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0443228:larger [Quantitative Concept]
  1000   C0549177:Larger [Quantitative Concept]
  1000   C1704243:Larger [Quantitative Concept]

Phrase: "and"

Phrase: "contaminated by 20% of all reticulocytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0035286:Reticulocytes [Cell]
   753   C0205279:Contaminated [Functional Concept]
   753   C2349974:CONTAMINATED [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.119: fractions 2and 3are somewhat thinner, while fraction 4was markedly reduced. 

Phrase: "fractions 2and 3are somewhat thinner,"

Phrase: "while"

Phrase: "fraction 4was markedly"

Phrase: "reduced."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]
Processing 00000000.tx.120: All fractions (2,3,and 4), as in controls, were completely devoid of reticulocytes. 

Phrase: "All fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "4"

Phrase: ")"

Phrase: ","

Phrase: "as in controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "completely devoid of reticulocytes."
Processing 00000000.tx.121: Fraction R appeared larger and thicker with 80% of the reticulocytes present in the samples (Table 5). 

Phrase: "Fraction R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "larger"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0443228:larger [Quantitative Concept]
  1000   C0549177:Larger [Quantitative Concept]
  1000   C1704243:Larger [Quantitative Concept]

Phrase: "and"

Phrase: "thicker with 80% of the reticulocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1280412:Thick [Qualitative Concept]

Phrase: "present in the samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "(Table 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.122: Fractions R (from controls and diabetics) were not considered in the sialidase study. 

Phrase: "Fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "R (from controls"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205090:R- [Spatial Concept]
   790   C0684010:R. [Professional or Occupational Group]
   790   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "diabetics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:diabetics [Finding]

Phrase: ")"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "considered in the sialidase study."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0027803:Sialidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0557651:Study [Manufactured Object]
   760   C0750591:considered [Idea or Concept]
   760   C2603343:Study [Research Activity]
Processing 00000000.tx.123: To assess possible changes in red blood cell hydration due to membrane fluxes via KCl cotrasport, according to the indications by Sorette,29 the Percoll gradient was performed also with an isotonic buffer with high KCl and low NaCl concentration (133mM and 4.5mM, respectively). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "possible changes in red blood cell hydration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   714 E C1705241:Change [Quantitative Concept]

Phrase: "due to membrane fluxes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0599830:membrane flux [Cell Function]
   827   C2348693:Flux [Natural Phenomenon or Process]

Phrase: "via KCl cotrasport,"

Phrase: "according to the indications"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0392360:Indications [Idea or Concept]
   966 E C3146298:Indication [Functional Concept]

Phrase: "by Sorette,"

Phrase: "29"

Phrase: "the Percoll gradient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439182:% gradient [Quantitative Concept]
   861   C0812409:Gradient [Quantitative Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "also with an isotonic buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "with high KCl"

Phrase: "and"

Phrase: "low NaCl concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(133mM"

Phrase: "and"

Phrase: "4.5mM,"

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.124: In our experimental conditions, we found no significant differences, with the exception of a nonsignificant increase (about 12%) of reticulocytes in fraction R. 

Phrase: "In our experimental conditions,"
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   861   C1517586:Experimental [Qualitative Concept]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no significant differences,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "with the exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1554961:exception [Idea or Concept]
  1000   C1705847:Exception [Conceptual Entity]

Phrase: "of a nonsignificant increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "(about 12%"

Phrase: ")"

Phrase: "of reticulocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035286:Reticulocytes [Cell]

Phrase: "in fraction R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.125: Distribution of differently aged erythrocytes in controls and diabetic patients On the basis of the evidence that the erythrocyte turnover is accelerated in diabetic subjects compared with controls,23 we evaluated the percentage of young, average aged, and senescent erythrocytes in the 2populations. 

Phrase: "Distribution of differently aged erythrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "in controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "diabetic patients On the basis of the evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0030705:Patients [Patient or Disabled Group]

Phrase: "that"

Phrase: "the erythrocyte turnover"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0031227:turnover [Quantitative Concept]
   861   C0243127:turnover [Functional Concept]
   861   C0443331:Turnover [Health Care Activity]

Phrase: "is"

Phrase: "accelerated in diabetic subjects"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0241863:DIABETIC [Finding]
   770   C0521110:Accelerated [Functional Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "compared with controls,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "we"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the percentage of young, average aged,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439165:Percentage [Quantitative Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]

Phrase: "and"

Phrase: "senescent erythrocytes in the 2populations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0014772:Erythrocytes [Laboratory Procedure]
   760   C0014792:Erythrocytes [Cell]
Processing 00000000.tx.126: The erythrocyte age distribution data in controls and diabetics, reported in Table 6, are expressed as micromoles of phosphorus content of membrane phospholipids and as number of cells. 

Phrase: "The erythrocyte age distribution data in controls"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C2699786:Distribution Data [Regulation or Law]
   748   C1511726:Data [Idea or Concept]
   748   C3245479:data [Medical Device]

Phrase: "and"

Phrase: "diabetics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:diabetics [Finding]

Phrase: "reported in Table 6,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0039224:Table [Manufactured Object]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "are"

Phrase: "expressed as micromoles of phosphorus content of membrane phospholipids"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   745   C0807386:Phospholipid phosphorus [Lipid]
   742   C0025255:Membrane [Tissue]
   742   C0031676:Phospholipids [Biologically Active Substance,Lipid]
   742   C0031705:Phosphorus [Element, Ion, or Isotope]
   742   C0080014:PHOSPHORUS [Element, Ion, or Isotope]
   742   C0423896:Content [Mental Process]
   742   C0439194:Micromole [Quantitative Concept]
   742   C0456205:Content [Conceptual Entity]
   742   C0596901:Membrane [Cell Component]
   742   C1706182:Membrane [Manufactured Object]
   708 E C0202177:Phospholipid [Laboratory Procedure]

Phrase: "and as number of cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   781   C0007584:Cell Number [Laboratory Procedure]
   760   C0007634:Cells [Cell]
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]
   760   C1515981:And [Idea or Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.127: It is evident that in diabetic patients the young erythrocytes are almost doubled relative to controls, the senescent ones are reduced by a quarter, while the average aged erythrocytes are equally represented in the 2populations.  

Phrase: "It"

Phrase: "is"

Phrase: "evident"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0332120:Evidence [Functional Concept]

Phrase: "that in diabetic patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0241863:DIABETIC [Finding]

Phrase: "the young erythrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014772:Erythrocytes [Laboratory Procedure]
   861   C0014792:Erythrocytes [Cell]

Phrase: "are"

Phrase: "almost"

Phrase: "doubled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205173:doubled [Functional Concept]
   966 E C1705764:Double [Activity]
   966 E C1705765:Double [Qualitative Concept]

Phrase: "relative to controls,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "the senescent ones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205447:One [Quantitative Concept]

Phrase: "are"

Phrase: "reduced by a quarter,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0392756:Reduced [Qualitative Concept]
   770   C2825406:Quarter [Quantitative Concept]
   770   C2986716:QUARTER [Body Part, Organ, or Organ Component]

Phrase: "while"

Phrase: "the average aged erythrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014772:Erythrocytes [Laboratory Procedure]
   827   C0014792:Erythrocytes [Cell]

Phrase: "are"

Phrase: "equally"

Phrase: "represented in the 2populations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1882932:Represent [Activity]
Processing 00000000.tx.128: View this table: [in this window] [in a new window]  Table 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 6."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.129: Erythrocyte age distribution in controls and diabetics Behavior of acidic and neutral sialidases in controls and diabetic patients in differently aged erythrocytes The assay of the 2sialidase forms performed in erythrocytes of different ages (Figure 2) showed that the distribution of the acidic and neutral sialidase changes in both control and diabetic subjects in relation to erythrocyte age. 

Phrase: "Erythrocyte age distribution in controls"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0001782:Age Distribution [Quantitative Concept]
   760   C0001779:Age [Organism Attribute]
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "diabetics Behavior of acidic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0004927:Behavior [Individual Behavior]
   770   C2707008:Behavior [Clinical Attribute]

Phrase: "and"

Phrase: "neutral sialidases in controls"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0027803:Sialidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "diabetic patients in differently aged erythrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030705:Patients [Patient or Disabled Group]

Phrase: "The assay of the 2sialidase forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]

Phrase: "performed in erythrocytes of different ages"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0001779:Age [Organism Attribute]
   753   C0014772:Erythrocytes [Laboratory Procedure]
   753   C0014792:Erythrocytes [Cell]
   753   C0884358:Performed [Functional Concept]
   753   C1705242:Different [Qualitative Concept]
   748   C0699810:age difference [Age Group]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Figure 2"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the distribution of the acidic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "neutral sialidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027803:Sialidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "changes in both control"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0243148:control [Qualitative Concept]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1550141:Control [Substance]
   770   C1705241:Change [Quantitative Concept]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "diabetic subjects in relation to erythrocyte age."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   757   C2348575:Subject Age [Organism Attribute]
   714   C0681850:Subject [Group]
   714   C1550501:{Subject} [Idea or Concept]
   714   C1706203:Subject [Idea or Concept]
   714   C2349001:Subject [Human]
   714   C2697811:Subject [Functional Concept]
Processing 00000000.tx.130: Histograms in Figure 3 show that, in controls, the acidic sialidase is the prevalent form of the enzyme in young cells (75%), while the neutral form prevails in senescent ones (84%). 

Phrase: "Histograms in Figure 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2348974:Histogram [Manufactured Object]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that,"

Phrase: "in controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "the acidic sialidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027803:Sialidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "the prevalent form of the enzyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "in young cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(75%"

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "the neutral form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "prevails in senescent ones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C3152857:Prevail [Pharmacologic Substance]
   737   C0205447:One [Quantitative Concept]

Phrase: "(84%"

Phrase: ")."
Processing 00000000.tx.131: In diabetic patients the acidic sialidase is the prevalent form of the enzyme, but the neutral sialidase does not increase with erythrocyte aging and in senescent red cells the levels of the latter enzyme are markedly diminished. 

Phrase: "In diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "the acidic sialidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027803:Sialidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "the prevalent form of the enzyme,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "but"

Phrase: "the neutral sialidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027803:Sialidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increase with erythrocyte aging"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0014768:Erythrocyte Aging [Cell Function]
   770   C0001811:Ageing [Organism Function]
   770   C0014792:Erythrocyte [Cell]
   770   C0442805:Increase [Functional Concept]
   715 E C1517378:Gain [Quantitative Concept]

Phrase: "and in senescent red cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0014792:Red cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0332575:Red [Finding]
   760   C1260956:Red [Qualitative Concept]
   760   C1515981:And [Idea or Concept]
   760   C3282337:Cells [Cell]
   745   C0007581:Cell Senescence [Cell Function]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "the levels of the latter enzyme"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   783   C0014440:enzyme levels [Laboratory Procedure]
   783   C1287349:enzyme levels [Laboratory or Test Result]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "diminished."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:Diminished [Quantitative Concept]
Processing 00000000.tx.132: View larger version (20K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.133: Effect of pH on the sialidase activity contained in resealed vesicles obtained from human erythrocytes of different ages. 

Phrase: "Effect of pH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on the sialidase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150037:sialidase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "contained in resealed vesicles"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0332256:contained [Functional Concept]
   770   C0333262:VESICLES [Acquired Abnormality]
   770   C2700400:Contained [Activity]
   737 E C1622418:vesicle [Cell Component]

Phrase: "obtained from human erythrocytes of different ages."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   748   C0001779:Age [Organism Attribute]
   748   C0014772:Erythrocytes [Laboratory Procedure]
   748   C0014792:Erythrocytes [Cell]
   748   C0086418:Human [Human]
   748   C1301820:Obtained [Functional Concept]
   748   C1705242:Different [Qualitative Concept]
   738   C0699810:age difference [Age Group]
   728   C0427458:erythrocytes increased [Finding]
   714 E C1706701:Obtain [Activity]
Processing 00000000.tx.134: View larger version (37K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(37K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.135: Behavior of acidic and neutral sialidase in differently aged human erythrocyte resealed vesicles obtained from control and diabetic subjects.  

Phrase: "Behavior of acidic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0004927:Behavior [Individual Behavior]
   790   C2707008:Behavior [Clinical Attribute]
   718 E C2986890:Behavioral [Idea or Concept]

Phrase: "and"

Phrase: "neutral sialidase in differently aged human erythrocyte"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0027803:Sialidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "resealed"

Phrase: "vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333262:VESICLES [Acquired Abnormality]
   966 E C1622418:vesicle [Cell Component]
   916 E C0205378:Vesicular [Qualitative Concept]

Phrase: "obtained from control"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1301820:Obtained [Functional Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "diabetic subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.136: Discussion Top Abstract Introduction Patients, materials, and... 

Phrase: "Discussion Top Abstract Introduction Patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030705:Patients [Patient or Disabled Group]

Phrase: "materials,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and..."
Processing 00000000.tx.137: Results Discussion References The evidence that in the diabetic condition the erythrocyte membrane presents structural and functional modifications,21-23,44 including altered levels of sialic acid,14,45 together with the demonstration in the same membrane of 2sialidase forms,19 prompted us to investigate the behavior of the erythrocyte plasma membrane sialidases in diabetes. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that in the diabetic condition"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0012634:condition [Disease or Syndrome]
   760   C0241863:DIABETIC [Finding]
   760   C0348080:Condition [Qualitative Concept]
   760   C1705253:Condition [Conceptual Entity]

Phrase: "the erythrocyte membrane"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0014780:Erythrocyte Membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "presents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "structural"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structural [Spatial Concept]

Phrase: "and"

Phrase: "functional modifications,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0581601:Functional modification [Therapeutic or Preventive Procedure]
   827   C0392747:Modification [Functional Concept]
   827   C1554963:modification [Qualitative Concept]

Phrase: "21-23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: "44"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "altered levels of sialic acid,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "14,"

Phrase: "45 together with the demonstration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883357:Together [Qualitative Concept]

Phrase: "in the same membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "of 2sialidase forms,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "19"

Phrase: "prompted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871157:prompted [Functional Concept]
   966 E C1602245:Prompt [Pharmacologic Substance]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the behavior of the erythrocyte plasma membrane sialidases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0004927:Behavior [Individual Behavior]
   744   C2707008:Behavior [Clinical Attribute]

Phrase: "in diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.138: This report provides evidence for the involvement of both sialidases in the diabetic condition: in fact, a significant increase (45%) of the acidic form and a significant decrease (22%) of the neutral form of the enzyme assayed on the exogenous substrate (MU-NeuAc) were observed in the erythrocyte resealed membranes from diabetic subjects. 

Phrase: "This report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "evidence for the involvement of both sialidases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in the diabetic condition"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0012634:condition [Disease or Syndrome]
   861   C0348080:Condition [Qualitative Concept]
   861   C1705253:Condition [Conceptual Entity]
   789 E C0009647:Conditioned [Mental Process]
   789 E C1701901:Conditional [Qualitative Concept]
   789 E C1963686:Conditional [Functional Concept]
   761 E C1519605:Conditionality [Conceptual Entity]

Phrase: ":"

Phrase: "in fact,"

Phrase: "a significant increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "(45%"

Phrase: ")"

Phrase: "of the acidic form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "a significant decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392756:Decrease [Qualitative Concept]
   861   C0547047:Decrease [Quantitative Concept]

Phrase: "(22%"

Phrase: ")"

Phrase: "of the neutral form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "of the enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "assayed on the exogenous substrate"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205101:Exogenous [Spatial Concept]
   760   C0205228:Exogenous [Functional Concept]
   760   C1710236:Substrate [Manufactured Object]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: "(MU-NeuAc"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0027801:Neuraminic acid [Biologically Active Substance,Carbohydrate]
   799   C0001128:Acid [Chemical]
   799   C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "were"

Phrase: "observed in the erythrocyte"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0014792:Erythrocyte [Cell]
   770   C1441672:Observed [Functional Concept]

Phrase: "resealed"

Phrase: "membranes from diabetic subjects."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0025255:Membranes [Tissue]
   737 E C0596901:Membrane [Cell Component]
   737 E C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.139: The lack of correlation with glycemic levels, metabolic compensation status, and disease duration suggests that the metabolic abnormalities may be related to insulin action impairment. 

Phrase: "The lack of correlation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "with glycemic levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "metabolic compensation status,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449438:Status [Qualitative Concept]

Phrase: "and"

Phrase: "disease duration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0872146:disease duration [Temporal Concept]
   861   C0449238:Duration [Temporal Concept]
   861   C2926735:Duration [Pharmacologic Substance]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the metabolic abnormalities"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0000768:Abnormalities [Congenital Abnormality]
   861   C0000769:abnormalities [Functional Concept]
   827 E C1704258:Abnormality [Finding]
   777 E C0205161:Abnormal [Qualitative Concept]
   777 E C2347472:% Abnormal [Quantitative Concept]
   777 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "related to insulin action impairment."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0439849:Related [Qualitative Concept]
   760   C0441472:Action [Functional Concept]
   760   C0445223:Related [Finding]
   760   C0684336:Impairment [Pathologic Function]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C3266814:Action [Activity]
   726 E C0163712:Relate [Organic Chemical]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.140: In fact, enzyme level variations occur regardless of the presence of complications, with the only exception observed being nephropatic diabetic patients, in whom a correlation between the acidic-neutral sialidase ratio and the severity of the disease was demonstrated. 

Phrase: "In fact,"

Phrase: "enzyme level variations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205419:variations [Qualitative Concept]
   734   C0014440:enzyme level [Laboratory Procedure]
   734   C1287349:Enzyme level [Laboratory or Test Result]

Phrase: "occur regardless of the presence of complications,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0009566:Complications [Pathologic Function]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1171258:complications [Pathologic Function]
   748   C1709305:Occur [Activity]
   748   C2745955:OCCUR [Temporal Concept]
   748   C3641650:Regardless [Qualitative Concept]
   714 E C2362589:Complication [Idea or Concept]

Phrase: "with the only exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1554961:exception [Idea or Concept]
   861   C1705847:Exception [Conceptual Entity]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "being"

Phrase: "nephropatic diabetic patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "in whom"

Phrase: "a correlation between the acidic-neutral sialidase ratio"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "the severity of the disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0521117:disease severity [Qualitative Concept]
   760   C0439793:Severity [Qualitative Concept]
   760   C2983285:Severity [Intellectual Product]

Phrase: "was"

Phrase: "demonstrated."
Processing 00000000.tx.141: The marked decrease observed in diabetic patients of the neutral sialidase, the only form of enzyme responsible for the release of sialic acid from endogenous sialoderivatives (present either at the erythrocyte membrane or in the plasma4,6), is likely responsible for the higher sialic acid content (40%) found in erythrocyte membranes of these subjects. 

Phrase: "The marked decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392756:Decrease [Qualitative Concept]
   861   C0547047:Decrease [Quantitative Concept]

Phrase: "observed in diabetic patients of the neutral sialidase,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0027803:Sialidase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0030705:Patients [Patient or Disabled Group]
   744   C0241863:DIABETIC [Finding]
   744   C1441672:Observed [Functional Concept]
   744   C1882074:Neutral [Qualitative Concept]
   744   C2825492:Neutral [Phenomenon or Process]

Phrase: "the only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "form of enzyme"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0014442:Enzyme [Enzyme,Organic Chemical]
   790   C0348078:Form [Qualitative Concept]
   790   C0376315:Form [Manufactured Object]
   790   C1522492:Form [Functional Concept]
   706 E C0014445:enzymes [Functional Concept]

Phrase: "responsible for the release of sialic acid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]

Phrase: "from endogenous sialoderivatives"

Phrase: "(present either at the erythrocyte membrane"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "or in the plasma4,"

Phrase: "6"

Phrase: ")"

Phrase: ","

Phrase: "is"

Phrase: "likely responsible for the higher sialic acid content"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1273518:Responsible [Finding]

Phrase: "(40%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "found in erythrocyte membranes of these subjects."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   778   C0014780:Membranes, Erythrocyte [Cell Component]
   748   C0014792:Erythrocyte [Cell]
   748   C0025255:Membranes [Tissue]
   748   C0150312:Found [Quantitative Concept]
   714 E C0243095:Find [Finding]
   714 E C0596901:Membrane [Cell Component]
   714   C0681850:Subject [Group]
   714   C1550501:{Subject} [Idea or Concept]
   714 E C1706182:Membrane [Manufactured Object]
   714   C1706203:Subject [Idea or Concept]
   714   C2349001:Subject [Human]
   714   C2697811:Subject [Functional Concept]
Processing 00000000.tx.142: The accumulation of sialoglycoproteins in the glomerular capillary wall, previously demonstrated in nephropatic patients,16,46 is in agreement with these observations. 

Phrase: "The accumulation of sialoglycoproteins"

Phrase: "in the glomerular capillary wall,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0677535:Wall [Manufactured Object]
   734   C0226356:Glomerular capillary [Body Part, Organ, or Organ Component]

Phrase: "previously"

Phrase: "demonstrated in nephropatic patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030705:Patients [Patient or Disabled Group]

Phrase: "16,"

Phrase: "46"

Phrase: "is in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with these observations."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]
Processing 00000000.tx.143: At this point it is important to remember that while the acidic sialidase is normally available to assay, the neutral sialidase is present in a "cryptic" form.19 Therefore, it may be suggested that its activity could be unmasked when major changes of the membrane enzymes and proteins occur, especially as a consequence of specific physiologic events involving certain domains of the erythrocyte membrane such as vesiculation processes.47,48 It cannot be excluded that the neutral sialidase is masked or negatively influenced in its expression by additional nonspecific alterations in the physicochemical and dynamic properties of erythrocyte membrane, which are known to occur in diabetes.21-23,44 In this condition, protein glycosylation and lipid peroxidation processes might contribute to the reduced lifespan and deformability of erythrocytes49 as well as to the altered content of specific membrane enzymes, ie, Ca/Mg-, Na/K-ATPase,50,51 Ach-esterase,23,52 and several glycohydrolases,20 with also an interference on the physiologic unmasking process of neutral sialidase. 

Phrase: "At this point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552961:Point [Quantitative Concept]
  1000   C2347617:point [Quantitative Concept]

Phrase: "it"

Phrase: "is"

Phrase: "important to"

Phrase: "remember"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679062:remember [Mental Process]

Phrase: "that"

Phrase: "while"

Phrase: "the acidic sialidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027803:Sialidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "normally available to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0470187:Available [Functional Concept]

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: ","

Phrase: "the neutral sialidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027803:Sialidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "present in a ""cryptic"" form.19 Therefore,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: "it"

Phrase: "may"

Phrase: "be"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "its activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "could"

Phrase: "be"

Phrase: "unmasked"

Phrase: "when"

Phrase: "major changes of the membrane enzymes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: ","

Phrase: "especially as a consequence of specific physiologic events"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0686907:Consequence of [Functional Concept]
           Consequence
   750   C1547646:Event Consequence [Idea or Concept]
   744   C0205369:Specific [Qualitative Concept]
   744   C0205463:Physiologic [Functional Concept]
   744   C0441471:Events [Event]
   744   C1552740:specific [Intellectual Product]
   744   C3541888:Events [Classification]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "certain domains of the erythrocyte membrane"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1880389:Domain [Functional Concept]
   719   C1883221:Domain [Conceptual Entity]
   719   C3541951:Domain [Intellectual Product]

Phrase: "such as vesiculation processes.47,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1184743:Process [Body Part, Organ, or Organ Component]
   793   C1522240:Process [Phenomenon or Process]

Phrase: "48"

Phrase: "It"

Phrase: "cannot"

Phrase: "be"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: "that"

Phrase: "the neutral sialidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027803:Sialidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "masked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0150108:masked [Research Activity]
  1000   C0150112:MASKED [Functional Concept]
  1000   C1555580:masked [Idea or Concept]
   966 E C0024861:Mask [Medical Device]
   966 E C1538279:MASK [Gene or Genome]
   966 E C1845191:MASK [Gene or Genome]

Phrase: "or"

Phrase: "negatively"

Phrase: "influenced in its expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "by additional nonspecific alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1515926:Alteration [Idea or Concept]

Phrase: "in the physicochemical"

Phrase: "and"

Phrase: "dynamic properties of erythrocyte membrane,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0871161:properties [Qualitative Concept]
   760   C1292721:properties [Functional Concept]
   726 E C1882134:Property [Conceptual Entity]
   726 E C2347695:Property [Entity]

Phrase: "which"

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur in diabetes.21-23,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0450348:23 [Quantitative Concept]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "44 In this condition,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0012634:condition [Disease or Syndrome]
   770   C0348080:Condition [Qualitative Concept]
   770   C1705253:Condition [Conceptual Entity]

Phrase: "protein glycosylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0376322:Protein Glycosylation [Molecular Function]
           Glycosylation
   861   C0017982:glycosylation [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "lipid peroxidation processes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1184743:Process [Body Part, Organ, or Organ Component]
   793   C1522240:Process [Phenomenon or Process]
   734   C0023775:Lipid Peroxidation [Molecular Function]

Phrase: "might"

Phrase: "contribute to the reduced lifespan"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0392756:Reduced [Qualitative Concept]
   760   C0870809:life span [Group Attribute]
   760   C1880177:Contribute [Activity]

Phrase: "and"

Phrase: "deformability of erythrocytes49"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0678559:deformability [Natural Phenomenon or Process]

Phrase: "as well as to the altered content of specific membrane enzymes,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   738   C0014442:Enzymes [Enzyme,Organic Chemical]
   738   C0014445:enzymes [Functional Concept]
   738   C0025255:Membrane [Tissue]
   738   C0205170:Well [Qualitative Concept]
   738   C0205369:Specific [Qualitative Concept]
   738   C0392747:Altered [Functional Concept]
   738   C0423896:Content [Mental Process]
   738   C0456205:Content [Conceptual Entity]
   738   C0596901:Membrane [Cell Component]
   738   C1552740:specific [Intellectual Product]
   738   C1706182:Membrane [Manufactured Object]
   738   C3146287:Well [Manufactured Object]

Phrase: "ie"

Phrase: ","

Phrase: "Ca/Mg-,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "Na/K-ATPase,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0001479:NA K ATPASE [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0525416:Na ATPase [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0001473:ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "50,"

Phrase: "51 Ach-esterase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014894:Esterase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "52"

Phrase: "and"

Phrase: "several glycohydrolases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017976:Glycohydrolases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "20 with also"

Phrase: "an interference on the physiologic unmasking process of neutral sialidase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0521102:Interference [Qualitative Concept]
Processing 00000000.tx.144: In fact, on the basis of our more recent experience, we know that in vitro vesiculation of erythrocyte membrane, which mimics the physiologic process of vesiculation, results in the release of vesicles enriched in acidic sialidase and Ach-esterase, with the concurrent unmasking of neutral sialidase.53 Therefore, it is conceivable that an impairment of this process, possibly caused by membrane alterations, could account in diabetic patients for the less pronounced decrease of acidic sialidase and Ach-esterase23 with their consequent apparent increase. 

Phrase: "In fact,"

Phrase: "on the basis of our more recent experience,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0237607:experience [Mental Process]
   827   C0596545:Experience [Mental Process]

Phrase: "we"

Phrase: "know"

Phrase: "that in vitro vesiculation of erythrocyte membrane,"

Phrase: "which"

Phrase: "mimics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0393040:mimics [Therapeutic or Preventive Procedure]
  1000   C1176299:mimics [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "the physiologic process of vesiculation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0031845:physiologic process [Physiologic Function]
   760   C1184743:Process [Body Part, Organ, or Organ Component]
   760   C1522240:Process [Phenomenon or Process]

Phrase: "results in the release of vesicles"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   753   C0030685:Release [Health Care Activity]
   753   C0333262:VESICLES [Acquired Abnormality]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1274040:Result [Functional Concept]
   753   C1283071:Release [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]
   753   C2825142:Result [Finding]
   719 E C1622418:vesicle [Cell Component]

Phrase: "enriched in acidic sialidase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0001128:Acidic [Chemical]
   770   C0027803:Sialidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0359583:enriched [Food]

Phrase: "and"

Phrase: "Ach-esterase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014894:Esterase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "with the concurrent unmasking"

Phrase: "of neutral sialidase.53 Therefore,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0027803:Sialidase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1882074:Neutral [Qualitative Concept]
   812   C2825492:Neutral [Phenomenon or Process]

Phrase: "it"

Phrase: "is"

Phrase: "conceivable"

Phrase: "that"

Phrase: "an impairment of this process,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0684336:Impairment [Pathologic Function]

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "caused by membrane alterations,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   816   C0541642:Membrane Alteration [Cell or Molecular Dysfunction]
   770   C0025255:Membrane [Tissue]
   770   C0596901:Membrane [Cell Component]
   770   C1706182:Membrane [Manufactured Object]
   737   C0015127:cause [Functional Concept]
   737   C1515926:Alteration [Idea or Concept]
   737   C1524003:Cause [Conceptual Entity]

Phrase: "could"

Phrase: "account in diabetic patients"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0241863:DIABETIC [Finding]
   770   C1551359:account [Idea or Concept]
   770   C2741673:Account # [Clinical Attribute]
   770   C2981730:Account [Classification]

Phrase: "for the less pronounced decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392756:Decrease [Qualitative Concept]
   827   C0547047:Decrease [Quantitative Concept]

Phrase: "of acidic sialidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027803:Sialidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Ach-esterase23 with their consequent apparent increase."
Processing 00000000.tx.145: Both above enzymes are associated to the membrane through a GPI anchor.18 Interestingly, the erythrocyte membrane of diabetic subjects was less sensitive to the action of a specific PIPLC: in fact, after treatment with B thuringiensis phospholipase C, diabetic erythrocyte resealed membranes liberated a much lower amount (only 26% vs 88%) of acidic sialidase than those obtained from healthy subjects. 

Phrase: "Both above enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]

Phrase: "are"

Phrase: "associated to the membrane"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0025255:Membrane [Tissue]
   770   C0332281:Associated [Qualitative Concept]
   770   C0596901:Membrane [Cell Component]
   770   C1706182:Membrane [Manufactured Object]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "through a GPI anchor.18 Interestingly,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0061688:Glycosyl-Phosphatidylinositol [Carbohydrate,Lipid,Organophosphorus Compound]
   812   C1293132:anchor [Therapeutic or Preventive Procedure]

Phrase: "the erythrocyte membrane of diabetic subjects"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0014780:Erythrocyte Membrane [Cell Component]
   753   C0025255:Membrane [Tissue]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]

Phrase: "was"

Phrase: "less sensitive to the action of a specific PIPLC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332324:Sensitive to [Functional Concept]
           Sensitive
   739   C1550474:sensitive [Idea or Concept]

Phrase: ":"

Phrase: "in fact,"

Phrase: "after"

Phrase: "treatment with B thuringiensis phospholipase C,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "diabetic erythrocyte"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014792:Erythrocyte [Cell]

Phrase: "resealed"

Phrase: "membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "liberated"

Phrase: "a much lower amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1265611:Amount [Quantitative Concept]

Phrase: "(only 26%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "vs"

Phrase: "88%"

Phrase: ")"

Phrase: "of acidic sialidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027803:Sialidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "than those"

Phrase: "obtained from healthy subjects."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C1708335:HEALTHY SUBJECTS [Population Group]
   770   C1301820:Obtained [Functional Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737 E C1706701:Obtain [Activity]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
Processing 00000000.tx.146: Probably, the characteristic changes occurring at the red cell membrane level,49,54 the first one being the increased level of sialic acid due to neutral sialidase activity reduction, could interfere with GPI-anchored proteins. 

Phrase: "Probably,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "the characteristic changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "occurring at the red cell membrane level,"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   778   C0007603:Cell Membrane [Cell Component]
   778   C0014792:Red Cell [Cell]
   778   C3161472:Cell Membrane [Cell Component]
   748   C0007634:Cell [Cell]
   748   C0025255:Membrane [Tissue]
   748   C0332575:Red [Finding]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C0596901:Membrane [Cell Component]
   748   C1260956:Red [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1547707:Level [Geographic Area]
   748   C1704653:Cell [Medical Device]
   748   C1706182:Membrane [Manufactured Object]
   748   C1948049:Cell [Spatial Concept]
   748   C2946261:Level [Pharmacologic Substance]
   714   C1709305:Occur [Activity]
   714   C2745955:OCCUR [Temporal Concept]

Phrase: "49,"

Phrase: "54"

Phrase: "the first one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "being"

Phrase: "the increased level of sialic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "due to neutral sialidase activity reduction,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0301630:Reduction [Natural Phenomenon or Process]
   812   C0392756:Reduction [Qualitative Concept]
   812   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "could"

Phrase: "interfere with GPI-anchored proteins."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C1622508:protein anchor [Molecular Function]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0061688:Glycosyl-Phosphatidylinositol [Carbohydrate,Lipid,Organophosphorus Compound]
   760   C0521102:Interfere [Qualitative Concept]
   760   C1293132:anchored [Therapeutic or Preventive Procedure]
Processing 00000000.tx.147: Thus, diabetic erythrocytes could become less susceptible to PIPLC action. 

Phrase: "Thus,"

Phrase: "diabetic erythrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014772:Erythrocytes [Laboratory Procedure]
   861   C0014792:Erythrocytes [Cell]

Phrase: "could"

Phrase: "become"

Phrase: "less susceptible to PIPLC action."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0231204:Susceptible [Functional Concept]
   753   C2827758:SUSCEPTIBLE [Laboratory or Test Result]
Processing 00000000.tx.148: A similar behavior has been shown in diabetes for Ach-esterase,23 a specific marker of the outer surface for GPI-anchored proteins. 

Phrase: "A similar behavior"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0004927:Behavior [Individual Behavior]
   861   C2707008:Behavior [Clinical Attribute]
   789 E C2986890:Behavioral [Idea or Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown in diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   756   C1547282:Show [Intellectual Product]

Phrase: "for Ach-esterase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014894:Esterase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "a specific marker of the outer surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0005516:Marker [Clinical Attribute]

Phrase: "for GPI-anchored proteins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0061688:Glycosyl-Phosphatidylinositol [Carbohydrate,Lipid,Organophosphorus Compound]
   827   C1293132:anchored [Therapeutic or Preventive Procedure]
Processing 00000000.tx.149: The increased content of sialic acid occurring in diabetics, as a consequence of the altered ratio between the 2forms of erythrocyte sialidases, is particularly important in the light of its role in the maintenance of erythrocyte viability and survival in circulating blood.55 On this basis, we investigated whether the erythrocyte population age in diabetics was different compared with healthy subjects. 

Phrase: "The increased content of sialic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]

Phrase: "occurring in diabetics,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0241863:diabetics [Finding]
   756   C1709305:Occur [Activity]
   756   C2745955:OCCUR [Temporal Concept]

Phrase: "as"

Phrase: "a consequence of the altered ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "between the 2forms"

Phrase: "of erythrocyte sialidases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0027803:Sialidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "particularly important in the light of its role"

Phrase: "in the maintenance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintenance [Activity]

Phrase: "of erythrocyte viability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443348:viability [Qualitative Concept]

Phrase: "and"

Phrase: "survival in circulating blood.55"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]

Phrase: "On this basis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1527178:Basis [Functional Concept]
  1000   C1874451:Basis [Pharmacologic Substance]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "whether"

Phrase: "the erythrocyte population age in diabetics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0001779:Age [Organism Attribute]

Phrase: "was"

Phrase: "different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1705242:Different [Qualitative Concept]
   928 E C1705241:*Difference [Quantitative Concept]
   900 E C0443199:Differential [Qualitative Concept]

Phrase: "compared with healthy subjects."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1708335:HEALTHY SUBJECTS [Population Group]
   770   C1707455:Compared [Activity]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
Processing 00000000.tx.150: The method used to separate differently aged erythrocytes allowed us to obtain young, average aged, and senescent elements clearly identified by specific characteristic markers (Table 5). 

Phrase: "The method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "separate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:Separate [Spatial Concept]

Phrase: "differently aged erythrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014772:Erythrocytes [Laboratory Procedure]
   827   C0014792:Erythrocytes [Cell]

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "young, average aged,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0001779:Aged [Organism Attribute]
   827   C0001792:Aged [Population Group]
   827   C1999167:aged [Population Group]

Phrase: "and"

Phrase: "senescent elements clearly"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0013879:Elements [Element, Ion, or Isotope]
   793 E C1705248:Element [Conceptual Entity]

Phrase: "identified by specific characteristic markers"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205369:Specific [Qualitative Concept]
   760   C0205396:Identified [Qualitative Concept]
   760   C1521970:Characteristic [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C1552740:specific [Intellectual Product]
   726   C0005516:Marker [Clinical Attribute]

Phrase: "(Table 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.151: In our experimental conditions, reticulocytes are present mainly in fraction R and in negligible amounts in fraction 1,while being completely absent in the other fractions. 

Phrase: "In our experimental conditions,"
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   861   C1517586:Experimental [Qualitative Concept]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "reticulocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035286:Reticulocytes [Cell]

Phrase: "are"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "mainly in fraction R"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205090:R- [Spatial Concept]
   770   C0684010:R. [Professional or Occupational Group]
   770   C1264633:Fraction [Quantitative Concept]
   770   C1554103:Fraction [Idea or Concept]
   770   C2603358:R' [Clinical Attribute]

Phrase: "and in negligible amounts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332269:Negligible [Qualitative Concept]
   770   C1265611:amounts [Quantitative Concept]
   770   C1515981:And [Idea or Concept]

Phrase: "in fraction 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "while"

Phrase: "being"

Phrase: "completely absent in the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:Absent [Quantitative Concept]
   770   C2699517:ABSENT [Finding]

Phrase: "other fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.152: Notably, no changes were observed in the erythrocyte distribution, from both controls and diabetic subjects, along the gradient used to separate red cells according to their age, due to the use of high Na+/low K+- or low Na+/high K+-containing buffers.29 This evidence reasonably excludes that the experimental conditions used to separate erythrocytes may cause per se modifications of the erythrocyte density affecting their distribution along the gradient. 

Phrase: "Notably,"

Phrase: "no changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "observed in the erythrocyte distribution,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0014792:Erythrocyte [Cell]
   760   C0520511:distribution [Idea or Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "from both controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "diabetic subjects,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "along the gradient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439182:% gradient [Quantitative Concept]
  1000   C0812409:Gradient [Quantitative Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "separate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:Separate [Spatial Concept]

Phrase: "red cells according to their age,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0014792:Red cells [Cell]
   783   C0178537:age cells [Temporal Concept]
   753   C0007634:Cells [Cell]
   753   C0332575:Red [Finding]
   753   C1260956:Red [Qualitative Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "due to the use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of high Na+/low K+-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1708601:K' [Quantitative Concept]

Phrase: "or"

Phrase: "low Na+/high K+-containing buffers.29"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   795   C0006353:Buffers [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   795   C0205250:High [Qualitative Concept]
   795   C0205251:low [Qualitative Concept]
   795   C0332256:Containing [Functional Concept]
   795   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   795   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   795   C1272460:{NA} [Qualitative Concept]
   795   C1299351:High [Qualitative Concept]
   795   C1299352:Low [Qualitative Concept]
   795   C1550472:low [Idea or Concept]
   795   C1708601:K' [Quantitative Concept]
   795   C2700149:HIGH [Intellectual Product]
   795   C2700400:Containing [Activity]

Phrase: "This evidence reasonably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "excludes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "that"

Phrase: "the experimental conditions"
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   861   C1517586:Experimental [Qualitative Concept]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "separate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:Separate [Spatial Concept]

Phrase: "erythrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014772:Erythrocytes [Laboratory Procedure]
  1000   C0014792:Erythrocytes [Cell]

Phrase: "may"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "per se modifications of the erythrocyte density affecting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C0392747:Modification [Functional Concept]
   711   C1554963:modification [Qualitative Concept]

Phrase: "their distribution along the gradient."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]
Processing 00000000.tx.153: These data suggest that in diabetic patients the red cell population is qualitatively different from healthy subjects, with a net prevalence of younger cells. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that in diabetic patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0241863:DIABETIC [Finding]

Phrase: "the red cell population"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]
   734   C0014792:Red Cell [Cell]

Phrase: "is"

Phrase: "qualitatively different from healthy subjects,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "with a net prevalence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033105:Prevalence [Quantitative Concept]
   861   C0220900:prevalence [Quantitative Concept]

Phrase: "of younger cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.154: Interestingly, while young erythrocytes from controls and diabetics have the same content of the 2sialidases, in diabetics senescent red cells have a markedly decreased expression of neutral sialidase. 

Phrase: "Interestingly,"

Phrase: "while"

Phrase: "young erythrocytes from controls"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0014772:Erythrocytes [Laboratory Procedure]
   770   C0014792:Erythrocytes [Cell]

Phrase: "and"

Phrase: "diabetics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:diabetics [Finding]

Phrase: "have"

Phrase: "the same content of the 2sialidases,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]

Phrase: "in diabetics senescent red cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0014792:Red cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0332575:Red [Finding]
   812   C1260956:Red [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "a markedly decreased expression of neutral sialidase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.155: This suggests that in this pathological condition the erythrocyte does not undergo a normal maturation process. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that in this pathological condition"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   760   C0012634:condition [Disease or Syndrome]
   760   C0030664:Pathological [Biomedical Occupation or Discipline]
   760   C0348080:Condition [Qualitative Concept]
   760   C1521733:Pathological [Functional Concept]
   760   C1705253:Condition [Conceptual Entity]
   704 E C0040607:Training [Educational Activity]
   704 E C0220931:Training [Educational Activity]
   704 E C0336809:Train [Manufactured Object]
   704 E C1552514:Train [Manufactured Object]
   704 E C2673163:training [Qualitative Concept]

Phrase: "the erythrocyte"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014792:Erythrocyte [Cell]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "undergo"

Phrase: "a normal maturation process."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.156: These data are consistent with the notion reported by Mazzanti et al45,56 regarding the accelerated erythrocyte aging in human diabetes mellitus. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "consistent with the notion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "reported by Mazzanti et al45,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1709908:Reported By [Group]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]

Phrase: "56"

Phrase: "regarding"

Phrase: "the accelerated erythrocyte aging in human diabetes mellitus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0014768:Erythrocyte Aging [Cell Function]
   744   C0001811:Ageing [Organism Function]
Processing 00000000.tx.157: Presumably, the higher negative charge at the erythrocyte surface due to sialic acid increase results in a premature sequestration of diabetic red cells by macrophages and proves the importance of the neutral sialidase for the physiologic death of erythrocytes. 

Phrase: "Presumably,"

Phrase: "the higher negative charge at the erythrocyte surface"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C2825491:Negative Charge [Qualitative Concept]
           Negative
   744   C0007961:Charge [Quantitative Concept]
   744   C0205160:Negative [Qualitative Concept]
   744   C1513916:Negative [Finding]
   744   C1706211:Charge [Organism Attribute]
   744   C2825415:Negative [Conceptual Entity]

Phrase: "due to sialic acid increase results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1274040:Result [Functional Concept]
   779   C1546471:Result [Idea or Concept]
   779   C2825142:Result [Finding]

Phrase: "in a premature sequestration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443301:Sequestration [Functional Concept]

Phrase: "of diabetic red cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0014792:Red cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0332575:Red [Finding]
   827   C1260956:Red [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "by macrophages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024432:Macrophages [Cell]
  1000   C1546706:Macrophages [Intellectual Product]
  1000   C1550652:Macrophages [Body Substance]

Phrase: "and"

Phrase: "proves"

Phrase: "the importance of the neutral sialidase"

Phrase: "for the physiologic death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011065:Death [Organism Function]
   861   C1306577:Death, NOS [Finding]

Phrase: "of erythrocytes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014772:Erythrocytes [Laboratory Procedure]
  1000   C0014792:Erythrocytes [Cell]
Processing 00000000.tx.158: On the basis of the overall evidence provided in this report, we believe that the diabetic condition induces functional alterations of the sialic acid-sialidase system of the erythrocyte membrane. 

Phrase: "On the basis of the overall evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "provided in this report,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0684224:Report [Intellectual Product]
   770   C0700287:Report [Health Care Activity]
   770   C1999230:Provided [Activity]
   770   C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "believe"

Phrase: "that"

Phrase: "the diabetic condition"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0012634:condition [Disease or Syndrome]
   861   C0348080:Condition [Qualitative Concept]
   861   C1705253:Condition [Conceptual Entity]
   789 E C0009647:Conditioned [Mental Process]
   789 E C1701901:Conditional [Qualitative Concept]
   789 E C1963686:Conditional [Functional Concept]
   761 E C1519605:Conditionality [Conceptual Entity]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "functional alterations of the sialic acid-sialidase system of the erythrocyte membrane."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0541642:Membrane Alteration [Cell or Molecular Dysfunction]
   703   C1515926:Alteration [Idea or Concept]
Processing 00000000.tx.159: The finding that the membrane perturbations occurring in diabetes alter the activity of the only enzyme able to reduce the sialic acid content of erythrocyte surface, with concomitant decrease of the lifespan of red cells, focuses the attention on the relevance of the molecular events involving the expression of sialidases in the process of erythrocyte aging.  

Phrase: "The finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that"

Phrase: "the membrane perturbations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332453:perturbation [Functional Concept]

Phrase: "occurring in diabetes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   756   C1709305:Occur [Activity]
   756   C2745955:OCCUR [Temporal Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the activity of the only enzyme able to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0243102:enzyme activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "reduce"

Phrase: "the sialic acid content of erythrocyte surface,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]

Phrase: "with concomitant decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392756:Decrease [Qualitative Concept]
   861   C0547047:Decrease [Quantitative Concept]

Phrase: "of the lifespan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0870809:life span [Group Attribute]

Phrase: "of red cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0014792:Red cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0332575:Red [Finding]
   861   C1260956:Red [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "focuses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205234:Focus [Spatial Concept]
  1000   C1285542:focus [Functional Concept]

Phrase: "the attention on the relevance of the molecular events"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0004268:Attention [Mental Process]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "the expression of sialidases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "of erythrocyte aging."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014768:Erythrocyte Aging [Cell Function]
   861   C0001811:Ageing [Organism Function]
Processing 00000000.tx.160: Footnotes Submitted December 13,2000; 

Phrase: "Footnotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825232:Footnote [Intellectual Product]

Phrase: "Submitted December 13,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1515023:Submitted [Functional Concept]

Phrase: "2000"

Phrase: ";"
Processing 00000000.tx.161: accepted October 1,2001. 

Phrase: "accepted October 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2001."
Processing 00000000.tx.162: Supported by grants from MURST PRIN 2000(B.V.) 

Phrase: "Supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from MURST PRIN 2000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0600587:prin [Molecular Biology Research Technique]

Phrase: "(B.V."

Phrase: ")"
Processing 00000000.tx.163: and from the University of Milan (60%-1999) (A.L.). 

Phrase: "and from the University of Milan"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0041740:University [Manufactured Object,Organization]
   753   C1515981:And [Idea or Concept]

Phrase: "(60%-1999"

Phrase: ")"

Phrase: "(A.L."

Phrase: ")."
Processing 00000000.tx.164: The publication costs of this article were defrayed in part by page charge payment. 

Phrase: "The publication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034036:Publication [Intellectual Product,Manufactured Object]
  1000   C0034037:Publication [Occupational Activity]
  1000   C1704324:Publication [Intellectual Product]

Phrase: "costs of this article"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010186:Cost [Quantitative Concept]
   770   C0220812:Costs [Quantitative Concept]
   770   C1706852:Article [Intellectual Product]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by page charge payment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0220808:payment [Quantitative Concept]
   827   C0680264:payment [Quantitative Concept]
Processing 00000000.tx.165: Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18U.S.C. section 1734. 

Phrase: "Therefore,"

Phrase: "and"

Phrase: "solely to"

Phrase: "indicate"

Phrase: "this fact,"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C. section 1734."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0205155:Section [Spatial Concept]
   804   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   804   C1522472:Section [Substance]
   804   C1552923:Section [Quantitative Concept]
   804   C1705191:Section [Physical Object]
Processing 00000000.tx.166: Reprints: Bruno Venerando, Dipartimento di Chimica e Biochimica MedicaFacolt di Medicina e ChirurgiaUniversit di Milano, LITA, Via Fratelli Cervi 93-20090Segrate, Milano, Italia; 

Phrase: "Reprints"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3273171:Reprint [Intellectual Product]

Phrase: ":"

Phrase: "Bruno Venerando,"

Phrase: "Dipartimento di Chimica e Biochimica MedicaFacolt di Medicina e ChirurgiaUniversit di Milano,"

Phrase: "LITA,"

Phrase: "Via Fratelli Cervi 93-20090Segrate,"

Phrase: "Milano,"

Phrase: "Italia"

Phrase: ";"
Processing 00000000.tx.167: e-mail: bruno.venerando{at}unimi.it .  References Top Abstract Introduction Patients, materials, and... 

Phrase: "e-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "bruno.venerando{at}unimi."

Phrase: "it ."

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "materials,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and..."
Processing 00000000.tx.168: Results Discussion References 1. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.169: Chari SN, Nath N. 

Phrase: "Chari SN,"

Phrase: "Nath N."
Processing 00000000.tx.170: Sialic acid content and sialidase activity of polymorphonuclear leukocytes in diabetes mellitus. 

Phrase: "Sialic acid content"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
   734   C0067762:Sialic Acid [Biologically Active Substance,Carbohydrate]

Phrase: "and"

Phrase: "sialidase activity of polymorphonuclear leukocytes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1150037:sialidase activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "in diabetes mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]
Processing 00000000.tx.171: Am J Med Sci. 

Phrase: "Am"

Phrase: "J Med Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.172: 1984;288:18-20[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1984"

Phrase: ";288"

Phrase: ":"

Phrase: "18-20"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.173: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.174: Isaev EI, Ergashova MZ, Salikhodzheva DS, Turakulov IK. 

Phrase: "Isaev EI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1414370:EI [Gene or Genome]
   861   C2348481:Ei [Quantitative Concept]

Phrase: "Ergashova MZ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026655:MZ [Geographic Area]
   861   C1705291:mz [Phenomenon or Process]

Phrase: "Salikhodzheva DS,"

Phrase: "Turakulov IK."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416378:IK [Gene or Genome]
Processing 00000000.tx.175: Sialic acid content of individual tissue glycolipids in rats under normal conditions and in alloxan diabetes. 

Phrase: "Sialic acid content of individual tissue glycolipids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]

Phrase: "in rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "under normal conditions"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   983   C0231162:Normal condition [Finding]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "and in alloxan diabetes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0002152:Alloxan Diabetes [Experimental Model of Disease]
   770   C0002151:Alloxan [Biologically Active Substance,Organic Chemical]
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]
   770   C1515981:And [Idea or Concept]
Processing 00000000.tx.176: Probl Endokrinol. 

Phrase: "Probl Endokrinol."
Processing 00000000.tx.177: 1983;29:67-71. 

Phrase: "1983"

Phrase: ";29"

Phrase: ":"

Phrase: "67-71."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450389:71 [Intellectual Product]
Processing 00000000.tx.178: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.179: Durand G, Dumont JP, Appel M, et al. 

Phrase: "Durand G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Dumont JP,"

Phrase: "Appel M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.180: Effect of streptozotocin diabetes on sialic acid content and glycoprotein binding of isolated hepatocytes. 

Phrase: "Effect of streptozotocin diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on sialic acid content"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
   734   C0067762:Sialic Acid [Biologically Active Substance,Carbohydrate]

Phrase: "and"

Phrase: "glycoprotein binding of isolated hepatocytes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1621831:glycoprotein binding [Molecular Function]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
Processing 00000000.tx.181: Horm Metab Res. 

Phrase: "Horm Metab Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]
Processing 00000000.tx.182: 1980;12:247-251[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1980"

Phrase: ";12"

Phrase: ":"

Phrase: "247-251"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.183: 4. 

Phrase: "4."
Processing 00000000.tx.184: Tomino Y, Inoue W, Yagame M, et al. 

Phrase: "Tomino Y,"

Phrase: "Inoue W,"

Phrase: "Yagame M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.185: Measurement of sialic acid and acute phase reactant proteins in sera of patients with diabetic nephropathy. 

Phrase: "Measurement of sialic acid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0242485:Measurement [Functional Concept]

Phrase: "and"

Phrase: "acute phase reactant proteins in sera of patients"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   800   C0001347:Acute phase reactant [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Acute-Phase Proteins
   770   C0439557:Acute phase [Temporal Concept]
   750   C0036825:Serum Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C1546542:Serum, Acute [Intellectual Product]
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205178:acute [Temporal Concept]
   744   C0205390:Phase [Temporal Concept]
   734 E C1304893:Protein.serum [Laboratory or Test Result]

Phrase: "with diabetic nephropathy."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0011881:Diabetic Nephropathy [Disease or Syndrome]
  1000   C1442864:diabetic nephropathy [Gene or Genome]
   861   C0022658:Nephropathy [Disease or Syndrome]
   861   C0241863:DIABETIC [Finding]
Processing 00000000.tx.186: J Diabetes Complicat. 

Phrase: "J Diabetes Complicat."
Processing 00000000.tx.187: 1988;2:175-188. 

Phrase: "1988"

Phrase: ";2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "175-188."
Processing 00000000.tx.188: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.189: Crook M, Cartwright K, Lumb P, Worsley A. 

Phrase: "Crook M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Cartwright K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Lumb P,"

Phrase: "Worsley A."
Processing 00000000.tx.190: Serum sialic acid in young type-1 diabetic patients. 

Phrase: "Serum sialic acid in young type-1 diabetic patients."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0067762:Sialic Acid [Biologically Active Substance,Carbohydrate]
   742   C0001128:Acid [Chemical]
   742   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.191: Diabetes Res Clin Pract. 

Phrase: "Diabetes Res Clin Pract."
Processing 00000000.tx.192: 2000;47:119-122[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "2000"

Phrase: ";47"

Phrase: ":"

Phrase: "119-122"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.193: 6. 

Phrase: "6."
Processing 00000000.tx.194: Pickup JC, Day C, Bailey CJ, et al. 

Phrase: "Pickup JC,"

Phrase: "Day C,"

Phrase: "Bailey CJ,"

Phrase: "et al."
Processing 00000000.tx.195: Plasma sialic acid in animal models of diabetes mellitus: evidence for modulation of sialic acid concentrations by insulin deficiency. 

Phrase: "Plasma sialic acid in animal models of diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0067762:Sialic Acid [Biologically Active Substance,Carbohydrate]
   742   C0001128:Acid [Chemical]
   742   C0202406:Acid [Laboratory Procedure]

Phrase: ":"

Phrase: "evidence for modulation of sialic acid concentrations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "by insulin deficiency."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0011155:Deficiency [Functional Concept]
   861   C0162429:Deficiency [Disease or Syndrome]
   861   C1623416:deficiency [Qualitative Concept]
   789 E C1636779:% deficient [Quantitative Concept]
Processing 00000000.tx.196: Life Sci. 

Phrase: "Life Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.197: 1995;57:1383-1391[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1995"

Phrase: ";57"

Phrase: ":"

Phrase: "1383-1391"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.198: 7. 

Phrase: "7."
Processing 00000000.tx.199: Rogers ME, Williams DT, Niththyananthan R, Rampling MW, Heslop KE, Johnston DG. 

Phrase: "Rogers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3463939:Roger [Eukaryote]

Phrase: "ME,"

Phrase: "Williams DT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3539739:DT [Gene or Genome]
   861   C3542920:DT [Idea or Concept]

Phrase: "Niththyananthan R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Rampling MW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024548:MW [Geographic Area]
   861   C0026385:mw [Quantitative Concept]
   861   C0556966:mW [Quantitative Concept]

Phrase: "Heslop KE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022558:KE [Geographic Area]

Phrase: "Johnston DG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]
Processing 00000000.tx.200: Decrease in erythrocyte glycophorin sialic acid content is associated with increased erythrocyte aggregation in human diabetes. 

Phrase: "Decrease in erythrocyte glycophorin sialic acid content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "is"

Phrase: "associated with increased erythrocyte aggregation"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   806   C0014766:Erythrocyte Aggregation [Laboratory Procedure]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C1608376:Erythrocyte aggregation [Cell Function]
   806   C1608880:Erythrocyte aggregation [Laboratory or Test Result]
   760   C0014792:Erythrocyte [Cell]
   760   C0205217:Increased [Quantitative Concept]
   760   C0332621:Aggregation [Functional Concept]
   760   C0439168:% aggregation [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in human diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.201: Clin Sci. 

Phrase: "Clin Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.202: 1992;82:309-313[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1992"

Phrase: ";82"

Phrase: ":"

Phrase: "309-313"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.203: 8. 

Phrase: "8."
Processing 00000000.tx.204: Salhanick AI, Amatruda JM. 

Phrase: "Salhanick AI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003353:AI [Geographic Area]
   861   C0003504:ai [Disease or Syndrome]

Phrase: "Amatruda JM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]
Processing 00000000.tx.205: Role of sialic acid in insulin action and the insulin resistance of diabetes mellitus. 

Phrase: "Role of sialic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in insulin action"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441472:Action [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C3266814:Action [Activity]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "the insulin resistance of diabetes mellitus."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   834   C0743125:Insulin resistant diabetes mellitus [Disease or Syndrome]
   820   C0342335:diabetes insulin resistance [Disease or Syndrome]
   797 E C0854110:Insulin resistant diabetes [Disease or Syndrome]
   790   C0021655:Insulin Resistance [Pathologic Function]
   790   C2700570:INSULIN RESISTANCE [Gene or Genome]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0237834:Resistance [Mental Process]
   753   C1514892:Resistance [Physiologic Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.206: Am J Physiol. 

Phrase: "Am"

Phrase: "J Physiol."
Processing 00000000.tx.207: 1988;255:173-179. 

Phrase: "1988"

Phrase: ";255"

Phrase: ":"

Phrase: "173-179."
Processing 00000000.tx.208: 9. 

Phrase: "9."
Processing 00000000.tx.209: Scionti L, Calafiore R, Coaccioli S, et al. 

Phrase: "Scionti L,"

Phrase: "Calafiore R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Coaccioli S,"

Phrase: "et al."
Processing 00000000.tx.210: RBC sialic acid levels in diabetic patients in poor glycemic control. 

Phrase: "RBC sialic acid levels in diabetic patients"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "in poor glycemic control."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0342299:Poor glycaemic control [Pathologic Function]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   755   C0005802:glycemia [Carbohydrate]
Processing 00000000.tx.211: Second Milan International Meeting on Diabetes, Nutrition and Atherosclerosis. 

Phrase: "Second Milan International Meeting on Diabetes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0556656:Meeting [Health Care Activity]

Phrase: "Nutrition"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0028707:Nutrition [Biomedical Occupation or Discipline]
  1000   C0392209:nutrition [Organism Attribute]
  1000   C1442959:Nutrition [Organism Function]
   928 E C1521739:Nutritional [Qualitative Concept]
   928 E C2707262:Nutritional [Clinical Attribute]

Phrase: "and"

Phrase: "Atherosclerosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004153:Atherosclerosis [Disease or Syndrome]
   928 E C0333482:Atherosclerotic [Functional Concept]
Processing 00000000.tx.212: Vol 26. 

Phrase: "Vol 26."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0449468:VOL [Quantitative Concept]
   861   C0560268:vol% [Quantitative Concept]
   861   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.213: Milan: Italy.; 

Phrase: "Milan"

Phrase: ":"

Phrase: "Italy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]

Phrase: ";"
Processing 00000000.tx.214: 1983:74-75. 

Phrase: "1983"

Phrase: ":"

Phrase: "74-75."
Processing 00000000.tx.215: 10. 

Phrase: "10."
Processing 00000000.tx.216: Gerbaut L, de Lauture D, Olive AG, Pequignot H. 

Phrase: "Gerbaut L,"

Phrase: "de Lauture D,"

Phrase: "Olive AG,"

Phrase: "Pequignot H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.217: Simultaneous determination of sialic acid and protein in erytrocyte membrane from diabetic patients. 

Phrase: "Simultaneous determination of sialic acid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1148554:determination [Laboratory Procedure]

Phrase: "and"

Phrase: "protein in erytrocyte membrane"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "from diabetic patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.218: Clin Chem. 

Phrase: "Clin Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.219: 1978;24:1287-1288[Free FullText]. 

Phrase: "1978"

Phrase: ";24"

Phrase: ":"

Phrase: "1287-1288"

Phrase: "[Free FullText"

Phrase: "]."
Processing 00000000.tx.220: 11. 

Phrase: "11."
Processing 00000000.tx.221: Aminoff D, Bell WC, Fulton I, Ingebrightsen N. 

Phrase: "Aminoff D,"

Phrase: "Bell WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Fulton I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Ingebrightsen N."
Processing 00000000.tx.222: Effect of sialidase on the viability of erythrocytes in circulation. 

Phrase: "Effect of sialidase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on the viability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443348:viability [Qualitative Concept]

Phrase: "of erythrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014772:Erythrocytes [Laboratory Procedure]
  1000   C0014792:Erythrocytes [Cell]

Phrase: "in circulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005775:Circulation [Physiologic Function]
  1000   C1516559:Circulation [Organism Function]
Processing 00000000.tx.223: Am J Haematol. 

Phrase: "Am"

Phrase: "J Haematol."
Processing 00000000.tx.224: 1976;1:419-432[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1976"

Phrase: ";1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "419-432"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.225: 12. 

Phrase: "12."
Processing 00000000.tx.226: Schauer R. 

Phrase: "Schauer R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.227: Chemistry, metabolism and biological functions of sialic acid. 

Phrase: "Chemistry,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007996:Chemistry [Occupation or Discipline]
  1000   C0079107:chemistry [Classification]
  1000   C0201682:Chemistry [Laboratory Procedure]

Phrase: "metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "biological functions of sialic acid."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   773   C0031845:Biological function, NOS [Physiologic Function]
   760   C0005532:Biological [Biomedical Occupation or Discipline]
   760   C0205460:biological [Qualitative Concept]
   760   C0542341:Functions [Functional Concept]
   726 E C0031843:function [Physiologic Function]
   726 E C0700205:FUNCTION [Classification]
   726 E C1705273:Function [Intellectual Product]
Processing 00000000.tx.228: Adv Carbohydr Chem Biochem. 

Phrase: "Adv Carbohydr Chem Biochem."
Processing 00000000.tx.229: 1982;40:131-143[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1982"

Phrase: ";40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ":"

Phrase: "131-143"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.230: 13. 

Phrase: "13."
Processing 00000000.tx.231: Jancik J, Schauer R. 

Phrase: "Jancik J,"

Phrase: "Schauer R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.232: Sialic acida determinant of the life-time of rabbit erythrocytes. 

Phrase: "Sialic acida determinant of the life-time of rabbit erythrocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1521761:Determinant [Functional Concept]
Processing 00000000.tx.233: Hoppe Seylers Z Physiol Chem. 

Phrase: "Hoppe Seylers Z Physiol Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.234: 1974;335:395-401. 

Phrase: "1974"

Phrase: ";335"

Phrase: ":"

Phrase: "395-401."
Processing 00000000.tx.235: 14. 

Phrase: "14."
Processing 00000000.tx.236: Gavella M, Lipovac V. 

Phrase: "Gavella M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lipovac V."
Processing 00000000.tx.237: Erythrocyte sialic acid alterations in experimental diabetes. 

Phrase: "Erythrocyte sialic acid alterations in experimental diabetes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1515926:Alteration [Idea or Concept]
Processing 00000000.tx.238: Cell Mol Biol. 

Phrase: "Cell Mol Biol."
Processing 00000000.tx.239: 1985;31:75-80[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1985"

Phrase: ";31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ":"

Phrase: "75-80"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.240: 15. 

Phrase: "15."
Processing 00000000.tx.241: Rellier N, Ruggiero-Lopez D, Lecomte M, Lagarde M, Wiernsperger N. 

Phrase: "Rellier N,"

Phrase: "Ruggiero-Lopez D,"

Phrase: "Lecomte M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lagarde M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Wiernsperger N."
Processing 00000000.tx.242: In vitro and in vivo alterations of enzymatic glycosylation in diabetes. 

Phrase: "In vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo alterations of enzymatic glycosylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1515926:Alteration [Idea or Concept]

Phrase: "in diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.243: Life Sci. 

Phrase: "Life Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.244: 1999;64:1571-1583[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1999"

Phrase: ";64"

Phrase: ":"

Phrase: "1571-1583"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.245: 16. 

Phrase: "16."
Processing 00000000.tx.246: Cardenas A, Schadeck C, Bernard A, Lauwerys R. 

Phrase: "Cardenas"

Phrase: "A,"

Phrase: "Schadeck C,"

Phrase: "Bernard A,"

Phrase: "Lauwerys R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.247: Depletion of sialic acid without changes in sialidase activity in glomeruli of uninephrectomized diabetic rats. 

Phrase: "Depletion of sialic acid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0333668:Depletion [Functional Concept]

Phrase: "without changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "in sialidase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150037:sialidase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "in glomeruli"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0022663:Glomerulus [Body Part, Organ, or Organ Component]
   916 E C0268731:GLOMERULAR [Disease or Syndrome]

Phrase: "of uninephrectomized diabetic rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C0241863:DIABETIC [Finding]
Processing 00000000.tx.248: Biochem Med Metabol Biol. 

Phrase: "Biochem Med Metabol Biol."
Processing 00000000.tx.249: 1991;46:416-421[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1991"

Phrase: ";46"

Phrase: ":"

Phrase: "416-421"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.250: 17. 

Phrase: "17."
Processing 00000000.tx.251: Shamansurova ZM, Ergashova MJ, Akbarov ZS. 

Phrase: "Shamansurova ZM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0043445:ZM [Geographic Area]
   861   C2346517:zm [Quantitative Concept]

Phrase: "Ergashova MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Akbarov ZS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043459:ZS [Congenital Abnormality,Disease or Syndrome]
Processing 00000000.tx.252: Erythrocyte sialidase activity increase in patients with diabetes mellitus. 

Phrase: "Erythrocyte sialidase activity increase in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "with diabetes mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]
Processing 00000000.tx.253: Diabetes Nutr Metab. 

Phrase: "Diabetes Nutr Metab."
Processing 00000000.tx.254: 1998;11:257-259. 

Phrase: "1998"

Phrase: ";11"

Phrase: ":"

Phrase: "257-259."
Processing 00000000.tx.255: 18. 

Phrase: "18."
Processing 00000000.tx.256: Chiarini A, Fiorilli A, Di Francesco L, Venerando B, Tettamanti G. 

Phrase: "Chiarini A,"

Phrase: "Fiorilli A,"

Phrase: "Di Francesco L,"

Phrase: "Venerando B,"

Phrase: "Tettamanti G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.257: Human erythrocye sialidase is linked to the plasma membrane by a glycosylphosphatidylinositol anchor and partly located on the outer surface. 

Phrase: "Human erythrocye sialidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0027803:Sialidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "linked to the plasma membrane"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0007603:Plasma membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0032105:Plasma [Body Substance]
   760   C0596901:Membrane [Cell Component]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1706182:Membrane [Manufactured Object]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]

Phrase: "by a glycosylphosphatidylinositol anchor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1293132:anchor [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "partly"

Phrase: "located on the outer surface."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205101:Outer [Spatial Concept]
   760   C0205148:Surface [Spatial Concept]
Processing 00000000.tx.258: Glycoconj J. 

Phrase: "Glycoconj J."
Processing 00000000.tx.259: 1993;10:64-71[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1993"

Phrase: ";10"

Phrase: ":"

Phrase: "64-71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450389:71 [Intellectual Product]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.260: 19. 

Phrase: "19."
Processing 00000000.tx.261: Venerando B, Fiorilli A, Croci GL, Tettamanti G. 

Phrase: "Venerando B,"

Phrase: "Fiorilli A,"

Phrase: "Croci GL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0018229:GL [Geographic Area]
   861   C1423073:GL [Gene or Genome]
   861   C1427674:GL [Gene or Genome]

Phrase: "Tettamanti G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.262: Presence in human erythrocyte membranes of a novel form of sialidase acting optimally at neutral pH. 

Phrase: "Presence in human erythrocyte membranes of a novel form of sialidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "acting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "optimally at neutral pH."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1882074:Neutral pH [Qualitative Concept]
           Neutral
   770   C0020283:[pH] [Quantitative Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
   770   C2825492:Neutral [Phenomenon or Process]
Processing 00000000.tx.263: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.264: 1997;90:2047-2056[Abstract/Free FullText]. 

Phrase: "1997"

Phrase: ";90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ":"

Phrase: "2047-2056"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.265: 20. 

Phrase: "20."
Processing 00000000.tx.266: Goi G, Bairati C, Segalini G, et al. 

Phrase: "Goi G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Bairati C,"

Phrase: "Segalini G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.267: Alterations in the activity of several glycohydrolases in red blood cell membrane from type 2diabetes mellitus patients. 

Phrase: "Alterations in the activity of several glycohydrolases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0184517:Activity alteration [Finding]
   714   C1515926:Alteration [Idea or Concept]

Phrase: "in red blood cell membrane"
Meta Candidates (Total=26; Excluded=9; Pruned=0; Remaining=17)
   923   C0014792:Red blood cell [Cell]
           Red Cell
   861   C0005773:Blood cell [Cell]
   861   C0007603:Cell Membrane [Cell Component]
   861   C3161472:Cell Membrane [Cell Component]
   833 E C2328697:Hemal cell [Cell]
   812   C0005767:Blood [Tissue]
   812   C0005768:blood [Body Substance]
   812   C0007634:Cell [Cell]
   812   C0025255:Membrane [Tissue]
   812   C0229664:Blood [Body Substance]
   812   C0332575:Red [Finding]
   812   C0596901:Membrane [Cell Component]
   812   C1260956:Red [Qualitative Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1706182:Membrane [Manufactured Object]
   812   C1948049:Cell [Spatial Concept]
   741 E C0205287:Membranous [Qualitative Concept]
   741 E C0333275:Bloody [Qualitative Concept]
   729 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C0392895:Bloods [Population Group]
   729 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   729 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C1558950:VASCULAR [Finding]
   712 E C1801960:Vascular [Qualitative Concept]

Phrase: "from type 2diabetes mellitus patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.268: Metabolism. 

Phrase: "Metabolism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.269: 1999;48:817-821[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1999"

Phrase: ";48"

Phrase: ":"

Phrase: "817-821"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.270: 21. 

Phrase: "21."
Processing 00000000.tx.271: Rabini RA, Fumelli P, Staffolani R, et al. 

Phrase: "Rabini RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Fumelli P,"

Phrase: "Staffolani R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "et al."
Processing 00000000.tx.272: Effects of diabetes mellitus on structural and functional properties of erythrocyte membranes. 

Phrase: "Effects of diabetes mellitus"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on structural"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structural [Spatial Concept]

Phrase: "and"

Phrase: "functional properties of erythrocyte membranes."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0871161:properties [Qualitative Concept]
   760   C1292721:properties [Functional Concept]
   726 E C1882134:Property [Conceptual Entity]
   726 E C2347695:Property [Entity]
Processing 00000000.tx.273: Membr Biochem. 

Phrase: "Membr Biochem."
Processing 00000000.tx.274: 1993;10:71-79[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1993"

Phrase: ";10"

Phrase: ":"

Phrase: "71-79"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450389:71 [Intellectual Product]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.275: 22. 

Phrase: "22."
Processing 00000000.tx.276: Watala C. 

Phrase: "Watala C."
Processing 00000000.tx.277: Hyperglycaemia alters the physico-chemical properties of proteins in erythrocyte membranes of diabetic patients. 

Phrase: "Hyperglycaemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the physico-chemical properties of proteins"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   809   C0243178:Property of Chemical [Natural Phenomenon or Process]
           chemical properties
   753   C0871161:properties [Qualitative Concept]
   753   C1292721:properties [Functional Concept]
   719 E C1882134:Property [Conceptual Entity]
   719 E C2347695:Property [Entity]

Phrase: "in erythrocyte membranes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0014780:Membranes, Erythrocyte [Cell Component]
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "of diabetic patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.278: Int J Biochem. 

Phrase: "Int J Biochem."
Processing 00000000.tx.279: 1992;24:1755-1761[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1992"

Phrase: ";24"

Phrase: ":"

Phrase: "1755-1761"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.280: 23. 

Phrase: "23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.281: Mazzanti L, Faloia E, Rabini RA, et al. 

Phrase: "Mazzanti L,"

Phrase: "Faloia E,"

Phrase: "Rabini RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "et al."
Processing 00000000.tx.282: Diabetes mellitus induces red blood cell plasma membrane alterations possibly affecting the aging process. 

Phrase: "Diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "red blood cell plasma membrane alterations possibly"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   845   C0544958:Plasma Membrane Alterations [Cell or Molecular Dysfunction]
           Cell membrane alteration
   841   C3536796:Cell Membrane Alteration [Cell or Molecular Dysfunction]
   811   C2267116:Vascular Alterations [Physiologic Function]
   801   C0541642:Membrane Alteration [Cell or Molecular Dysfunction]
   762   C1515926:Alteration [Idea or Concept]

Phrase: "affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the aging process."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1510835:Aging Process [Organism Function]
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.283: Clin Biochem. 

Phrase: "Clin Biochem."
Processing 00000000.tx.284: 1992;25:41-46[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1992"

Phrase: ";25"

Phrase: ":"

Phrase: "41-46"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.285: 24. 

Phrase: "24."
Processing 00000000.tx.286: Diabetes Mellitus. 

Phrase: "Diabetes Mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]
Processing 00000000.tx.287: Report of a WHO study group. 

Phrase: "Report of a"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0684224:Report [Intellectual Product]
   790   C0700287:Report [Health Care Activity]
   790   C3273238:Report [Intellectual Product]

Phrase: "WHO study group."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0441833:Group [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.288: World Health Organ Tech Rep Ser. 

Phrase: "World Health Organ Tech Rep Ser."
Processing 00000000.tx.289: 1985;727:1-113[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1985"

Phrase: ";727"

Phrase: ":"

Phrase: "1-113"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.290: 25. 

Phrase: "25."
Processing 00000000.tx.291: American Diabetes Association. 

Phrase: "American Diabetes Association."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1705019:American Diabetes Association [Professional Society]
   827   C0004083:Association [Mental Process]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0439849:Association [Qualitative Concept]
   827   C0596070:American [Population Group]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]
Processing 00000000.tx.292: Standards of medical care for patients with diabetes mellitus. 

Phrase: "Standards of medical care"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   881   C2936643:Standards of Care [Therapeutic or Preventive Procedure]
           Care Standards
   770   C0038137:standards [Intellectual Product]
   770   C0175675:Standards [Qualitative Concept]
   737 E C1442989:Standard [Qualitative Concept]
   737 E C2828392:Standard [Intellectual Product]

Phrase: "for patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with diabetes mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]
Processing 00000000.tx.293: Diabetes Care. 

Phrase: "Diabetes Care."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1947933:Care [Activity]
Processing 00000000.tx.294: 1995;18(suppl 1):8-15. 

Phrase: "1995"

Phrase: ";18"

Phrase: "(suppl 1"

Phrase: ")"

Phrase: ":"

Phrase: "8-15."
Processing 00000000.tx.295: 26. 

Phrase: "26."
Processing 00000000.tx.296: Beutler E, Blume KG, Kaplan JC, Lohr GW, Ramot B, Valentine WN. 

Phrase: "Beutler E,"

Phrase: "Blume KG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022718:KG [Geographic Area]
   861   C0439209:kg [Quantitative Concept]

Phrase: "Kaplan JC,"

Phrase: "Lohr GW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018387:GW [Geographic Area]

Phrase: "Ramot B,"

Phrase: "Valentine WN."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520114:WN [Mammal]
Processing 00000000.tx.297: International Committee for Standardization in Haematology: recommended methods for red-cell enzyme analysis. 

Phrase: "International Committee for Standardization in Haematology"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   799   C0018943:Haematology NOS [Biomedical Occupation or Discipline]
   799   C0038136:Standardization [Research Activity]
   799   C0200627:HEMATOLOGY [Laboratory Procedure]
   799   C1512888:International [Idea or Concept]
   799   C2699414:Committee [Group]
   727 E C0205488:Haematologic [Functional Concept]

Phrase: ":"

Phrase: "recommended methods for red-cell enzyme analysis."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   757   C0450074:Enzyme method [Intellectual Product]
   757   C2707190:Analysis method [Laboratory Procedure]
   748   C0025663:Methods [Intellectual Product]
   748   C0025664:methods [Intellectual Product]
   748   C0449851:Methods [Functional Concept]
   714 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.298: Br J Haematol. 

Phrase: "Br J Haematol."
Processing 00000000.tx.299: 1977;35:331-341[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1977"

Phrase: ";35"

Phrase: ":"

Phrase: "331-341"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.300: 27. 

Phrase: "27."
Processing 00000000.tx.301: Salvo G, Caprari P, Samoggia P, Mariani G, Salvati AM. 

Phrase: "Salvo G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Caprari P,"

Phrase: "Samoggia P,"

Phrase: "Mariani G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Salvati"

Phrase: "AM."
Processing 00000000.tx.302: Human erytrocyte separation according to age on a discontinuous "Percoll" density gradient. 

Phrase: "Human erytrocyte separation according to age"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0036679:Separation [Pathologic Function]
   753   C0237868:Separation [Social Behavior]
   753   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "on a discontinuous ""Percoll"" density gradient."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0178587:density [Quantitative Concept]
   812   C0439182:% gradient [Quantitative Concept]
   812   C0812409:Gradient [Quantitative Concept]
   741 E C0439794:Dense [Qualitative Concept]
Processing 00000000.tx.303: Clin Chim Acta. 

Phrase: "Clin Chim Acta."
Processing 00000000.tx.304: 1982;122:293-300[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1982"

Phrase: ";122"

Phrase: ":"

Phrase: "293-300"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.305: 28. 

Phrase: "28."
Processing 00000000.tx.306: Mosca A, Paleari, Modenese A, Rossini S, Parma R, Galanello R. 

Phrase: "Mosca A,"

Phrase: "Paleari,"

Phrase: "Modenese"

Phrase: "A,"

Phrase: "Rossini S,"

Phrase: "Parma R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Galanello R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.307: Clinical utility of fractionating erythrocytes into "Percoll" density gradients. 

Phrase: "Clinical utility of fractionating erythrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0582205:utility [Organization]

Phrase: "into ""Percoll"" density gradients."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0178587:density [Quantitative Concept]
   827   C0812409:gradients [Quantitative Concept]
   793 E C0439182:% gradient [Quantitative Concept]
   755 E C0439794:Dense [Qualitative Concept]
Processing 00000000.tx.308: In: Magnani M,De Flora A, eds. 

Phrase: "In"

Phrase: ":"

Phrase: "Magnani"

Phrase: "M,"

Phrase: "De Flora A,"

Phrase: "eds."
Processing 00000000.tx.309: Red Blood Cell Aging. 

Phrase: "Red Blood Cell Aging."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007581:Cell Aging [Cell Function]
   812   C0001811:Ageing [Organism Function]
   756   C0014792:Red blood cell [Cell]
           Red Cell
Processing 00000000.tx.310: New York, NY: Plenum; 

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ":"

Phrase: "Plenum"

Phrase: ";"
Processing 00000000.tx.311: 1991:227-232. 

Phrase: "1991"

Phrase: ":"

Phrase: "227-232."
Processing 00000000.tx.312: 29. 

Phrase: "29."
Processing 00000000.tx.313: Sorette MP, Shiffer K, Clark MR. 

Phrase: "Sorette MP,"

Phrase: "Shiffer K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Clark MR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]
Processing 00000000.tx.314: Improved isolation of normal hyman reticulocytes via exploitation of chloride-dependent potassium transport. 

Phrase: "Improved isolation of normal hyman reticulocytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0204727:Isolation [Therapeutic or Preventive Procedure]
   753   C0205409:Isolation [Functional Concept]
   753   C0220862:isolation [Laboratory Procedure]

Phrase: "via exploitation"

Phrase: "of chloride-dependent potassium transport."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   902   C1159591:chloride transport [Cell Function]
   861   C1159689:potassium transport [Cell Function]
   812   C0005528:Transport, NOS [Cell Function]
   812   C1317949:Transport [Manufactured Object]
   812   C3495449:transport [Medical Device]
   708   C0032825:chloride potassium [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.315: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.316: 1992;80:249-254[Abstract]. 

Phrase: "1992"

Phrase: ";80"

Phrase: ":"

Phrase: "249-254"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.317: 30. 

Phrase: "30."
Processing 00000000.tx.318: Griffiths WJ. 

Phrase: "Griffiths WJ."
Processing 00000000.tx.319: The determination of creatine in body fluids and muscle. 

Phrase: "The determination of creatine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1148554:determination [Laboratory Procedure]

Phrase: "in body fluids"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
  1000   C0005889:Body Fluids [Body Substance]
           Fluids
   861   C0242821:body [Human]
   861   C0302908:fluids [Substance]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1521806:Fluids [Tissue]
   827 E C0444611:Fluid [Qualitative Concept]
   827 E C1704353:Fluid [Substance]
   777 E C1995017:Bodies [Cell Component]

Phrase: "and"

Phrase: "muscle."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.320: Clin Chim Acta. 

Phrase: "Clin Chim Acta."
Processing 00000000.tx.321: 1964;9:210-221. 

Phrase: "1964"

Phrase: ";9"

Phrase: ":"

Phrase: "210-221."
Processing 00000000.tx.322: 31. 

Phrase: "31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.323: Brecher G. 

Phrase: "Brecher G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.324: New Methylene Blue as a reticulocyte stain. 

Phrase: "New Methylene Blue as a reticulocyte stain."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C0068662:new methylene blue [Organic Chemical,Pharmacologic Substance]
   804   C0025746:Methylene blue stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
           Methylene blue
   748   C0054666:methylene [Organic Chemical,Pharmacologic Substance]
   748   C1260957:Blue [Qualitative Concept]
Processing 00000000.tx.325: Am J Clin Pathol. 

Phrase: "Am"

Phrase: "J Clin Pathol."
Processing 00000000.tx.326: 1949;19:895. 

Phrase: "1949"

Phrase: ";19"

Phrase: ":"

Phrase: "895."
Processing 00000000.tx.327: 32. 

Phrase: "32."
Processing 00000000.tx.328: Steck TL, Kant JA. 

Phrase: "Steck TL,"

Phrase: "Kant JA."
Processing 00000000.tx.329: Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes. 

Phrase: "Preparation of impermeable ghosts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0455052:Preparation [Health Care Activity]
   770   C1521827:Preparation [Functional Concept]

Phrase: "and"

Phrase: "inside-out vesicles from human erythrocyte membranes."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0333262:VESICLES [Acquired Abnormality]
   741   C1167317:vesicle membrane [Cell Component]
   714 E C1622418:vesicle [Cell Component]
Processing 00000000.tx.330: Methods Enzymol. 

Phrase: "Methods Enzymol."
Processing 00000000.tx.331: 1974;31:172-184[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1974"

Phrase: ";31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ":"

Phrase: "172-184"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.332: 33. 

Phrase: "33."
Processing 00000000.tx.333: Ellman GL, Courtney DK, Andreas V, Featherstone RM. 

Phrase: "Ellman GL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0018229:GL [Geographic Area]
   861   C1423073:GL [Gene or Genome]
   861   C1427674:GL [Gene or Genome]

Phrase: "Courtney DK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011318:DK [Geographic Area]

Phrase: "Andreas V,"

Phrase: "Featherstone RM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]
Processing 00000000.tx.334: A new and rapid colorimetric determination of acetyl cholinesterase activity. 

Phrase: "A new"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205314:New [Temporal Concept]

Phrase: "and"

Phrase: "rapid colorimetric determination of acetyl cholinesterase activity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1148554:determination [Laboratory Procedure]
Processing 00000000.tx.335: Biochem Pharmacol. 

Phrase: "Biochem Pharmacol."
Processing 00000000.tx.336: 1961;234:466-472. 

Phrase: "1961"

Phrase: ";234"

Phrase: ":"

Phrase: "466-472."
Processing 00000000.tx.337: 34. 

Phrase: "34."
Processing 00000000.tx.338: Caimi L, Lombardo A, Preti A, Weissmann U, Tettamanti G. 

Phrase: "Caimi L,"

Phrase: "Lombardo A,"

Phrase: "Preti A,"

Phrase: "Weissmann U,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0439148:Units [Quantitative Concept]
   861   C1519795:Units [Quantitative Concept]
   827 E C1704753:Unit [Manufactured Object]
   827 E C1880519:Unit [Quantitative Concept]

Phrase: "Tettamanti G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.339: Optimal conditions for a assay of fibroblast neuraminidase with different natural substrates. 

Phrase: "Optimal conditions for a assay of fibroblast neuraminidase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C0012634:condition [Disease or Syndrome]
   711   C0348080:Condition [Qualitative Concept]
   711   C1705253:Condition [Conceptual Entity]

Phrase: "with different natural substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.340: Biochim Biophys Acta. 

Phrase: "Biochim Biophys Acta."
Processing 00000000.tx.341: 1979;571:137-142[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1979"

Phrase: ";571"

Phrase: ":"

Phrase: "137-142"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.342: 35. 

Phrase: "35."
Processing 00000000.tx.343: Tettamanti G, Bonali F, Marchesini S, Zambotti V. 

Phrase: "Tettamanti G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Bonali F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Marchesini S,"

Phrase: "Zambotti V."
Processing 00000000.tx.344: A new procedure for the extraction, purification and fractionation of brain gangliodises. 

Phrase: "A new procedure for the extraction,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0185115:extraction procedure [Therapeutic or Preventive Procedure]
   753   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   753   C1948041:Procedure [Therapeutic or Preventive Procedure]
   753   C2700391:Procedure [Activity]
   753   C3274430:PROCEDURE [Health Care Activity]
   753   C3538935:Procedure [Idea or Concept]
   753   C3539779:Procedure [Intellectual Product]

Phrase: "purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "and"

Phrase: "fractionation of brain gangliodises."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0016640:fractionation [Laboratory Procedure]
   770   C0524811:fractionation [Therapeutic or Preventive Procedure]
   770   C3161031:Fractionation [Therapeutic or Preventive Procedure]
Processing 00000000.tx.345: Biochim Biophys Acta. 

Phrase: "Biochim Biophys Acta."
Processing 00000000.tx.346: 1973;296:160-170[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1973"

Phrase: ";296"

Phrase: ":"

Phrase: "160-170"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.347: 36. 

Phrase: "36."
Processing 00000000.tx.348: Svennerholm L. 

Phrase: "Svennerholm L."
Processing 00000000.tx.349: Quantitative estimation of sialic acid. 

Phrase: "Quantitative estimation of sialic acid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0680844:estimation [Mental Process]
   760   C0681916:Estimation [Quantitative Concept]
   760   C0750572:Estimation [Quantitative Concept]
Processing 00000000.tx.350: IIa colorimetric resorcinol-hydrochloric acid method. 

Phrase: "IIa colorimetric resorcinol-hydrochloric acid method."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0025663:Method [Intellectual Product]
   799   C0449851:Method [Functional Concept]
   799   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.351: Biochim Biophys Acta. 

Phrase: "Biochim Biophys Acta."
Processing 00000000.tx.352: 1957;24:604-610[CrossRef]. 

Phrase: "1957"

Phrase: ";24"

Phrase: ":"

Phrase: "604-610"

Phrase: "[CrossRef"

Phrase: "]."
Processing 00000000.tx.353: 37. 

Phrase: "37."
Processing 00000000.tx.354: Marchesini S, Venerando B, Fiorilli A, Preti A. 

Phrase: "Marchesini S,"

Phrase: "Venerando B,"

Phrase: "Fiorilli A,"

Phrase: "Preti A."
Processing 00000000.tx.355: Use of 2-(4 methyl-umbelliferyl) -D-N-acetylneuraminic acid for the determination of the sialidase activity in different tissues. 

Phrase: "Use of 2-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   882   C1524063:Use of [Functional Concept]
   790   C0042153:use [Functional Concept]
   790   C0457083:Use [Functional Concept]
   790   C1947944:Use [Intellectual Product]

Phrase: "(4 methyl-umbelliferyl"

Phrase: ")"

Phrase: "-"

Phrase: "D-"

Phrase: "N-acetylneuraminic acid for the determination of the sialidase activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   782   C0067762:N-Acetylneuraminic Acid [Biologically Active Substance,Carbohydrate]
   739   C0001128:Acid [Chemical]
   739   C0202406:Acid [Laboratory Procedure]
   739   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0441922:N+ [Intellectual Product]
   739   C1553036:[n] [Quantitative Concept]

Phrase: "in different tissues."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.356: Perspect Inherited Metab Dis. 

Phrase: "Perspect Inherited Metab Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0451119:DIS [Intellectual Product]
   812   C1444662:DIS [Finding]
Processing 00000000.tx.357: 1981;4:191-203. 

Phrase: "1981"

Phrase: ";4"

Phrase: ":"

Phrase: "191-203."
Processing 00000000.tx.358: 38. 

Phrase: "38."
Processing 00000000.tx.359: Lowry OM, Rosebrough NJ, Farr AL, Randall RJ. 

Phrase: "Lowry OM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0028971:OM [Geographic Area]
   861   C1705272:OM [Idea or Concept]

Phrase: "Rosebrough NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Farr AL,"

Phrase: "Randall RJ."
Processing 00000000.tx.360: Protein measurement with Folin-phenol reagent. 

Phrase: "Protein measurement with Folin-phenol reagent."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0202202:Protein measurement [Laboratory Procedure]
   783   C0202446:Phenol measurement [Laboratory Procedure]
   753   C0242485:Measurement [Functional Concept]
Processing 00000000.tx.361: J Biol Chem. 

Phrase: "J Biol Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.362: 1951;193:265-275[Free FullText]. 

Phrase: "1951"

Phrase: ";193"

Phrase: ":"

Phrase: "265-275"

Phrase: "[Free FullText"

Phrase: "]."
Processing 00000000.tx.363: 39. 

Phrase: "39."
Processing 00000000.tx.364: Bradford MM. 

Phrase: "Bradford MM."
Processing 00000000.tx.365: A rapid and sensitive method for the quantitation of migrogram quantities of protein utilizing the principle of protein-dye binding. 

Phrase: "A rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "and"

Phrase: "sensitive method for the quantitation of migrogram quantities of protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   741   C1547724:Quantity method [Idea or Concept]
   739   C0025663:Method [Intellectual Product]
   739   C0449851:Method [Functional Concept]
   739   C0871511:METHOD [Intellectual Product]

Phrase: "utilizing"

Phrase: "the principle of protein-dye binding."
Processing 00000000.tx.366: Ann Biochem. 

Phrase: "Ann Biochem."
Processing 00000000.tx.367: 1976;72:248-251[CrossRef]. 

Phrase: "1976"

Phrase: ";72"

Phrase: ":"

Phrase: "248-251"

Phrase: "[CrossRef"

Phrase: "]."
Processing 00000000.tx.368: 40. 

Phrase: "40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.369: Ladisch S, Gillard B. 

Phrase: "Ladisch S,"

Phrase: "Gillard B."
Processing 00000000.tx.370: Isolation and purification of phospholipids and gangliosides from plasma. 

Phrase: "Isolation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0204727:Isolation [Therapeutic or Preventive Procedure]
  1000   C0205409:Isolation [Functional Concept]
  1000   C0220862:isolation [Laboratory Procedure]
   928 E C1548221:Isolated [Idea or Concept]

Phrase: "and"

Phrase: "purification of phospholipids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0243114:purification [Functional Concept]
   790   C1998793:Purification [Functional Concept]

Phrase: "and"

Phrase: "gangliosides from plasma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017082:Gangliosides [Lipid,Pharmacologic Substance]
Processing 00000000.tx.371: Methods Enzymol. 

Phrase: "Methods Enzymol."
Processing 00000000.tx.372: 1987;138:300-310[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1987"

Phrase: ";138"

Phrase: ":"

Phrase: "300-310"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.373: 41. 

Phrase: "41."
Processing 00000000.tx.374: Barlett GR. 

Phrase: "Barlett GR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552950:[gr] [Quantitative Concept]
Processing 00000000.tx.375: Phosphorus assay in column chromatography. 

Phrase: "Phosphorus assay in column chromatography."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   840   C0684296:Column Chromatography [Laboratory Procedure]
   804   C0008550:Chromatography [Laboratory Procedure]
   704 E C0302647:chromatograph [Medical Device]
Processing 00000000.tx.376: J Biol Chem. 

Phrase: "J Biol Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.377: 1959;234:466-471[Free FullText]. 

Phrase: "1959"

Phrase: ";234"

Phrase: ":"

Phrase: "466-471"

Phrase: "[Free FullText"

Phrase: "]."
Processing 00000000.tx.378: 42. 

Phrase: "42."
Processing 00000000.tx.379: Norusis MJ. 

Phrase: "Norusis MJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]
Processing 00000000.tx.380: SPSS/PCV3.0 in "Base Manual," ed. 

Phrase: "SPSS/PCV3.0 in ""Base Manual,"" ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C3538926:ED [Idea or Concept]
Processing 00000000.tx.381: Chicago, IL: SPSS Inc.; 

Phrase: "Chicago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008044:Chicago [Geographic Area]

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ":"

Phrase: "SPSS Inc."

Phrase: ";"
Processing 00000000.tx.382: 1986. 

Phrase: "1986."
Processing 00000000.tx.383: 43. 

Phrase: "43."
Processing 00000000.tx.384: Rennie CM, Thompson S, Parker AC, Maddy A. 

Phrase: "Rennie CM,"

Phrase: "Thompson S,"

Phrase: "Parker AC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: "Maddy A."
Processing 00000000.tx.385: Human erythrocyte fractionation in "Percoll" density gradients. 

Phrase: "Human erythrocyte fractionation in ""Percoll"" density gradients."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   795   C0178587:density [Quantitative Concept]
   795   C0812409:gradients [Quantitative Concept]
   762 E C0439182:% gradient [Quantitative Concept]
   724 E C0439794:Dense [Qualitative Concept]
Processing 00000000.tx.386: Clin Chim Acta. 

Phrase: "Clin Chim Acta."
Processing 00000000.tx.387: 1979;98:119-125[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1979"

Phrase: ";98"

Phrase: ":"

Phrase: "119-125"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.388: 44. 

Phrase: "44."
Processing 00000000.tx.389: Watala C, Jozwiak Z. 

Phrase: "Watala C,"

Phrase: "Jozwiak Z."
Processing 00000000.tx.390: The phospholipid composition of erythrocyte ghosts and plasma lipoproteins in diabetes type 1in children. 

Phrase: "The phospholipid composition of erythrocyte ghosts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0486616:Composition [Clinical Attribute]
   753   C1555710:composition [Idea or Concept]

Phrase: "and"

Phrase: "plasma lipoproteins in diabetes type 1in children."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0023820:Lipoproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.391: Clin Chim Acta. 

Phrase: "Clin Chim Acta."
Processing 00000000.tx.392: 1990;188:211-219[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1990"

Phrase: ";188"

Phrase: ":"

Phrase: "211-219"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.393: 45. 

Phrase: "45."
Processing 00000000.tx.394: Mazzanti L, Rabini RA, Staffolani R, et al. 

Phrase: "Mazzanti L,"

Phrase: "Rabini RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Staffolani R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "et al."
Processing 00000000.tx.395: Diabetes mellitus and red blood cell aging: a structural and functional study. 

Phrase: "Diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "red blood cell aging"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007581:Cell Aging [Cell Function]
   812   C0001811:Ageing [Organism Function]
   756   C0014792:Red blood cell [Cell]
           Red Cell

Phrase: ":"

Phrase: "a structural"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structural [Spatial Concept]

Phrase: "and"

Phrase: "functional study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.396: In: Magnani M,De Flora A, eds. 

Phrase: "In"

Phrase: ":"

Phrase: "Magnani"

Phrase: "M,"

Phrase: "De Flora A,"

Phrase: "eds."
Processing 00000000.tx.397: Red Blood Cell Aging. 

Phrase: "Red Blood Cell Aging."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007581:Cell Aging [Cell Function]
   812   C0001811:Ageing [Organism Function]
   756   C0014792:Red blood cell [Cell]
           Red Cell
Processing 00000000.tx.398: New York, NY: Plenum; 

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ":"

Phrase: "Plenum"

Phrase: ";"
Processing 00000000.tx.399: 1991:85-89. 

Phrase: "1991"

Phrase: ":"

Phrase: "85-89."
Processing 00000000.tx.400: 46. 

Phrase: "46."
Processing 00000000.tx.401: Tomino Y, Inoue W, Watanabe S, et al. 

Phrase: "Tomino Y,"

Phrase: "Inoue W,"

Phrase: "Watanabe S,"

Phrase: "et al."
Processing 00000000.tx.402: Detection of glomerular sialic acids in patients with diabetic nephropathy. 

Phrase: "Detection of glomerular sialic acids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with diabetic nephropathy."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0011881:Diabetic Nephropathy [Disease or Syndrome]
  1000   C1442864:diabetic nephropathy [Gene or Genome]
   861   C0022658:Nephropathy [Disease or Syndrome]
   861   C0241863:DIABETIC [Finding]
Processing 00000000.tx.403: Am J Nephrol. 

Phrase: "Am"

Phrase: "J Nephrol."
Processing 00000000.tx.404: 1988;8:21-26[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1988"

Phrase: ";8"

Phrase: ":"

Phrase: "21-26"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.405: 47. 

Phrase: "47."
Processing 00000000.tx.406: Sills RH, Tamburlin JH, Barrios NJ, Yeagle PL, Glomski CA. 

Phrase: "Sills RH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: "Tamburlin JH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: "Barrios NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Yeagle PL,"

Phrase: "Glomski CA."
Processing 00000000.tx.407: Physiologic formation of intracellular vesicles in mature erythrocytes. 

Phrase: "Physiologic formation of intracellular vesicles"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C1749557:vesicle formation [Cell Function]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "in mature erythrocytes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C1254573:Mature erythrocyte [Cell]
   861   C0014772:Erythrocytes [Laboratory Procedure]
   861   C0014792:Erythrocytes [Cell]
Processing 00000000.tx.408: Am J Hematol. 

Phrase: "Am"

Phrase: "J Hematol."
Processing 00000000.tx.409: 1988;28:219-226[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1988"

Phrase: ";28"

Phrase: ":"

Phrase: "219-226"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.410: 48. 

Phrase: "48."
Processing 00000000.tx.411: Wagner SM, Chiu DTY, Yee MC, Lubin BH. 

Phrase: "Wagner SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Chiu DTY,"

Phrase: "Yee MC,"

Phrase: "Lubin BH."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004684:BH [Geographic Area]
   861   C1412800:BH [Gene or Genome]
   861   C2986890:BH [Idea or Concept]
Processing 00000000.tx.412: Red cell vesiculationa common membrane physiologic event. 

Phrase: "Red cell vesiculationa common membrane physiologic event."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0441471:Event [Event]
Processing 00000000.tx.413: J Lab Clin Med. 

Phrase: "J Lab Clin Med."
Processing 00000000.tx.414: 1986;108:315-324[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1986"

Phrase: ";108"

Phrase: ":"

Phrase: "315-324"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.415: 49. 

Phrase: "49."
Processing 00000000.tx.416: Jain SK, Mohandas N, Clark MR, Shohet SB. 

Phrase: "Jain SK,"

Phrase: "Mohandas N,"

Phrase: "Clark MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Shohet SB."
Processing 00000000.tx.417: The effect of malonyldialdheide, a product of lipid peroxidatiuon of the deformability, dehydration and 51Cr-survival of erythrocyte. 

Phrase: "The effect of malonyldialdheide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "a product of lipid peroxidatiuon of the deformability,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1514468:product [Entity]
   744   C1704444:Product [Quantitative Concept]

Phrase: "dehydration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011175:Dehydration [Disease or Syndrome]

Phrase: "and"

Phrase: "51Cr-survival of erythrocyte."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0086251:Erythrocyte Survival [Quantitative Concept]
   770   C0038952:Survival [Activity]
   770   C0220921:survival [Functional Concept]
Processing 00000000.tx.418: Br J Haematol. 

Phrase: "Br J Haematol."
Processing 00000000.tx.419: 1983;53:247-255[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1983"

Phrase: ";53"

Phrase: ":"

Phrase: "247-255"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.420: 50. 

Phrase: "50."
Processing 00000000.tx.421: Baldini P, Incerpi S, Lambert-Gardini S, Spinedi A, Luly P. 

Phrase: "Baldini P,"

Phrase: "Incerpi S,"

Phrase: "Lambert-Gardini S,"

Phrase: "Spinedi A,"

Phrase: "Luly P."
Processing 00000000.tx.422: Membrane lipid alteration and Na+ pumping activity in erythrocytes from IDDM and NIDDM subjects. 

Phrase: "Membrane lipid alteration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0541642:Membrane Alteration [Cell or Molecular Dysfunction]
   827   C1515926:Alteration [Idea or Concept]
   734   C0025249:Membrane lipid [Cell Component,Lipid]

Phrase: "and"

Phrase: "Na+ pumping activity in erythrocytes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1153663:pump activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "from IDDM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011854:IDDM [Disease or Syndrome]

Phrase: "and"

Phrase: "NIDDM subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.423: Diabetes. 

Phrase: "Diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.424: 1989;38:825-831[Abstract]. 

Phrase: "1989"

Phrase: ";38"

Phrase: ":"

Phrase: "825-831"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.425: 51. 

Phrase: "51."
Processing 00000000.tx.426: Schaefer W, Priessen J, Mannhold R, Gries AF. 

Phrase: "Schaefer W,"

Phrase: "Priessen J,"

Phrase: "Mannhold R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Gries AF."
Processing 00000000.tx.427: Ca2+-Mg2+-ATPase activity of human red blood cells in healthy and diabetic volunteers. 

Phrase: "Ca2+-Mg2+-ATPase activity of human red blood cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1148651:Mg2+-ATPase activity [Molecular Function]
   764   C1148926:ATPase activity [Molecular Function]
   762   C0020115:Human Activity [Activity]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "in healthy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C0018684:Health [Idea or Concept]
   928   C0031206:healthiness [Finding]

Phrase: "and"

Phrase: "diabetic volunteers."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0042960:Volunteers [Professional or Occupational Group]
   827 E C1549078:Volunteer [Idea or Concept]
   827 E C1997894:volunteer [Population Group]
Processing 00000000.tx.428: Klin Wochenschr. 

Phrase: "Klin Wochenschr."
Processing 00000000.tx.429: 1987;65:17-21[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1987"

Phrase: ";65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ":"

Phrase: "17-21"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.430: 52. 

Phrase: "52."
Processing 00000000.tx.431: Testa I, Rabini RA, Fumelli P, Bertoli E, Mazzanti L. 

Phrase: "Testa I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Rabini RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Fumelli P,"

Phrase: "Bertoli E,"

Phrase: "Mazzanti L."
Processing 00000000.tx.432: Abnormal membrane fluidity and acetylcholinesterase activity in erythrocytes from insulin dependent diabetic patients. 

Phrase: "Abnormal membrane fluidity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   901   C0025245:Membrane Fluidity [Molecular Function]
   827   C0596579:fluidity [Quantitative Concept]
   755 E C0005889:FLUID [Body Substance]
   755 E C0302908:fluid [Substance]
   755 E C0444611:Fluid [Qualitative Concept]
   755 E C1704353:Fluid [Substance]

Phrase: "and"

Phrase: "acetylcholinesterase activity in erythrocytes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1149827:acetylcholinesterase activity [Molecular Function]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "from insulin dependent diabetic patients."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0581116:dependent patients [Functional Concept]
   812   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.433: J Clin Endocrinol Metab. 

Phrase: "J Clin Endocrinol Metab."
Processing 00000000.tx.434: 1988;67:1129-1132[Abstract]. 

Phrase: "1988"

Phrase: ";67"

Phrase: ":"

Phrase: "1129-1132"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.435: 53. 

Phrase: "53."
Processing 00000000.tx.436: Tringali C, Fiorilli A, Venerando B, Tettamanti G.

Phrase: "Tringali C,"

Phrase: "Fiorilli A,"

Phrase: "Venerando B,"

Phrase: "Tettamanti G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.437: Differential behavior of ghost-linked acidic and neutral sialidases upon human erythrocyte aging in vivo and vesiculation in vitro. 

Phrase: "Differential behavior of ghost-linked acidic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0004927:Behavior [Individual Behavior]
   753   C2707008:Behavior [Clinical Attribute]

Phrase: "and"

Phrase: "neutral sialidases upon human erythrocyte"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0027803:Sialidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "vesiculation"

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.438: Glycoconj J.In press. 

Phrase: "Glycoconj J.In press."
Processing 00000000.tx.439: 54. 

Phrase: "54."
Processing 00000000.tx.440: Kirschenbaum DM. 

Phrase: "Kirschenbaum DM."
Processing 00000000.tx.441: Glycosylation of proteins: its implications in diabetic control and complications. 

Phrase: "Glycosylation of proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0376322:glycosylation proteins [Molecular Function]
           Glycosylation
   790   C0017982:glycosylation [Natural Phenomenon or Process]

Phrase: ":"

Phrase: "its implications in diabetic control"

Phrase: "and"

Phrase: "complications."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0009566:Complications [Pathologic Function]
  1000   C1171258:complications [Pathologic Function]
   966 E C2362589:Complication [Idea or Concept]
   916 E C0231242:Complicated [Functional Concept]
Processing 00000000.tx.442: Pediatr Clin North Am. 

Phrase: "Pediatr Clin North"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709269:North [Spatial Concept]

Phrase: "Am."
Processing 00000000.tx.443: 1984;31:611-614[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1984"

Phrase: ";31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ":"

Phrase: "611-614"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.444: 55. 

Phrase: "55."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]
Processing 00000000.tx.445: Traving C, Schauer R. 

Phrase: "Traving C,"

Phrase: "Schauer R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.446: Structure, function and metabolism of sialic acids. 

Phrase: "Structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "metabolism of sialic acids."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   865   C1156890:sialic acid metabolism [Molecular Function]
   770   C0025519:Metabolism [Organism Function]
   770   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.447: Cell Mol Life Sci. 

Phrase: "Cell Mol Life Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.448: 1998;54:1330-1349[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1998"

Phrase: ";54"

Phrase: ":"

Phrase: "1330-1349"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.449: 56. 

Phrase: "56."
Processing 00000000.tx.450: Mazzanti L, Rabini RA, Salvolini E, et al. 

Phrase: "Mazzanti L,"

Phrase: "Rabini RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Salvolini E,"

Phrase: "et al."
Processing 00000000.tx.451: Sialic acid, diabetes and aging: a study on the erythrocyte membrane. 

Phrase: "Sialic acid,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0067762:Sialic Acid [Biologically Active Substance,Carbohydrate]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]
   805   C0036087:Salivas [Body Substance]
   805   C1546769:Saliva [Intellectual Product]
   805   C1608524:Saliva [Body Substance]

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: ":"

Phrase: "a study on the erythrocyte membrane."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]
Processing 00000000.tx.452: Metabolism. 

Phrase: "Metabolism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.453: 1977;46:59-61.  

Phrase: "1977"

Phrase: ";46"

Phrase: ":"

Phrase: "59-61."
Processing 00000000.tx.454: 2002 by The American Society of Hematology.  

Phrase: "2002 by The American Society of Hematology."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C1515949:American Society of Hematology [Professional Society]
   748   C0018943:Haematology NOS [Biomedical Occupation or Discipline]
   748   C0037455:society [Organization]
   748   C0200627:HEMATOLOGY [Laboratory Procedure]
   748   C0596070:American [Population Group]
Processing 00000000.tx.455: Related Letter in Blood Online: Acidic and neutral sialidase in the erythrocytes of patients with Type 2 diabetes: influence on erythrocyte lifespan Thibault Richard, Karim Zouaoui Boudjeltia, Michal Piagnerelli, and Michel Vanhaeverbeek Blood 2002 100: 1511. 

Phrase: "Related Letter in Blood"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1096774:Letter [Intellectual Product]
   770   C2360551:Letter [Clinical Attribute]
   715 E C0079691:Levothyroxine Sodium [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "Online"

Phrase: ":"

Phrase: "Acidic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001128:Acidic [Chemical]
   928 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "neutral sialidase in the erythrocytes of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0027803:Sialidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "with Type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: ":"

Phrase: "influence on erythrocyte lifespan Thibault Richard,"

Phrase: "Karim Zouaoui Boudjeltia,"

Phrase: "Michal Piagnerelli,"

Phrase: "and"

Phrase: "Michel Vanhaeverbeek Blood 2002 100"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   804   C0005767:Blood [Tissue]
   804   C0005768:blood [Body Substance]
   804   C0229664:Blood [Body Substance]
   733 E C0333275:Bloody [Qualitative Concept]
   721 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   721 E C0392895:Bloods [Population Group]
   721 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   721 E C1511228:VESSEL, BLOOD [Tissue]
   704 E C1558950:VASCULAR [Finding]
   704 E C1801960:Vascular [Qualitative Concept]

Phrase: ":"

Phrase: "1511."
Processing 00000000.tx.456: [Full Text]

Phrase: "[Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1527021:Text [Intellectual Product]
   861   C1554111:Text [Idea or Concept]
   861   C1705606:Text [Intellectual Product]
   861   C3541382:Text [Intellectual Product]

Phrase: "]"

